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Györgyi Horváth, Viktória Lilla Balázs and Judit Krisch
Anti-Biofilm Effect of Selected Essential Oils and Main Components on Mono- and
Polymicrobic Bacterial Cultures
Reprinted from: Microorganisms 2019, 7, 345, doi:10.3390/microorganisms7090345 . . . . . . . . . 27
Barbara Speranza, Arcangelo Liso, Vincenzo Russo and Maria Rosaria Corbo
Evaluation of the Potential of Biofilm Formation of Bifidobacterium longum subsp. infantis and
Lactobacillus reuteri as Competitive Biocontrol Agents Against Pathogenic and Food Spoilage
Bacteria
Reprinted from: Microorganisms 2020, 8, 177, doi:10.3390/microorganisms8020177 . . . . . . . . . 41
Hadar Kimelman and Moshe Shemesh
Probiotic Bifunctionality of Bacillus subtilis—Rescuing Lactic Acid Bacteria from Desiccation and
Antagonizing Pathogenic Staphylococcus aureus
Reprinted from: Microorganisms 2019, 7, 407, doi:10.3390/microorganisms7100407 . . . . . . . . . 55
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In recent years, increased resistance to antibiotics and disinfectants from foodborne bacterial
pathogens has become a relevant consumer health issue and a growing concern for food safety
authorities. In this situation, and with an apparent stagnation in the development of broad-spectrum
antibiotics, research into new antibacterial agents and strategies for the control of foodborne pathogens
that have good acceptability, low toxicity levels, and high sustainability is greatly demanded at present.
This Special Issue on “Natural Alternatives against Bacterial Foodborne Pathogens” aims to
contribute to the visibility of some of these new antibacterial agents and contains eight research
articles and one review, presenting different strategies potentially applicable in the control of various
foodborne pathogens.
The antibacterial properties of extra virgin olive oil against different foodborne pathogens
and their relationship with phenolic composition of the extract are described by Nazzaro et al. [1].
This study may contribute to the design of optimal mixtures of polyphenols with improved antibacterial
efficacy. The paper by Silvan et al. [2] reports that plum extract powders gained after freeze-,
vacuum- and spray-drying have promising antibacterial, antioxidant, and anti-inflammatory properties,
demonstrating that the drying method selected can be an effective tool for modulating the composition,
physical, and bioactive properties of plum extracts powders. The antimicrobial effect of essential
oils obtained from cinnamon, marjoram, and thyme on single and dual biofilms of Escherichia coli,
Listeria monocytogenes, Pseudomonas putida, and Staphylococcus aureus is described by Kerekes et al. [3].
These studies are the starting point for new approaches, such as encapsulation of essential oils,
that could potentially reduce its organoleptic impact and increase antibacterial activity. Following a
different strategy, Speranza et al. [4] proposes to exploit the in vivo metabolism of two probiotic strains
(Bifidobacterium longum subsp. infantis and Lactobacillus reuteri) with the capacity to adhere on different
surfaces (i.e., packaging materials, ceramic, plastic, paper, polymers, etc) forming a biofilm able to
control the growth of pathogenic and food spoilage bacteria. This could be useful as a new biocontrol
solution for different industrial applications. The probiotic functionality of a Bacillus subtilis strain
protecting probiotic lactic acid bacteria during their exposure to unfavorable environmental conditions,
such as desiccation and acid stresses, is described by Kimelman and Shemesh [5]. In addition to
this protective capability, B. subtilis strains have demonstrated a potent antimicrobial activity against
pathogenic S. aureus. Luis et al. [6] report the development of hydrophobic zein-based functional films
incorporating licorice essential oil as new alternative materials for food packaging. These new films
are biodegradable and possess antioxidant and antibacterial properties against different foodborne
pathogens, making them potential alternatives to the conventional plastics used in food packaging
solutions, reducing environmental pollution and increasing the shelf-life of foods. Zhang et al. [7]
present the antibacterial activity of different spice extracts against several antibiotic resistant strains of
foodborne pathogens. They conclude that some extracts with relevant antibacterial and antioxidant
activity could have potential for use as both antibiotic alternatives in animal feeding and as a natural
Microorganisms 2020, 8, 762 www.mdpi.com/journal/microorganisms1
Microorganisms 2020, 8, 762
food preservative in the food industry. Kaewkod et al. [8] report the study of different biological
properties of Kombucha tea from various kinds of tea leaves including green, oolong, and black tea.
They observe that the extent of the antibacterial effect against several foodborne pathogens was related
with the amount of organic acids in the beverage, indicating the great potential health benefits of
Kombucha tea. Finally, Zorraquin-Peña et al. [9] present a detailed review on the main applications of
silver nanoparticles as antibacterial agents for food control, as well as the current legislation concerning
these materials. They also summarize the current knowledge about the impact of dietary exposure to
silver nanoparticles in human health, with special emphasis on the changes that nanoparticles undergo
after passing through the gastrointestinal tract and how they alter the oral and gut microbiota.
Acknowledgments: Thanks to all the authors and reviewers for their excellent contributions to this Special Issue.
Additional thanks to the Microorganisms Editorial Office for their professional assistance and continuous support.
Conflicts of Interest: The editors declares no conflict of interest.
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Abstract: Production of extra virgin olive oil (EVOO) represents an important element for the
economy of Southern Italy. Therefore, EVOO is recognized as a food with noticeable biological effects.
Our study aimed to evaluate the antimicrobial activity exhibited by the polyphenolic extracts of
EVOOs, obtained from three varieties of Olea europea L. (Ruvea antica, Ravece, and Ogliarola) cultivated
in the village of Montella, Avellino, Southern Italy. The study evaluated the inhibiting effect of the
extracts against some Gram-positive and Gram-negative bacteria. Statistical analysis, used to relate
values of antimicrobial activity to total polyphenols and phenolic composition, revealed a different
behavior among the three EVOO polyphenol extracts. The method applied could be useful to predict
the influence of singular metabolites on the antimicrobial activity.
Keywords: extra virgin olive oil; polyphenols; antimicrobial activity
1. Introduction
Extra virgin olive oil (EVOO) is a food extracted by the mechanical pressing of the fruits of the
olive tree (Olea europaea L.). EVOO and other products from olive tree are central components of the
Mediterranean diet, characterized, as it is well known, by a scarce intake of products of terrestrial
animal origin, and, concomitantly, by a high intake of fruits, vegetables, cereals, fish, as well as by
a moderate wine consumption. Fruits and vegetables, including cereals, are rich in phytochemicals,
with proven protective effects in limiting several chronic diseases, such as cancer and cardiovascular
illnesses. EVOO represents an important source of nutritionally and healthfully compounds, so that it
is considered as a real functional food [1]. Apart from fatty acids (mainly triglycerides, fat-soluble
substances and polar compounds, representing 95–98% of the whole EVOO)—pulp and seed of
olive contain several other types of compounds, which are present in the final product after the
extractive process. Polyphenols are probably one of the most important groups of minor polar
components present in the EVOO. The biological importance of polyphenols gives rise from their
numerous ascertained biochemical activities, such as the prevention of oxidation reactions to fatty
acids. In addition, for this reason they contribute to the stability of the oil over time, delaying rancidity.
Polyphenols are also capable of preventing and inhibiting radical-type reactions in the human body,
thus limiting the formation of anomalous molecules that might alter the smooth functioning of cell
membranes. Generally, EVOO is rich in polyphenols, until 1 g gallic acid equivalents (GAE)/kg of
product [2]. The principal subfamilies of polyphenols detectable in the EVOO are phenolic acids,
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phenolic alcohols, secoridoids, lignans and flavonoids. Each of the above-mentioned subfamilies can
then be differentiated from the others by chemical composition and reactivity, as well as, probably, by its
organoleptic characteristics. It is therefore clear that the proportions and rate between the different
polyphenols present in the EVOO considerably change its nutraceutical and sensory qualities. Olives
and its derived-products, including EVOO, are capable, within certain limits, to resist against the
biotic and abiotic stresses, for instance against pathogen attack, affecting the host-pathogen interaction.
Such property is mainly due to the presence of polyphenols, which can also exhibit antimicrobial
activity [3]. Polyphenols of EVOOs are able to inhibit in vitro, generally in a synergistic way, the
growth of pathogens responsible for some intestine and respiratory diseases. Olive polyphenols could
contribute in inhibiting the growth of Helicobacter pylori [4] and that of some foodborne pathogens,
such as Escherichia coli, Listeria monocytogenes and Salmonella enteriditis [5]. EVOO demonstrated a
good antimicrobial effect against Salmonella Typhi [6]. EVOO polyphenols are considerably absorbed
(up to 95%) in humans mainly in the small intestine, where they might exert a significant local action [7].
Therein, they undergo different fate: some of them are directly absorbed; others are metabolized giving
rise to other molecules, which can play a double role: act against enteropathogens, for instance, and,
among other activities, improve the growth of beneficial microbes, acting as prebiotics [8,9]. Taking
also into account the bioavailability of polyphenols, several authors ascertained that the use of EVOO
in food might help in supporting the prevention against foodborne pathogens [5,10]. Recently, the
inhibitory effect of EVOO polyphenols was demonstrated also against some oral microorganisms,
such as oral streptococci, Porphyromonas gingivalis, Fusobacterium nucleatum, and Parvimonas micra [11].
In olive mill wastewater, phenolic compounds and their secoiridoid derivatives present in an ethanol
fraction contribute to support the noticeable antimicrobial activity exhibited against the foodborne
pathogen Campylobacter [12]. Cultivar, genetics, agronomic practices and climatic conditions, as well
as the degree of ripening, storage conditions and fruit processing techniques are all factors that may
affect the characteristics of EVOO, including the polyphenol profile and the subsequent biological
properties [13,14]. The aim of our work was to evaluate the antibacterial activity exhibited by the
polyphenol fraction of EVOOs, produced with the fruits of three varieties of Olea europea L. (Ruvea antica,
Ravece, and Ogliarola) cultivated in Southern Italy. The study evaluated in particular the inhibitory
effect of the extracts against several Gram-positive and Gram-negative bacterial strains. Statistical
analysis correlated the antibacterial activity to the total polyphenols and to the percentage of the single
components identified by a chromatographic approach within the three extracts.
2. Materials and Methods
The EVVOs used in this study were obtained by cold pressing from three varieties, Ruvea antica,
Ogliarola, and Ravece of O. europea, grown in the village of Montella, Irpinia province, Campania region,
Southern Italy. Samples of the three varieties were identified by Vincenzo De Feo, University of Salerno.
Voucher specimens of the three varieties are stored in the herbarium of the University of Salerno.
2.1. Polyphenols Analysis
2.1.1. Standards and Reagents
Most of the standards used for the Ultra Pressure Liquid Chromatography (UPLC) analysis
(caffeic, ferulic, p-coumaric, gallic, and chlorogenic acids; catechin; quercetin; 3-hydroxytyrosol,
spiraeoside, oleureopin, dadzein, luteolin, naringenin, formononentin), as well as high pressure
liquid chromatography (HPLC)-grade ethanol and acetonitrile were purchased from Sigma-Aldrich
(Milano, Italy). Apigenin and hyperoside were purchased from Extrasynthese (Genay, France).
2.1.2. Extraction and Determination of Total Polyphenols
The extraction of polyphenols from EVOOs, necessary for the chromatographic analyses, was
performed using hexane (1:1 w/v), following the method of Fratianni et al. [15]. The mixture was
4
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then charged onto cartridges SPE C18, and eluted three times with methanol. The three residues
were pooled, dried, re-suspended in 1 mL of methanol and filtered through a 0.20 mm filter before
the analysis. Total phenolic (TP) content was determined using the Folin-Ciocalteau reagent [16].
The absorbance at λ = 760 nm was determined (Cary UV/Vis spectrophotometer, Varian, Palo Alto,
CA, USA) at room temperature. A standard curve generated using gallic acid as standard was used to
quantify total polyphenols.
2.1.3. Chromatographic Analysis
Polyphenol composition was obtained through ultra-high-performance liquid chromatography
(UPLC) using an ACQUITY Ultra Performance system linked to a PDA 2996 photodiode array detector
(Waters, Milford, MA, USA), linked to an Empower software (Waters). The analysis was performed
following the method of Ombra et al. [17] at λ= 280 nm with a reversed-phase column (BEH C18, 1.7 μm,
2.1 mm× 100 mm, Waters), at 30 ◦C, at a flow rate of 250 μL/min, and with pressure ranging from 6000
to 8000 psi. The effluent was introduced to an LC detector (scanning range 210–400 nm, resolution
1.2 nm). The injection volume was 5 μL. Phenolic compounds were identified and quantified through
comparison of the peak areas on the chromatograms of samples with those of diluted standard solutions.
2.2. Antibacterial Activity
2.2.1. Microorganisms and Culture Conditions
Five Gram-positive (Bacillus cereus DSM 4313, Bacillus cereus DSM 4384, Staphylococcus aureus
DMS 25923, Enterococcus faecalis DSM 2352 and Listeria innocua DSM 20649) and two Gram-negative
(Escherichia coli DSM 8579, and Pseudomonas aeruginosa ATCC 50071) bacterial strains were cultured for
18 h in Luria Bertani (LB) broth (Sigma, Milano, Italy) at 37 ◦C and 80 rpm (Corning LSE, Pisa, Italy).
2.2.2. Determination of the Antibacterial Susceptibility by Agar Diffusion
The agar diffusion test was performed following the method of Fratianni et al. [18] with some
modifications. Microbial suspensions (1 × 107 colony-forming units (cfu)/mL) were spread on LB
agar plates in sterile conditions. Different amounts of extracts (2.5 and 4.9 μg) were spotted on the
inoculated plates. After 10 min in sterile conditions, plates were incubated at 37 ◦C for 24 h. The
diameter of the clear zone shown on plates (inhibition zone) was accurately measured (“Extra steel
Caliper mod 0289”, mm/inch reading scale, precision 0.05 mm, Mario De Maio, Milan, Italy). Sterile
dimethylsulfoxide (DMSO, Sigma Aldrich Italy, Milano, Italy) and tetracycline (7 μg; Sigma Aldrich
Italy) served as the negative and positive control, respectively. The experiments were performed in
triplicate and averaged.
2.2.3. Minimal Inhibitory Concentration (MIC)
The resazurin microtiter-plate assay [19] was used to evaluate the MIC. Samples were dissolved
in sterile DMSO; then, they were distributed in a multiwell plate with different volumes of sterile
Muller-Hinton broth (Sigma Aldrich Italy) previously prepared. Two-fold serial dilutions were
performed to have 50 μL of the test material in serially descending concentrations in each well. A 35 μL
amount of 3.3 × strength iso-sensitized broth and 5 μL of resazurin, used as indicator solution, were
added to achieve a final volume/well of 240 μL. Finally, 10 μL of bacterial suspension was added to
each well to reach a concentration of about 5 × 105 cfu/mL. Sterile DMSO and ciprofloxacin (Sigma
Aldrich Italy, prepared dissolving 1 mg/mL in DMSO) were used as negative and positive control,
respectively. Multiwell plates were prepared in triplicate and incubated at 37 ◦C for 24 h. The lowest
concentration at which a color change occurred (from dark purple to colorless) revealed the MIC value.
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2.3. Statistical Analysis
Data were expressed as mean ± standard deviation of triplicate measurements. The PC software
“Excel Statistics” was used for the calculations. The analysis correlated the values of antibacterial
activity, specifically to the inhibition zone data, to total polyphenols and phenolic composition, using
the free software environment for statistical computing and graphics R (https://www.r-project.org/) [15].
3. Results and discussion
3.1. Antibacterial Activity of the Extracts
The antibacterial capability of the polyphenol (PF) extracts of Ogliarola, Ravece, and Ruvea antica
EVOOs was assayed against different Gram-positive and Gram-negative bacteria, through the inhibition
zone test and the determination of the Minimal Inhibitory Concentration (MIC). Results are shown in
Tables 1 and 2 respectively.
Table 1. Antibacterial activity evaluated through the inhibition zone test of the three polyphenol
(PF) extracts of Ogliariola, Ravece and Ruvea antica EVOOs, against different pathogens. The test was
performed using 2.5 and 4.9 μg of extract. Data are expressed in mm. Results are shown as mean (± SD)
(n = 3). For details, see Materials and Methods.
‘Ogliarola’ ‘Ravece’ ‘Ruvea Antica’ Tetracycline




























































































Table 2. Minimal Inhibitory Concentration (MIC, μg/mL) of the PF extracts of ‘Ogliarola’, ‘Ravece’
and ‘Ruvea antica’ EVOOs, evaluated through the resazurin test, as reported in the Materials and
Methods section.
Ogliarola Ravece Ruvea Antica
B. cereus 4313 1.00 1.00 1.00
B. cereus 4384 1.00 1.00 2.00
E.coli 1.00 1.00 2.00
P. aeruginosa 1.00 1.00 2.00
S. aureus 1.00 >15.00 2.00
L. innocua 2.00 2.00 2.00
E. faecalis 2.00 2.00 >10.00
The minimum concentration necessary to inhibit the growth of the pathogenic tester strains was
low for all the PF extracts, usually equal to 1–2 μg, except when PF of Ravece were tested against
S. aureus (MIC > 15 μg), and when those of Ruvea antica were assayed against E. faecalis (MIC > 10 μg).
This confirms that polyphenols present in the EVOO have a general capacity to inhibit the growth of
pathogenic or unwanted microorganisms [3]. Therefore, different in vitro studies demonstrated that
6
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some polyphenols from olive oil are able to inhibit the growth of different bacteria, including those
responsible for some respiratory infection and intestinal diseases, as well as against bacteria, such as
Helicobacter pylori, one of the agents of peptic ulcers and some types of cancer [4,20].
In general, 4.9 μg of the PF extract from Ogliarola were very effective in inhibiting the microbial
growth of all the strains considered, with inhibition zone not lesser than 10.67 (against L. innocua) up
to 18.33 mm (against B. cereus 4313). Overall, 4.9 μg of the polyphenol extract from Ravece produced
inhibition zones also superior to 17 mm (17.33 mm, against B. cereus 4313 and E. faecalis). 4.9 μg of
PF extract from Ruvea antica resulted less effective, producing zones not greater than 12.67 mm. All
three EVOO PF extracts were effective in inhibiting the growth of E. coli, producing (with 4.9 μg of
PF extracts from Ravece and Ogliarola) inhibition zones up to 13 mm. This result, in our opinion,
could find an interesting practical application. E. coli is the most frequent cause of urinary tract
infections. Like other E. coli pathotypes, the strain used in our experiments differs from the commensal
E. coli, due to the presence of some virulence factors, which can concur, with other microbial systems,
to increase its resistance against conventional antibiotics, to form biofilm, as well as to contaminate
food or medical support (e.g., catheters), with difficulty to eradicate the infection and serious damage
to health [21]. Thus, the capability of EVOO polyphenols to avoid the growth of this pathogen strain
could be exploited not only for the EVOO per se, or for the great bioavailability of EVOO PFs, but also
taking into account that the EVOO by-products are rich in polyphenols, which can convert them from a
problem for the environment to a resource of biomolecules of high added value, potentially useful for
food and pharmaceutical purposes. Therefore, other olive by-products, such as leaves demonstrated
activity against different species of pathogens, including those used in our experiments [22]. The three
PF extracts were also capable of inhibiting the growth of Ps. aeruginosa. Such microorganism, similar to
E. coli, not only is a well-known pathogen, but it is also capable to form biofilm, increasing its resistance
to the conventional drugs [23]. The effect was well visible, so that we measured inhibition halos until
8.67 mm just using 2.5 μg. In both cases, the extracts Ogliarola and Ravece were more effective than
those of Ruvea antica in inhibiting the growth of the strain; in particular, 2.5 μg of PF extract of Ravece
were twice as effective as that of Ruvea antica against Ps. aeruginosa; 4.9 μg of Ravece PF extracts were
even three times more effective than the Ruvea antica ones. The different effectiveness exhibited by
the extracts against the two strains of B. cereus (DSM 4313 and DSM 4384) proved once again that the
resistance/sensitivity of a microorganism to a natural extract or to a singular compound might be not
only linked to the genera or species but, in some cases, it might even be strain-specific [24,25].
3.2. Statistical Analysis
Some of the individual phenolic compounds present in the EVOOs extracts were identified and
quantified by UPLC. However, the choice to evaluate the antibacterial activity of the entire extracts
was taken for different reasons. First, the antibacterial activity of phenolic compounds is generally
well-known [26–31]. Moreover, PF extracts might exhibit more beneficial effects than their individual
constituents, which can change own properties in the presence of other compounds present in the
extracts [32]. As said by Liu [33], the health benefits of fruits and vegetables give rise from synergistic
effects of phytochemicals and the advantages on human health of a diet rich in fruits and vegetables
is attributed to the complex mixture of phytochemicals present in whole foods. This explains why
generally no individual antibacterial effect can substitute the combination of natural phytochemicals to
achieve the health benefits [34]. Thus, we statistically correlated the total polyphenols and individual
molecules to the antibacterial activity exhibited by the EVOO extracts. The correlation between total
polyphenols and the average antibacterial activity resulted high (=0.85). We identified 10 polyphenols
through UPLC analysis, based on the retention time of corresponding standards. For all of them,
we calculated the percentage present in each extract. Data on polyphenol composition are reported
in Table 3. The statistical approach allowed us to divide such molecules into different groups, with
respect to their potential influence on the average antibacterial activity of the extracts. Correlation
coefficients (Corr-coeffs) are reported in Table 4. In the first group, we found that flavonol quercetin
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and isoflavone formononetin, which Corr-coeffs (0.94 and 0.97, respectively) seemed to let us foresee by
the whole their highest influence on the antibacterial activity with respect to the other molecules. Other
two polyphenols, flavanone naringenin and the secoiridoid oleuropein exhibited lower Corr-coeffs
(0.55 and 0.47, respectively).
Taking into account the percentage of the two molecules in the extracts, it is possible to hypothesize
for this other group a little bit of predominance of correlation between oleuropein and the average
antibacterial activity of the ‘Ravece’ extract (Figure 1, left) and between naringenin on the average
antibacterial activity exerted by the ‘Ogliarola’ extract (Figure 1, right).
Table 3. Polyphenol composition, obtained by Ultra Pressure Liquid Chromatography (UPLC), of the
three PF extracts of Ogliarola, Ravece and Ruvea antica EVOOs. The data are reported as percentage of
total polyphenols.
Polyphenols (%) ‘Ogliarola’ ‘Ravece’ ‘Ruvea Antica’
Gallic acid 0.00 0.00 0.00
3 Hydroxytirosol 1.86 0.43 1.10
Catechin 1.08 0.00 0.43
p-Coumaric acid 0.00 0.28 0.11
Quercetin-4-glucoside (spiraeoside) 9.48 0.00 5.75
Oleuropein 15.77 5.92 12.82
Dadzein 4.13 0.00 2.36
Luteolin 0.00 6.22 1.57
Quercetin 24.06 18.03 10.61
Apigenin 0.00 0.00 3.18
Naringenin 3.99 6.57 6.49
Formononentin 4.45 4.81 2.27
Table 4. Correlation coefficients between the potential average antibacterial activity and polyphenols
identified in the extracts of Ogliarola, Ravece and Ruvea antica EVOOs. The analysis was elaborated with
respect to the percentage of each molecule present in the extracts and in an independent way with












The correlation between another group of polyphenols and the antibacterial activity of the extracts
was still less strict; thus, flavone luteolin (Corr-coeff = 0.37) and the hydroxycinnamic p-coumaric acid
(Corr-coeff = 0.33) seemed to break the antibacterial activity of the extract Ogliarola. Concurrently,
isoflavone dadzein (Corr-coeff = 0.28) and flavonol spiraeoside (Corr-coeff = 0.27) did not seem to
enhance that of the extract Ravece. The other flavone apigenin exhibited a negative coefficient of
correlation (Corr-coeff = −0.34). This metabolite is a known antibacterial compound [34,35]. However,
in some cases its effect could be nil against some microorganisms [36].
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Figure 1. Average antibacterial activity exerted by the three PF extracts vs. oleuropein (left) and vs.
naringenin (right). On X it is reported the amount (in μg) of the molecules present in 2.5 and 4.9 μg of
the PF extracts tested.
The statistical approach was also applied to evaluate the correlation between the singular molecules
and the antibacterial activity with respect to the microorganisms. Table 5 reports the coefficients
of correlation.
Table 5. Correlation coefficients between the potential antibacterial activity and polyphenols identified
in the extracts of ‘Ogliarola’, ‘Ravece’ and ‘Ruvea antica’ EVOOs, with respect to different pathogens.
The analysis was elaborated with respect to the percentage of each molecule present in the extracts,
taking into account the amounts (2.5 μg and 4.9 μg) of the extracts used to determine the antibacterial
activity of the extracts against different pathogens. BC: Bacillus cereus (strains DSM 4313 and DSM
4384); EC: Escherichia coli; LI: EF: Enterococcus faecalis; Listeria innocua; SA: Staphylococcus aureus; PA:
Pseudomonas aeruginosa.
Microorganisms
Polyphenol BC 4313 BC 4384 EC EF LI SA PA
Formononentin 0.97 0.95 0.94 0.91 0.91 −0.16 0.95
Quercetin 0.96 0.93 0.90 0.75 0.77 0.18 0.74
Naringenin 0.47 0.57 0.65 0.26 0.78 0.02 0.55
Oleuropein 0.50 0.53 0.51 −0.09 0.33 0.89 0.00
Luteolin 0.30 0.33 0.39 0.62 0.59 −0.76 0.73
Catechin 0.41 0.38 0.33 −0.04 0.086 0.80 −0.10
p-Coumaric acid 0.25 0.30 0.36 0.52 0.58 −0.69 0.66
Dadzein 0.34 0.33 0.29 −0.19 0.06 0.90 −0.19
Spiraeoside 0.32 0.32 0.27 −0.21 0.05 0.91 −0.21
Apigenin −0.38 −0.27 −0.21 −0.75 −0.15 0.56 −0.51
3-Hydroxytyrosol 0.51 0.51 0.47 −0.01 0.25 0.84 0.00
With respect to the strains used in the agar diffusion test, we could suppose a noticeable
inhibitory effect of formononentin and quercetin against B. cereus. In fact, both strains of B. cereus
(DSM 4313 and DSM 4384) seemed to be strongly inhibited by the presence of these two metabolites
(Corr-coeffs = 0.97 and 0.95, respectively); concurrently, quercetin seemed to prevent the bacterial
growth too (Corr-coeffs = 0.96 and 0.93, respectively). A similar effect was hypothesized against
E. coli (Corr-coeffs = 0.94 and 0.90, respectively) and against E. faecalis (Corr-coeffs = 0.91 and 0.75,
respectively). Thus, for instance, if formononentin seemed to confirm its influence also against
Ps. aeruginosa (Corr-coeff = 0.95) and L. innocua (Corr-coeff = 0.91), on the other hand the effect of
quercetin versus these two microorganisms seemed to be less effective (Corr-coeffs = 0.74 and 0.77,
respectively). Therefore, other studies demonstrated a limited inhibitory effect of quercetin against
Ps. aeruginosa [37]. A potential inhibitory effect exhibited also by luteolin (Corr-coeff = 0.73) and
p-coumaric acid (Corr-coeff = 0.66) against Ps. aeruginosa was observed indeed. At the same time
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naringenin (Corr-coeff = 0.78), luteolin (Corr-coeff = 0.59) and p-coumaric acid (Corr-coeff = 0.58)
would concur in influencing, although with minor efficacy, the potential antibacterial activity of
the extracts against L. innocua. The potential behavior exhibited by metabolites on the antibacterial
activity-hypothesized through such approach- seemed to be completely different when we considered
S. aureus. In fact, by the analysis of correlation coefficients we could hypothesize that other metabolites
in place of formononentin and quercetin may have contributed to the antibacterial activity of the
extracts, in particular spiraeoside, dadzein, and catechin (Corr-coeffs = 0.91; 0.90 and 0.80, respectively).
Moreover, this was the unique case in which oleuropein (one of the most important and known
metabolites characterizing the EVOO polyphenols) seemed to have contributed to the antibacterial
activity of the extracts (Corr-coeff = 0.89). Therefore, oleuropein as well as 3-hydroxytirosol (which
in our case showed a correlation coefficient of 0.84) have antibacterial activity against S. aureus,
as demonstrated by Bisignano et al. [38]. Concurrently, statistics confirmed the controversial behavior
exhibited by 3-hydroxytirosol that was active against S. aureus but had lower effect (Corr-coeff = 0.47)
against E. coli, corroborating the indications given by other studies [39]. The fact that the Ravece extract
did not contain dadzein might suggest that such metabolite in particular affected the resistance of
S. aureus. In fact, as shown in Table 2, the MIC Ravece extract versus S. aureus was higher than 10 μg and
much lower in the case of the other two extracts. The absence of catechin, which gave a correlation
coefficient of 0.80 and the concurrent presence of luteolin (6.22% in Ravece, Corr-coeff = −0.76) could
have contributed to its higher MIC value. Concomitantly, the presence of apigenin found only in the
Ruvea antica extract with the most negative coefficient of correlation (= −0.75) would seem to support
its influence on the resistance of E. faecalis versus that extract, as indicated by the MIC value and by the
results of the inhibition zone test.
4. Conclusions
The polyphenol fraction present in EVOO oil confirms once again its antibacterial properties.
The different qualitative and quantitative profile of polyphenols present in a PF extract can affect in a
different way its antibacterial effectiveness. The statistical method herein applied is easy and useful to
predict the synergistic effect of polyphenols and the influence that each of them has—based also on their
amount—on the activity of the whole extract. In a future perspective this could be a basis of possible
complementary studies, for example, to formulate ideal drugs of natural origin, composed of optimal
mixtures of polyphenols which are able to exercise with the minimum effort (in terms of quantity) and
the maximum result (against the greatest number of pathogens) their antibacterial efficacy.
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Abstract: The consumption of plums in a fresh form is seasonal, therefore the transformation of plum
juice extracts into powdered form is a good alternative for its longer availability throughout the
year. The drying process can moderate the physical and chemical properties of the plum extracts,
thus, this study examined the changes in biological activity, i.e., antibacterial, antioxidant, and
anti-inflammatory properties moderated by freeze, vacuum, and spray drying. It was suggested
that the drying processes and the applied parameters might moderate the content of polyphenolic
compounds in the powders, which influence the different levels of growth inhibition against the
foodborne pathogens (17% to 58% of inhibition), demonstrating a strain-dependent effect. These
powders could also induce cellular protection against oxidative stress by preventing intracellular
reactive oxygen species (ROS) accumulation (23% to 37% of reduction), but the level of antioxidant
capacity may be determined by the conditions applied during the drying process. Moreover, plum
extract powders exhibited a greater anti-inflammatory capacity (24% to 39% of inhibition), which
would be influenced both, by the type of treatment used and by the temperature used in each
treatment. The results demonstrate that the selection of the drying method can be an effective tool for
modulating the composition, physical, and bioactive properties of plum extracts powders.
Keywords: Prunus domestica L.; plum extracts; drying; polyphenolics; bioactive properties;
antibacterial; antioxidant anti-inflammatory
1. Introduction
Diets rich in fruits are beneficial to human health because of their polyphenolic compound content.
In this regard, plums (Prunus domestica L.) represent an excellent source of such components, which
can contribute significantly to the prevention of several diseases [1]. This fruit is cultivated all over
the world and its production in the last 10 years has exceeded 11 million tons [2]. Plum is a seasonal
fruit, and the harvest period and the period of supply of fresh fruit are relatively short. Therefore,
plums cannot be consumed fresh throughout the year, thus, the development of new dried powder
products, obtained by drying industrial techniques, offers an alternative for the consumption at any
season of the year. Plum powders can be obtained from whole fruit [3], plum by-products [4], or
juices/concentrates [5]. Commonly used drying industrial processes include, apart from conventional
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air-drying, freeze-drying (FD), vacuum drying (VD), and spray drying (SPD) [6]. However, the drying
techniques, used to obtain powders from whole fruit, modify some of their physical and chemical
properties [3,7]. In general, FD is considered one of the best method of obtaining high-quality products
because the absence of liquid water and the low temperatures required for the process allows relatively
high retention of bioactive compounds [8]. VD partially prevents thermal degradation of bioactive
compounds in raw material because the temperature of the product is usually low and can be easily
controlled [9]. And SPD is an effective technique in drying liquid products directly into powders, and
is used broadly in processing dairy and fruit products, i.e., juices, extracts, or concentrates [10], and
the resulting powders present a better preservation and retention of polyphenolic compounds [11,12].
Numerous studies confirmed that the above-mentioned processes had a strong influence on the physical
properties of the dried whole fruits and pomace [3,5,13], as well as of the fruit juice powders [12].
Plums are phenolic-rich fruits that contain a mixture of polyphenolic compounds that can exert
several biological effects, including antibacterial [14,15], antioxidant [5,16], and anti-inflammatory
properties [17,18]. In commercially available plums, the most predominant and bioactive
relevant compounds are phenolic acids, such as chlorogenic and neochlorogenic acids; flavonol
glycosides, quercetin-3-glucoside and quercetin-3-galactoside; and anthocyanins, such as cyanidin and
peonidin [19]. However, the profile and level of bioactive polyphenolic compounds in dried plum
products is affected by the drying industrial processes. Until now, there is a lack of information in the
literature on how the drying processes can modify the biological properties of fruit powders, regardless
of the type of the fruit used for drying. Therefore, the objective of the present study was to evaluate the
influence of different drying techniques applied for preparation of plum juice extract powders on the
physical properties and the alterations in polyphenolic compounds contents and bioactive properties,
i.e., antibacterial, antioxidant, and anti-inflammatory.
2. Materials and Methods
2.1. Reagents
3,4,5-Dimethylthiazol-2,5-diphenyl-tetrazolium bromide (MTT), carboxy-2′,7′-dichloro-dihydro-
fluorescein diacetate (DCFH-DA), dimethyl sulfoxide (DMSO) were acquired from Sigma (Madrid,
Spain). Dulbecco’s Modified Eagle’s Medium (DMEM), penicillin/streptomycin (5000 U/mL), phosphate
buffered saline (PBS) and trypsin/EDTA solution (170,000 U/L) were purchased from Lonza (Madrid,
Spain). Fetal bovine serum (FBS) of South American origin (Hyclone, GE Healthcare, Logan, UK) was
obtained from Thermo Scientific (Madrid, Spain). Cell culture dishes were obtained from Sarstedt
(Barcelona, Spain).
2.2. Materials
Material used in the study consisted of plum (Prunus domestica L.) (cv. Valor) juice obtained by
laboratory hydraulic press (SRSE, Warsaw, Poland) that was used for preparation of polyphenolic
extract. This was done by application of amberlite XAD-16 resin previously washed with water. The
absorbed compounds were removed by ethanol that was evaporated by rotary evaporator Laborota 20
(Heidolph, Schwabag, Germany) at 40 ◦C to avoid the excessive degradation of the polyphenols. The
solution was divided into 100 mL portions and subjected to the drying processes without the addition
of any carrier agent due to the sugars’ removal [5].
2.3. Drying Procedure
The plum juice extracts were submitted to drying techniques: (a) freeze-drying (FD) was
performed in freeze-dryer (FreeZone, Labconco Corp., Kansas City, MO, USA) for 24 h (temperature
of the chamber −60 ◦C and the heating plate +25 ◦C); (b) vacuum drying (VD) in Vacucell 111 Eco
Line (MMM Medcenter Einrichtungen GmbH, Planegg, Germany) at the temperature of 40 ◦C, 60 ◦C
and 80 ◦C at a pressure of 300 Pa for, respectively, 20, 16, and 10 h; (c) spray drying (SPD) done by
14
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mini spray dryer (Buchi, Flawil, Switzerland) with the inlet temperature of 180 ◦C and the outlet
temperature of 70 ◦C. All drying techniques were performed at least in duplicate (n = 2). The obtained
plum extracts powders (PEP) were milled (Bosch MKM 6003c, Gerlingen, Germany), vacuum packed
(PP-5.14, Tepro SA, Koszalin, Poland), and stored at −20 ◦C until they were analyzed.
2.4. Physicochemical Properties
The moisture content of PEP was determined in duplicate (n = 2) according to Figiel et al. [20]
using Vacucell 111 Eco Line at 80 ◦C for 20 h. The results were expressed as %. The water activity of
the PEP was done at 25 ◦C by Water Activity Meter AquaLab (DewPoint 4Te, Decagon Devices Inc.,
Pullman, WA, USA) (n = 2). The colour of the samples was determined in a CIE L*a*b* system using a
Minolta Chroma Meter CR-400 (Minolta Co. Ltd., Osaka, Japan). Data were presented as an average
value of five measurements (n = 5).
2.5. Characterization of Polyphenolic Compounds by UPLC-PDA System
The preparation of the PEP extracts subjected to characterization of polyphenolic compounds
using the UPLC-PDA system was performed according to Wojdyło et al. [21]. All determinations were
done in duplicate. The results were expressed as grams per 100 g of dry basis (db) of plum extract
power (g/100 g db).
2.6. Bacterial Strains, Growth Media, and Culture Conditions
Five of the most relevant foodborne pathogen bacteria were tested for antibacterial activity of PEP:
Campylobacter jejuni NCTC11168, Escherichia coli ATCC®25922™, Staphylococcus aureus ATCC®25923™,
Listeria monocytogenes CECT935, and Salmonella enterica subsp. enterica serovar Typhimurium ATCC®
14028™. All bacteria strains were stored at −80 ◦C in Brucella Broth (BB) (Becton, Dickinson, &
Co, Madrid, Spain) plus 20% glycerol. The agar-plating medium consisted of Müeller-Hinton agar
supplemented with 5% defibrinated sheep blood (MHB) (Becton, Dickinson, & Co), and liquid growth
medium consisted of BB. Bacteria cultures were prepared as follows: The frozen stored strains
were reactivated by inoculation in MHB and incubation under aerobic conditions (E. coli, S. aureus,
L. monocytogenes, and S. typhimurium) and microaerophilic conditions (C. jejuni) using a Variable
Atmosphere Incubator (85% N2, 10% CO2, 5% O2) (VAIN, MACS-VA500, Don Whitley Scientific,
Bingley, UK) at 37 ◦C for 24–48 h. Isolated colonies were inoculated into 50 mL of BB and incubated
in the conditions described above following stirring (150 rpm) for 24–48 h until the late exponential
phase, and used as experimental inoculum. These bacterial inoculum cultures ~1 × 108 colony forming
units (CFU/mL) were used for the different experimental assays.
2.7. Antibacterial Activity
The antibacterial activity of PEP against foodborne bacteria was evaluated following the procedure
described by Silvan et al. [22]. Briefly, 1 mL of PEP (1 mg/mL final concentrations) was transferred
into different flasks containing 4 mL of BB. Bacterial inoculum (50 μL of ~1 × 108 CFU/mL) was then
inoculated into the flasks under aseptic conditions. The culture was prepared in triplicate and incubated
under stirring (150 rpm) during 24 h at 37 ◦C. Growth controls were prepared by transferring 1 mL of
sterile water to 4 mL of BB and 50 μL of bacterial inoculum. After incubation, serial decimal dilutions
of mixtures were prepared in saline solution (0.9% NaCl) and they were plated (20 μL) onto fresh MHB
agar and incubated as previously described. The number of CFU was assessed after incubation. The
results of antibacterial activity were expressed as percentage of growth inhibition for the foodborne
bacteria respect to the controls of bacteria growth.
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2.8. Cell Cultures
Human intestinal epithelial HT-29 and murine macrophage RAW 264.7 cell lines were obtained
from the American Type Culture Collection (ATCC). Both cell lines were cultured in Dulbecco’s
modified Eagles’s medium (Lonza) supplemented with 10% fetal bovine serum (Hyclone) and 1%
penicillin/streptomycin (5000 U/mL, Lonza). The cells were plated at densities of ~1 × 106 cells in
75 cm2 culture flasks and maintained at 37 ◦C under 5% CO2 in a humidified incubator until 90%
confluence. The culture medium was changed every 2 days. Before a confluent monolayer appeared,
sub-culturing cell process was carried out.
2.9. Cell Viability
Before the cellular antioxidant and anti-inflammatory experiments, it was necessary to find out if
the plum powders were cytotoxic for both cell lines (HT-29 and RAW 264.7). With this purpose, cell
viability was determined by MTT reduction assay as previously was described by Silvan et al. [23].
Confluent stock cultures (~90%) were trypsinized (Trypsin/EDTA), and cells were seeded in 96-well
plates (~5 × 104 cells per well) and incubated in culture medium at 37 ◦C under 5% CO2 in a humidifier
incubator for 24 h. Briefly, cell medium was replaced with serum-free medium containing PEP
(1 mg/mL final concentrations), and the cells were incubated at 37 ◦C for 24 h under 5% CO2. Control
cells (non-treated) were incubated in serum-free medium without plum powders. Thereafter, cells
were washed with PBS, the medium was replaced by 200 μL of serum-free medium, and 20 μL of MTT
solution in PBS (5 mg/mL) was added to each well for the quantification of the living metabolically
active cells after 1-h incubation. MTT is reduced to purple formazan in the mitochondria of living
cells. Formazan crystals in the wells were solubilized in 200 μL DMSO. Finally, the absorbance was
measured at 570 nm wavelength by employing a microplate reader Synergy HT (BioTek Instruments
Inc., Winooski, VT, USA). The viability was calculated considering controls containing serum-free
medium as 100% viable. Data represent the mean and standard deviation of three independent
experiments (n = 3). All experiments were carried out between passage 10 to passage 30 to ensure cell
uniformity and reproducibility.
2.10. Antioxidant Activity Against Intracellular Reactive Oxygen Species (ROS) Production
Human intestinal epithelial cell line HT-29 was used for the evaluation of oxidative stress.
Intracellular ROS were measured by the DCFH-DA assay as previously was reported by Martín et
al. [24]. Cells were seeded (5 × 104 cells per well) in 24-well plates and grown until they reached 70% of
confluence. Cells were pre-treated with plum powders (1 mg/mL) dissolved in serum-free medium for
24 h. After that, the cells were washed with PBS and incubated with 20μM DCFH-DA for 30 min at 37 ◦C.
Then, cells were washed twice with PBS to remove the unabsorbed probe and treated with serum-free
medium, containing 2.5 mM tert-butyl hydroperoxide (TBHP). ROS production was immediately
monitored for 180 min in a fluorescent microplate reader Synergy HT using a λex 485 nm and λem
530 nm. After being oxidized by intracellular oxidants, DCFH-DA changes to dichlorofluorescein
(DCF) and emits fluorescence. The cells treated with TBHP was used as oxidative control (100% of
intracellular ROS production). All samples were analyzed in triplicate (n = 3). All experiments were
carried out between passage 10 to passage 30 to ensure cell uniformity and reproducibility. Data were
expressed as percentage of fluorescence generation relative to negative control cells.
2.11. Anti-Inflammatory Activity
For inflammatory experiments, murine macrophage cell line RAW 264.7 was used. Cells were
seeded in a 96-well plate at density of ~5 × 104 cells/well. Nitrite accumulation, indicator of nitric oxide
(NO) synthesis, was measured in the culture medium of treated and control cells by the Griess reaction.
After 24 h of incubation, the medium was removed, the cells were washed with 200 μL PBS and treated
with PEP (1 mg/mL) and 10 μg/mL of LPS from Escherichia coli O55:B5 for 24 h. Control cells were
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incubated in serum-free medium with LPS (Control+) and without LPS (Control−) for 24 h. Finally, the
media were collected and used for NO quantification. Briefly, 100 μL of collected cell supernatants were
plated in 96-well plate and an equal amount of Griess reagent constituted by 1% (w/v) sulfanilamide
and 0.1% (w/v) N-1-(naphthyl) ethylenediamine-diHCl in 2.5% (v/v) H3PO4, was added. The plate
was incubated for 5 min and the absorbance measured at 550 nm in a microplate reader Synergy HT.
The amount of NO was calculated using a sodium nitrite standard curve (0–10 μg/mL). Data were
expressed as percentage of NO production calculated relative to Control+. Data represent the mean
and standard deviation of three independent experiments (n = 3). All experiments were carried out
between passage 10 to passage 30 to ensure cell uniformity and reproducibility.
2.12. Statistical Analysis
The results were reported as means ± standard deviations (SD) performed in triplicate. A t-test
was used to assess the differences in antibacterial activity. Significant differences among the data were
estimated by applying analysis of variance (ANOVA). The Tukey’s least significant differences (LSD)
test was used to evaluate the significance of the analysis. Differences were considered significant at
p < 0.05. All statistical tests were performed with IBM SPSS Statistics for Windows, Version 25.0 (IBM
Corp., Armonk, NY, USA).
3. Results and Discussion
3.1. Physical Properties
The powders obtained from plum juice extracts submitted to different drying techniques differed
in terms of moisture content and water activity (Table 1). The moisture content ranged from 2.44% up
to 7.34% and was within the range described by Boonyai et al. [25]. The values of moisture content
depended on the drying method and the parameters applied. The lowest water content was noted after
spray drying during which the highest temperature for water removal was applied [12]. The evaluation
of water activity in powders is a key aspect as this parameter informs about their stability, both chemical
and microbial. It is connected with the quality of the dried products as the rate for some chemical
reactions begins above a water activity of 0.3 [26]. Similarly, a high positive correlation (r = 0.789)
between moisture content and water activity have been previously described in fruit powders [12].
PEP also differed in color attributes (Table 1).







L* a* b* C* h*
FD 7.34 ± 0.14 d 0.289 ± 0.001 d 42.84 ± 0.13 b 23.37 ± 0.1 d 10.73 ± 0.03 d 25.72 ± 0.10 c 24.67 ± 0.13 b
VD 40 ◦C 3.74 ± 0.17 c 0.227 ± 0.002 b 40.28 ± 0.05 a 17.73 ± 0.04 c 7.64 ± 0.01 b 19.31 ± 0.03 b 23.33 ± 0.05 a
VD 60 ◦C 7.17 ± 0.04 d 0.243 ± 0.001 c 43.10 ± 0.67 b 16.94 ± 0.61 b 8.33 ± 0.10 c 18.88 ± 0.59 b 26.19 ± 0.56 c
VD 80 ◦C 3.29 ± 0.08 b 0.242 ± 0.001 c 40.40 ± 0.09 a 13.56 ± 0.02 a 6.64 ± 0.02 a 15.11 ± 0.03 a 26.09 ± 0.07 c
SPD 2.44 ± 0.06 a 0.146 ± 0.002 a 45.76 ± 0.02 c 24.97 ± 0.06 e 13.15 ± 0.03 e 28.22 ± 0.04 d 27.78 ± 0.09 d
Freeze drying (FD); Vacuum drying 40 ◦C (VD 40 ◦C), 60 ◦C (VD 60 ◦C), 80 ◦C (VD 80 ◦C); Spray drying (SPD);
colour parameters (L*, a*, b*), chroma (C*) and hue (h). Different letters (a,b,c,d,e) within the same column indicated
statistical differences between samples (p ≤ 0.05; LSD Tukey).
Among products obtained, lower values of coordinate L* were noted after VD, when compared to
FD and SPD, that was in agreement with previously conducted research on chokeberry [11] and apple
powders [12]. The L* values were connected with coordinate a* and b* pointing a strong influence of
the drying technique on the retention of red and yellow pigments. Chroma (C*) is connected with
the color intensity and opposite to apple powders [12], the highest values were linked to FD and SPD
processes. This could be connected with the fact that, in the current study, the extract of plum juice
was dried, and thereby the material differed in terms of the chemical composition, as the obtained
extracts were significantly darker when compared to the juice. Taking the above into consideration, the
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chemical changes that have occurred during drying are strictly connected with the chemical properties
of the initial materials. The hue angle (h*) values indicated that the analyzed samples were more
reddish as an angle of approximately 0 represents red colour. The highest h* values were obtained
for powders gained after FD that was in line with the coordinate a*. Additionally, the lowest values
were noted after FD and VD 40 ◦C, pointing to a strong influence on the temperature of the process on
this parameter.
3.2. Polyphenolic Compounds Composition
The total polyphenolic compounds content in PEP ranged from 34.66 to 47.65 g/100 g db and
differed due to the drying technique and parameters applied for their dehydration (Table 2) [5]. In
general, the highest total content of identified polyphenolic compounds was noted after SPD, which
was almost 19% higher when compared to FD, and is regarded as the technique that preserve bioactive
compounds the most. Similarly, the highest retention of polyphenolic compounds in sugar-free
extracts, submitted to SPD, was noted in case of chokeberry [11] and cranberry [27], which pointed
to this dehydration method as being successfully used when the retention of selected polyphenolic
compounds is concerned.
Table 2. Content of identified major phenolic compounds in plum extracts powders (PEP) obtained by
selected drying methods (g/100 g db).
Compound FD VD 40 ◦C VD 60 ◦C VD 80 ◦C SPD
Phenolic acids
Neochlorogenic acid 10.25 ± 0.12 c 10.18 ± 0.02 c 8.85 ± 0.11 b 6.45 ± 0.02 a 11.04 ± 0.33 c
3-feruoylquinic acid 10.51 ± 0.06 c 9.96 ± 0.11 c 8.51 ± 0.36 b 5.42 ± 0.15 a 11.69 ± 0.28 d
3-O-p-coumaroylquinic acid 4.41 ± 0.09 ab 4.73 ± 0.11 b 4.59 ± 0.15 ab 4.05 ± 0.21 a 5.30 ± 0.14 c
Chlorogenic acid 4.14 ± 0.01 c 3.96 ± 0.01 bc 3.58 ± 0.02 ab 3.36 ± 0.12 a 4.70 ± 0.04 d
Methyl 3-caffeoylquinate 0.25 ± 0.01 a 0.37 ± 0.01 ab 0.55 ± 0.02 b 7.08 ± 0.11 d 3.92 ± 0.06 c
Total phenolic acids 29.56 29.20 26.08 26.36 36.65
Flavonols
Quercetin-3-O-rutinoside 1.25 ± 0.01 c 0.09 ± 0.01 a 0.24 ± 0.04 b 1.09 ± 0.16 c 1.88 ± 0.17 d
Quercetin-3-O-galactoside 5.01 ± 0.05 d 1.29 ± 0.01 b 1.41 ± 0.01 c 1.47 ± 0.06 c 0.73 ± 0.04 a
Quercetin-3-O-glucoside 0.73 ± 0.01 a 5.24 ± 0.02 c 5.14 ± 0.07 c 4.58 ± 0.09 b 6.11 ± 0.14 d
Quercetin-3-O-(6′′
acetylgalactoside) 1.03 ± 0.01
c 1.04 ± 0.01 c 0.89 ± 0.11 b 0.61 ± 0.01 a 1.21 ± 0.09 d
Total flavonols 8.02 7.66 7.68 7.75 9.93
Anthocyanins
Cyanidin-3-O-glucoside 0.27 ± 0.02 c 0.26 ± 0.01 c 0.24 ± 0.04 b 0.17 ± 0.03 a 0.28 ± 0.01 c
Cyanidin-3-O-rutinoside 0.70 ± 0.01 bc 0.70 ± 0.00 bc 0.66 ± 0.11 ab 0.53 ± 0.03 a 0.78 ± 0.04 bc
Peonidin-3-O-rutinoside 0.0058 ± 0.0001 b 0.0058 ± 0.0002 b 0.0055 ± 0.0009 b 0.0044 ± 0.0007 a 0.0065 ± 0.0003 c
Total anthocyanins 0.97 0.96 0.90 0.70 1.07
Total polyphenolics content 38.55 37.82 34.66 34.81 47.65
Freeze drying (FD); Vacuum drying 40 ◦C (VD 40 ◦C), 60 ◦C (VD 60 ◦C), 80 ◦C (VD 80 ◦C); Spray drying (SPD);
different letters (a,b,c,d) within the rows indicate significant differences between samples (p ≤ 0.05; LSD Tukey test).
Going into the details, the major group of polyphenolic compounds present in PEP consisted of
five identified phenolic acids, among which the chlorogenic and 3-feruoylquinic acids were dominant.
The highest retention of these constituents was noted after SPD. As previously observed [5], the drying
processes led to the degradation of phenolic acids within the increase of the temperature during VD,
except methyl 3-caffeoylquinate. Interestingly, the increase in the temperature during VD up to 80 ◦C,
followed by SPD (170 ◦C) resulted in, respectively, 29-, and 16-times higher content of this compound
in the powders when compared to those gained after FD. In case of flavonols, processing during which
the temperature above 40 ◦C (VD 40 ◦C, VD 60 ◦C, VD 80 ◦C and SPD) caused a strong degradation
of quercetin-3-O-galactoside, the application of such conditions caused an increase in the content of
quercetin-3-O-glucoside when compared to FD. This might be connected with the thermally-induced
release of this constituent during drying. In general, the SPD process resulted in better retention of
flavonols being almost 20% higher when compared to FD. In the current study, three anthocyanins
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had been identified and their content followed the same patterns as the above-mentioned groups of
polyphenolic compounds.
3.3. Antibacterial Activity
The antibacterial activity of PEP against five representative foodborne pathogens (C. jejuni, S.
typhimurium, E. coli, S. aureus, and L. monocytogenes) was evaluated. As shown in Figure 1, all extracts
were active against at least one of the pathogens studied, and their antibacterial activity was related to
the drying procedure used for their conservation. PEP exhibited different levels of growth inhibition
against the foodborne pathogens evidencing a strain-dependent effect. Among all the studied powders,
the most relevant antibacterial activity was observed for FD extract. In fact, this extract inhibited
significantly (p < 0.05) the growth of all the bacteria studied except E. coli strain. This extract showed a
growth inhibition range between 22–52%, depending on the bacterial strain. VD 60 ◦C extract inhibited
the growth of three of the five foodborne bacterial strains (C. jejuni, S. aureus, and L. monocytogenes),
compressing a growth inhibition range of 17–36%. VD 40 ◦C and VD 80 ◦C inhibited the growth
of two bacterial strains (C. jejuni-L. monocytogenes, and E. coli-L. monocytogenes) with an inhibition
range of 46–58%, and 26–46%, respectively. Otherwise, SPD extract inhibited only the growth of L.
monocytogenes strain (17% of inhibition). Taking into account the nature of the microorganism, the
results showed that L. monocytogenes was inhibited by all the PEP in the range of 17%–46%, regardless
of the drying process used (Figure 1).
Figure 1. Effect of PEP (1 mg/mL) on foodborne bacteria growth after 24 h of incubation. Results
represent the percentage of growth inhibition respect to the untreated control (100% of growth) and
are expressed as mean ±SD (n = 3). Bars marked with asterisk indicate significant growth inhibition
respect to the control by t-test (p ≤ 0.05). Freeze drying (FD); Vacuum drying 40 ◦C (VD 40 ◦C), 60 ◦C
(VD 60 ◦C), 80 ◦C (VD 80 ◦C); Spray drying (SPD).
C. jejuni, the leading cause of bacterial foodborne diarrheal illness worldwide, was also inhibited
for three of the powders used (FD, VD 40 ◦C, and VD 60 ◦C) in a range of 22–58%. FD and VD
60 ◦C (27–36%) affected the growth of S. aureus, while S. typhimurium and E. coli were the bacterial
strains with the lowest sensitivity to the all PEP. The different antibacterial activities by PEP against
foodborne bacterial strains may be related to the different composition of phenolic compounds of
each sample (Table 2), assuming that it is generally accepted that phenolic compounds, present in
plant extracts, play a mandatory role in their antibacterial effects [28]. However, as can be deduced
from Table 2, it is not the total concentration of phenolic compounds present in the sample, which
determines its antibacterial effect, but rather the presence of certain specific polyphenolic compounds
in the extract. In this regard, FD was the most active bactericidal extract (Figure 1), showed a significant
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higher concentration of quercetin-3-O-galactoside (hyperoside). Hyperoside is a flavonol glycoside
with variety of biological activities, including anti-inflammatory, antioxidant, and antimicrobial
activities [29–31]. Its antibacterial effect has been demonstrated both, against gram-negative bacteria
such as P. aeruginosa [32] and against gram-positive bacteria, such as S. aureus [33]. The results obtained
in this work suggest that the hyperoside could be involved in the antimicrobial effect observed, since
this compound has a significantly higher concentration in the powder obtained by FD, while the rest
of the phenolic compounds identified are in concentrations similar or lower than those obtained for
the rest of the extracts (Table 2). Apparently, the antibacterial effect of PEP used to be more effective
against gram-positive bacteria [14]. This behavior is influenced by differences in the cell membrane
constituents. Gram-positive bacteria contain an outer peptidoglycan layer, which is an ineffective
permeability barrier; meanwhile gram-negative bacteria have outer phospholipidic membrane carrying
structural lipopolysaccharide components, which represent an obstacle for polyphenolic compounds to
enter the cell cytoplasm [14,34]. This pattern is also observed in our work, except for C. jejuni. Although
it is a gram-negative bacterium, Campylobacter lacks many of the genetic regulatory networks found in
other gram-negative bacteria that allow them to respond to, and cope with, adverse conditions [35].
Accordingly, we have previously demonstrated that Campylobacter can be significantly inhibited by
different polyphenolic compounds [22,36]. Therefore, antibacterial activity of PEP could be modulated
depending of the drying procedure used. The drying process involves several variables, which can
change the polyphenolic composition of the extract, resulting in a modified antibacterial response.
3.4. Antioxidant Activity Against Intracellular Reactive Oxygen Species (ROS) Production
Oxidative stress is involved in several acute and chronic pathological processes due to its ability in
activating inflammatory pathways [37,38]. The antioxidant activity of plum polyphenolic compounds
has been previously investigated in different system models, such as ABTS, DPPH, FRAP, and ORAC
assays [5,16]. However, due to the absence of information on the scavenger activity of ROS in biological
models, we investigated the ability of PEP in reducing intracellular oxidative stress. The experiment
was carried out using similar concentrations of PEP to those used in the antibacterial activity assay
(1 mg/mL). This concentration did not significantly affect cell viability at 24 h after treatment (data
not shown). As shown in Figure 2, HT-29 cells, exposed to TBHP, increased the ROS level (oxidative
control). Pre-treatment of intestinal cells with PEP showed a significant (p < 0.05) reduction in cellular
ROS generation, stimulated by TBHP, compared with the oxidative control, except when the cells were
pre-treated with VD 40 ◦C sample. VD 80 ◦C and SPD caused the highest protection against oxidative
damage in stressed cells, inducing an inhibition percentage of ROS production close to 37% respect to
the oxidative control cells. Although, FD and VD 60 ◦C had a significant antioxidant activity with
respect to the experimental control, this was lower than the samples obtained with treatments carried
out at higher temperatures. Previously, others have shown that drying processes can influence the
antioxidant capacity of the dried products, observing an increase in the antioxidant capacity of plum
extracts dried by microwave vacuum at high temperatures [3]. Apparently, the temperature applied
during plum juice drying is related to the increase in the content of polyphenolic compounds able
to scavenge ROS, as the highest values of those compounds were noted after drying at 80 ◦C. In this
regard, the drying temperature of the PEP and the subsequent polyphenolic composition affected the
antioxidant capacity of the obtained powders, therefore, the extracts exposed to higher temperatures
during the drying process showed a higher content in the methyl 3-caffeoylquinate (Table 2) and
significantly improved antioxidant activities. It is well known that phenolic acids can prevent oxidative
damage because of their ability to scavenge ROS [39]. Within the phenolic acids, chlorogenic acid and
their derivatives, such as methyl 3-caffeoylquinate acid, act as potent ROS scavengers by donating
hydrogen atoms to reactive molecules, transforming them to less active radicals, and maintaining an
optimal cellular oxidative balance [40–42].
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Figure 2. Protective effect of PEP (1 mg/mL) on intracellular ROS production. HT-29 cells were
incubated with the powders for 24 h and then treated with 2.5 mM TBHP for 3 h, and ROS production
was determined. Values are expressed as a percentage relative to the control conditions and are
represented by mean ±SD (n = 3). Bars with different letters indicate significant differences on ROS
production by ANOVA post hoc LSD Tukey test (p ≤ 0.05). Freeze drying (FD); Vacuum drying 40 ◦C
(VD 40 ◦C), 60 ◦C (VD 60 ◦C), 80 ◦C (VD 80 ◦C); Spray drying (SPD).
Our findings show that PEP could induced cellular protection against TBHP-induced oxidative
stress by preventing intracellular ROS accumulation. However, the level of antioxidant capacity of the
PEP may be determined by the conditions applied during the drying process.
3.5. Anti-Inflammatory Activity
We investigated the impact of PEP on the inflammatory process in RAW264.7 cells stimulated
with LPS. During an inflammatory event, the inducible enzyme nitric oxide synthase (iNOS) is
responsible for an exacerbated production of NO, which can lead to tissue lesions, organ dysfunction,
and inflammation-related diseases [43]. As shown in Figure 3, LPS significantly (p < 0.05) stimulated
the production of NO in macrophages (Control+) with respect to non-stimulated cells (Control−).
The percentage of NO production was significantly (p < 0.05) reduced by 24–39% in RAW264.7 cells
pre-treated with PEP. Pre-treatment of LPS-stimulated cells with VD 80 ◦C and VD 60 ◦C powders
led to greater attenuation of NO production with an inhibition range between 33% and 39%. The rest
of the extracts had a similar behavior (p < 0.05), regardless of the drying treatment conducted, and
caused an attenuation in the production of NO in a range between 24% and 30%. Apparently, a greater
anti-inflammatory capacity would be influenced both, by the type of treatment used (VD > SPD > FD)
and by the temperature used in each treatment. Overall, this behavior is similar to that observed in the
results obtained from the analysis of antioxidant activity (ROS inhibition), where VD 80 ◦C was the
most active sample in both determinations. Some investigators have demonstrated that the cellular
inflammatory responses are caused because of ROS production [17,44]. Consequently, a reduction in
intracellular ROS levels could lead to an inhibition of the inflammation process through the reduction of
NO production. This postulate agrees with our results, since the samples that showed high antioxidant
activity by reducing intracellular ROS (Figure 2) also showed relevant anti-inflammatory properties by
reducing NO production (Figure 3).
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Figure 3. Effect of PEP (1 mg/mL) on nitric oxide (NO) production in LPS-stimulated RAW264.7
macrophage cells. Values are expressed as a percentage relative to the LPS-stimulated control group
and are represented by mean ±SD (n = 3). Bars with different letters indicate significant differences on
NO production by ANOVA LSD Tukey test (p ≤ 0.05). Freeze drying (FD); Vacuum drying 40 ◦C (VD
40 ◦C), 60 ◦C (VD 60 ◦C), 80 ◦C (VD 80 ◦C); Spray drying (SPD).
However, it is difficult to precise the main polyphenolic compounds that would be most involved
in the anti-inflammatory response observed, although apparently, several of them appear to be
involved. Previous studies have demonstrated that the anti-inflammatory effects of plum phenolic
compounds [1,18], mainly due to the presence of phenolic acids, can decrease the expression of
inflammatory mediators, such as nuclear factor κB (NF-κB), vascular cell adhesion molecule 1
(VCAM-1), cyclooxygenase-2 (COX-2), and iNOS mRNA [45]. In addition, plum phenolic compounds
can contribute to the modulation of the inflammatory responses in human cells by inhibiting various
inflammatory factors, such as cytokines IL-6 and IL-8 [17]. In addition, the potential anti-inflammatory
activity of the PEP could be particularly important, considering that activation inflammatory pathways
can stimulate proliferation of cancer cells [38].
4. Conclusions
This study has shown that plum extract powders gained after freeze-, vacuum-, and spray-drying
have promising antibacterial, antioxidant, and anti-inflammatory properties that have been tested in
different biological models. The drying processes significantly influences both, the physical properties
and the composition of polyphenols, and thus, the bioactive properties plum juice extract powders. The
drying techniques moderated the content of polyphenolic compounds in the powders, which influence
the different levels of growth inhibition against the foodborne pathogens, evidencing a strain-dependent
effect being the most relevant for FD extract. This extract inhibited significantly (p < 0.05) the growth
of all the bacteria studied, except E. coli strain. It was observed that L. monocytogenes was inhibited by
all the dried plum juice extracts in the range of 17–46%, regardless of the drying process used. These
powders could also induce cellular protection against oxidative stress by preventing intracellular ROS
accumulation, but the level of antioxidant capacity may be determined by the conditions applied
during the drying process. It was shown that VD 80 ◦C and SPD caused the highest protection
against oxidative damage in stressed cells, inducing an inhibition percentage of ROS production close
to 37% respect to the oxidative control cells. Moreover, plum extracts powders exhibited a greater
anti-inflammatory capacity, which would be influenced both, by the type of treatment used and by the
temperature used in each treatment, being the VD 80 ◦C - the sample with the highest protection level.
The results demonstrate that the drying method selected can be an effective tool for modulating the
composition, physical, and bioactive properties of plum extracts powders.
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Abstract: Biofilms are surface-associated microbial communities resistant to sanitizers and
antimicrobials. Various interactions that can contribute to increased resistance occur between
the populations in biofilms. These relationships are the focus of a range of studies dealing with
biofilm-associated infections and food spoilage. The present study investigated the effects of cinnamon
(Cinnamomum zeylanicum), marjoram (Origanum majorana), and thyme (Thymus vulgaris) essential oils
(EOs) and their main components, i.e., trans-cinnamaldehyde, terpinen-4-ol, and thymol, respectively,
on single- and dual-species biofilms of Escherichia coli, Listeria monocytogenes, Pseudomonas putida,
and Staphylococcus aureus. In dual-species biofilms, L. monocytogenes was paired with each of the
other three bacteria. Minimum inhibitory concentration (MIC) values for the individual bacteria
ranged between 0.25 and 20 mg/mL, and trans-cinnamaldehyde and cinnamon showed the highest
growth inhibitory effect. Single-species biofilms of L. monocytogenes, P. putida, and S. aureus were
inhibited by the tested EOs and their components at sub-lethal concentrations. Scanning electron
microscopy images showed that the three-dimensional structure of mature biofilms embedded in the
exopolysaccharide matrix disappeared or was limited to micro-colonies with a simplified structure.
In most dual-species biofilms, to eliminate living cells from the matrix, concentrations exceeding the
MIC determined for individual bacteria were required.
Keywords: antibacterial activity; biofilm; polymicrobial biofilm; essential oil; food spoilage
1. Introduction
Surfaces in the food industry provide an excellent substrate for the development of biofilms by
spoilage and pathogenic bacteria [1]. These biofilms are typically highly persistent and can increase the
likelihood of cross-contamination, potentially leading to food deterioration and/or serious food-borne
diseases [2–5].
Biofilms are heterogeneous in vivo, comprising different microorganisms that interact with each
other and form a complex multi-species community. Cooperation or competition occurs between
the species and it shapes the community by influencing attachment, microcolony formation, and/or
resistance to stress conditions [6–10]. Multi-species biofilms may exhibit enhanced fitness and react
differently to antimicrobials from monocultures and planktonic cells [11].
Contamination with Listeria monocytogenes causes a large number of food poisoning outbreaks
annually [12]. According to a study performed by the European Food Safety Authority in 2018, this
Microorganisms 2019, 7, 345 www.mdpi.com/journal/microorganisms27
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food-borne pathogen is the leading cause of hospitalization and death in Europe [13]. Listeriosis is
frequently associated with fish and fishery products, ready-to-eat salads, and different meat products.
Paté, butter, and soft and semi-soft cheeses are also potential carriers of the pathogen [13,14]. Its
persistence under different environmental stresses (e.g., low temperature) makes it difficult to eradicate
and cross-contamination risk is high [15]. Staphylococcus aureus, Escherichia coli, and Pseudomonas putida
strains are also associated with food spoilage and food poisoning outbreaks [16,17]. Moreover, certain
food-spoilage bacteria such as P. putida can enhance the adhesion, colonization, and biofilm formation
of L. monocytogenes, whereas others such as Staphylococcus sciuri can inhibit it [18,19]. Although the
chemical preservatives that are permitted in foods are considered to not cause any side effects, concerns
have been raised about the safety of nitrites and sulphites. To date, no conclusive evidence that
nitrite is directly carcinogenic has been provided, but at high doses it has been suggested to be a
co-carcinogen [20,21].
Against this background, there is increasing demand for healthier products and natural food
additives. To meet these demands, researchers have started to examine natural preservatives instead
of synthetic ones [22]. Plants are a source of a range of substances with antimicrobial properties, which
are promising candidates for the development of new anti-infective agents [23]. Among these, essential
oils (EOs) from aromatic and medicinal plants have been a focus of attention in recent decades [24–27].
In addition, the capacity of some EOs to inhibit biofilm formation in mono- and polymicrobial systems
has been documented, suggesting their potential utilization as food preservatives and sanitizing
agents [28–30]. In this context, targeting polymicrobial cultures with EOs might be effective for
reducing the growth and activity of food-related pathogens.
In previous studies, lemon, marjoram, and cinnamon EOs showed inhibitory effects against E. coli
and P. putida biofilms in mixed-culture systems [31,32]. Here the influence of cinnamon, marjoram,
and thyme EOs and their major components, namely, trans-cinnamaldehyde, terpinen-4-ol, and
thymol, respectively, on the formation of L. monocytogenes, E. coli, S. aureus, and P. putida mono- and
polymicrobial biofilms was investigated.
2. Materials and Methods
2.1. Bacterial Strains
The bacterial strains used in this study were provided by the Szeged Microbiological Collection
(SZMC). The Gram-positive L. monocytogenes SZMC 21307 and S. aureus SZMC 110007 and the
Gram-negative E. coli SZMC 0582 and P. putida SZMC 291T were used to form mono- and
dual-species biofilms.
For pre-culturing and biofilm formation, tryptic soy broth (TSB) containing (in %) peptone
from casein 1.7 (Merck; Budapest, Hungary), peptone from soy meal 0.3 (Oxoid; Hampshire,
UK), D(+)-glucose 0.25 (VWR; Debrecen, Hungary), NaCl 0.5 (VWR), and K2HPO4 0.25 was used.
Pre-culturing was performed for 18–20 h at the optimum temperature for the bacteria to achieve high
viable cell counts.
Dual-species biofilms were formed in TSB broth with L. monocytogenes paired with E. coli or
S. aureus at 37 ◦C, or with P. putida at 30 ◦C. Quantification of bacteria in the supernatants before and
after treatments was done by spreading on selective media (Palcam for L. monocytogenes, Chromocult
for E. coli, Pseudomonas Selective Agar for P. putida, and Baird Parker Agar for S. aureus). Lab M
Limited (Heywood, UK) provided the first three media and Biolab (Budapest, Hungary) provided
Baird Parker Agar.
2.2. EOs
EOs of cinnamon (Cinnamomum zeylanicum), marjoram (Origanum majorana), and thyme (Thymus
vulgaris) were purchased from Aromax Natural Products Zrt. (Budapest, Hungary). Their main
components, i.e., trans-cinnamaldehyde, terpinen-4-ol, and thymol, respectively, were obtained from
28
Microorganisms 2019, 7, 345
Sigma-Aldrich (Munich, Germany). The composition of the oils was determined by GC-MS (Agilent
GC: 6850 Series II; MS: 5975C VL MSD; Agilent, Santa Clara, CA, USA) using an Agilent 19091S-433E
(Agilent) column at the laboratory of Aromax Natural Products Zrt.
2.3. Determination of Minimum Inhibitory Concentration (MIC)
For the determination of MIC values, the EOs and their components were diluted in liquid culture
medium (TSB) in combination with Tween 40 (1%). At the concentration used, Tween 40 had no effect
on the viability of the investigated bacteria.
One hundred microliters of 24 h-old cell suspension (106 CFU/mL) of each bacterium in liquid
culture medium was added to each well of a 96-well microtiter plate, followed by 100 μL of the diluted
EO or its major component. Positive controls contained the inoculated growth medium without any
EOs or components, and negative controls contained EOs or components in sterile medium. After
24 h of incubation at the appropriate temperature (37 ◦C for E. coli, L. monocytogenes, and S. aureus and
30 ◦C for P. putida), absorbance was measured at 600 nm (SPECTROstar Nano Spectrophotometer;
BMG Labtech, Offenburg, Germany). Absorbance lower than 10% of the positive control samples, i.e.,
growth inhibition of 90% or more, was considered as the MIC value. Measurements were performed
in triplicate.
2.4. Mono- and Dual-Species Biofilm Formation
For biofilm formation, the method described by Peeters et al. [33] was used. Briefly, polystyrene
microtiter plates were inoculated with 200 μL of 24-h-old bacterial culture containing cell count of
approximately 108 CFU/mL. Following 4 h of cell adhesion at the corresponding temperatures, the
supernatant was removed, and the plates were rinsed with physiological saline. Subsequently, 200 μL
of fresh medium containing the EO or its component to be examined was added at MIC/2 concentration
to avoid total growth inhibition. Plates were further incubated for 24 h to allow a biofilm to form.
Positive controls contained the inoculated growth medium but without any EOs or components, and
negative controls contained EOs or their components in growth medium. Experiments were repeated
at least twice, and six parallel measurements were conducted each time.
The inhibition of biofilm formation was detected by the crystal violet staining method. Briefly,
after 24 h of treatment, the supernatant was removed, and the wells were rinsed with physiological
saline. For fixation of the biofilms, methanol was added, and the supernatant was removed again.
Then, 0.1% crystal violet (CV) solution was added to each well and, 20 min later, the excess dye was
removed by washing the plates under running tap water. The bound CV was released by adding
200 μL of 33% acetic acid followed by an incubation for 10 min at room temperature. The absorbance
was measured at 590 nm (SPECTROstar Nano Spectrophotometer).
For polymicrobial biofilms, except for those produced from the culture containing L. monocytogenes
and E. coli, 24-h-old liquid monocultures containing approximately 105 CFU/mL were mixed at a 1:1
ratio in TSB broth. In contrast, the inoculum size for L. monocytogenes and E. coli was 103 CFU/mL
because the cell count of the dual culture reached more than 1010 CFU/mL after 24 h when a larger
inoculum was used. For dual-species biofilms, the EO concentrations were chosen according to the MIC
values of the individual strains. For investigation of the possible interactions, for example, synergism
or antagonism between the species, concentrations corresponding to half and double the MIC level
were examined. When the MIC values were equal for the two species, the levels corresponding to
one-quarter of MIC, half of MIC, MIC, and double MIC were used.
2.5. Scanning Electron Microscopy (SEM) Observations
SEM was used to investigate the structural differences between biofilms before and after treatment
with selected EOs and their components.
Polymicrobial biofilms were prepared in six-well microtiter plates, where sterile 2 × 2 cm cover
slips served as the surfaces to which the cells attached. After 4 h of incubation, the cover slips were
29
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rinsed with sterile water, then, fresh medium containing the EOs or their components was added, and
the plates were further incubated for 24 h at 37 ◦C. The concentrations of EOs and components used in
this experiment were based on the results on dual-species biofilms.
Preparation of the cover slip-biofilm samples for SEM was performed as described previously [31].
Briefly, samples were immersed in 2.5% glutaraldehyde for 2 h at room temperature and then dehydrated
using increasing ethanol concentrations. Final dehydration was performed with t-butanol–100% ethanol
solution at different ratios, followed by absolute t-butanol. After replacing the t-butanol with a fresh
volume of it and storing the samples at 4 ◦C for 1 h, they were freeze-dried overnight. Before SEM
analysis, a gold membrane was applied, the whole field was examined, and photographs were taken
from relevant areas with a Hitachi S4700 scanning electron microscope (Hitachi, Tokyo, Japan). Changes
in the three-dimensional structure were mainly visualized with small scale magnification, while higher
magnification was used for a more detailed view of the cell wall degrading effect of EOs.
2.6. Statistical Analysis
Data were analyzed by one-way ANOVA followed by Tukey’s test or paired t-test using GraphPad
Prism version 6.0 (GraphPad Software Inc., San Diego, CA, USA. Differences were considered significant
at p < 0.05.
3. Results
3.1. Composition of EOs and MICs
The compositions of the EOs were previously determined by the producers, and detailed data
on them were also reported in previous studies [32,34]. The major components of the EOs were
terpinen-4-ol (33.5%) for marjoram, trans-cinnamaldehyde (93.1%) for cinnamon, and thymol (51.8%)
for thyme.
MIC values ranged between 0.25 and 20 mg/mL and the bacterium most sensitive to the agents
was found to be E. coli (Table 1). Among the substances investigated, cinnamon and the components
cinnamaldehyde and thymol presented the lowest MIC values. The latter result supports the generally
accepted finding that phenolics have the best antimicrobial activity among EO compounds [25,35,36].
Table 1. Minimum inhibitory concentration (MIC) of essential oils (EOs) and their components against








Cinnamon 0.25 1 0.25 0.4
Marjoram 0.5 1 4 2 2 1 3.2
Thyme 1.0 2 2 20 0.8
Trans-cinnamaldehyde 0.25 0.25 0.25 0.4
Terpinene-4-ol 2 1 4 4 1 3.2
Thymol 0.5 0.5 2 0.5 0.8
1 Results from Kerekes et al. (2013). 2 Results from Kerekes et al. (2016).
3.2. Anti-Biofilm-Forming Effect of EOs and Their Major Components
3.2.1. Monocultures
Table 2 summarizes the effects of the tested EOs on monoculture biofilms. For E. coli, each
components and the thyme EO showed significant inhibitory effect when compared to the control.
Cinnamon, despite its notable antibacterial effect, did not reduce the biofilm-forming ability of E. coli,
but its main component and thyme did. Thymol exhibited the best effect against biofilm formation.
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Table 2. Effect of essential oils and components (in MIC/2 concentration) on monoculture biofilm
formation of food-related bacteria.
Bacteria
Biofilm Formation (OD 590)
1
Positive Control Cinnamon Marjoram Thyme Trans-cinnamaldehyde Terpinene-4-ol Thymol
Escherichia coli 0.68 ± 0.17a 0.77 ± 0.13a 0.72 ± 0.10a 2 0.34 ± 0.02b 0.32 ± 0.08b 0.44 ± 0.11b 2 0.14 ± 0.02c
Listeria monocytogenes 1.34 ± 0.14a 0.14 ± 0.02c 0.28 ± 0.04b 0.30 ± 0.04b 0.17 ± 0.02c 0.34 ± 0.34b 0.53 ± 0.08b
Pseudomonas putida 1.52 ± 0.4a 0.48 ± 0.05d 0.08 ± 0.00b 2 0.51 ± 0.05d 0.70 ± 0.05d 1.09 ± 0.10b 2 0.43 ± 0.07d
Staphylococcus aureus 2.36 ± 0.07a 1.31 ± 0.30b 1.18 ± 0.20b 1.22 ± 0.16b 1.19 ± 0.17b 1.60 ± 0.30b 1.37 ± 0.41b
1 Data are presented as mean ± standard deviation of six replicates. Values within a row with different letters are
significantly different (p < 0.05). 2 Results from Kerekes et al. (2013).
All EOs and their investigated components had considerable anti-biofilm-forming effects on
L. monocytogenes, as reflected in significant differences compared with the control. Cinnamon and
trans-cinnamaldehyde were the best inhibitors and there were no significant differences between the
anti-biofilm-forming capacity of the EOs and their main components (p > 0.05). Similar results could
be seen in the case of P. putida, for which cinnamon, thyme, and their major components inhibited
biofilm formation, but no significant differences were observed among these groups. Marjoram and
terpinene-4-ol also had a strong effect against biofilm formation of all bacteria studied.
For S. aureus biofilms, all EOs and components tested proved to be effective against their formation.
Absorbance of the treated samples differed significantly from that in the control (p < 0.001), but not
from each other (Table 2).
3.2.2. Polymicrobial Cultures
L. monocytogenes and E. coli
The concentration used for cinnamon was 0.1–2 mg/mL and for trans-cinnamaldehyde
0.06–0.5 mg/mL. After biofilm formation for 24 h, the cell number of control samples was 11 log CFU/mL
for L. monocytogenes and 5 log CFU/mL for E. coli. Treatment with cinnamon at concentrations higher
than 0.1 mg/mL decreased the biofilm formation (CFU: 10 log CFU/mL for both bacteria) (Figure 1A).
At 0.25 mg/mL (MIC of E. coli), both bacteria grew up to 10 log CFU/mL each. At 0.5 mg/mL concentration
(double the MIC for E. coli and half the MIC for L. monocytogenes, see Table 1), a monoculture biofilm
appeared with Listeria being absent. From a concentration of 1 mg/mL (MIC for L. monocytogenes, see
Table 1), no survivors of either bacterium were detected. Trans-cinnamaldehyde exhibited similar
activity against biofilm formation as compared to cinnamon (Figure 1B).
After treatment with marjoram (concentration range: 0.5–8 mg/mL) and the component
terpinen-4-ol (concentration range: 1–8 mg/mL), cell number analysis showed that E. coli was
eliminated from the biofilm at the lowest concentration, so that this culture contained L. monocytogenes
cells only (p < 0.001). Biofilm elimination started form the lowest concentrations used (0.5 mg/mL for
marjoram and 1 mg/mL for terpinene-4-ol) (Figure 1C,D).
Finally, thyme EO (concentration range: 0.5–4 mg/mL) exhibited strong inhibitory effect against
the L. monocytogenes and E. coli mixed culture biofilm, at all the concentrations investigated (p = 0.03)
(Figure 1E). Moreover, no survivors were detected at 1 mg/mL (half the MIC for L. monocytogenes, see
Table 1). In addition, thymol (concentration range: 0.1–1 mg/mL) inhibited biofilm formation from its
lowest concentration (Figure 1F). Surviving cells were undetectable at the sub-MIC value of 0.2 mg/mL.
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Figure 1. Effect of essential oils (EOs) on the biofilm formation of Listeria monocytogenes and Escherichia
coli polymicrobial cultures. (A) cinnamon EO, (B) cinnamaldehyde, (C) marjoram EO, (D) terpinen-4-ol,
(E) thyme EO, and (F) thymol. Columns represent the OD590 values, dashed lines represent cell numbers
of L. monocytogenes, and dotted lines cell numbers of E. coli. Results are presented as mean ± standard
deviation of six replicates. Different letters indicate statistically significant differences between columns
(p < 0.05).
L. monocytogenes and S. aureus
In the control sample, 7 log CFU/mL was recorded for both bacteria after biofilm formation
for 24 h. All EOs and their components significantly decreased biofilm formation (Figure 2). The
results indicate that only concentrations higher than the MIC values were effective at eliminating the
bacteria. At 8 mg/mL (double the MIC for Listeria and more than double the MIC for S. aureus, see
Table 1), marjoram EO (concentration range: 1.6–8 mg/mL) eliminated Listeria from the mixed
culture, but S. aureus was still present (Figure 2E). At the same concentration, terpinen-4-ol
(concentration range: 1.6–8 mg/mL) reduced the CFU of both bacteria to an undetectable level
(Figure 2F). Similar results were obtained with cinnamon (concentration range: 0.2–2 mg/mL) and
its component trans-cinnamaldehyde (concentration range: 0.1–0.8 mg/mL) (Figure 2A,B). Moreover,
thyme (concentration range: 0.4–4 mg/mL) reduced polymicrobial biofilms from a concentration of 0.4
mg/mL (MIC for L. monocytogenes) (Figure 2C). Finally, thymol (concentration range: 0.2–1.5 mg/mL)
reduced the biofilm investigated and killed both bacteria from a concentration of 0.2 mg/mL (MIC for
Listeria) (Figure 2D).
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Figure 2. Effect of EOs on the biofilm formation of Listeria monocytogenes and Staphylococcus aureus
polymicrobial cultures. (A) cinnamon EO, (B) trans-cinnamaldehyde, (C) thyme EO, (D) thymol,
(E) marjoram EO, and (F) terpinen-4-ol. Columns represent the OD590 values, dashed lines represent
cell numbers of L. monocytogenes, and dotted lines cell numbers of S. aureus. Results are presented as
mean ± standard deviation of six replicates. Different letters indicate statistically significant differences
between columns (p < 0.05).
L. monocytogenes and P. putida
Figure 3 shows that the number of Listeria cells was 8 log CFU/mL and that of P. putida was 7 log
CFU/mL in the control samples. Concerning cinnamon EO (concentration range: 0.1–1 mg/mL) and
trans-cinnamaldehyde (concentration range: 0.1–1 mg/mL), significant reduction in biofilm formation
was observed at 0.1 mg/mL; although higher concentrations up to 0.5 mg/mL did not achieve better
inhibition (Figure 3A, B). Thyme EO (concentration range 1–20 mg/mL) inhibited the formation of
L. monocytogenes and P. putida co-cultured biofilm as well, at 1 mg/mL (Figure 3C). However, P. putida
was present (4 log CFU/mL) in the biofilm even at the highest concentration of thyme (20 mg/mL)
(Figure 3C), which was equal to the MIC against this bacterium (Table 1). Thymol was applied between
0.1–1 mg/L where biofilm inhibition and decrease in CFU started at the lowest concentration used.
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Figure 3. Effect of EOs and EO main components on the biofilm formation of Listeria monocytogenes and
Pseudomonas putida polymicrobial cultures. (A) cinnamon EO, (B) trans-cinnamaldehyde, (C) thyme
EO, (D) thymol, (E) marjoram EO, and (F) terpinen-4-ol. Columns represent the OD590 values, dashed
lines represent cell numbers of L. monocytogenes, and dotted lines cell numbers of P. putida. Results
are presented as mean ± standard deviation of six replicates. Different letters indicate statistically
significant differences between columns (p < 0.05).
Marjoram EO (concentration range: 1–8 mg/mL) decreased the number of P. putida cells at 8 mg/mL
by only 2 log CFU/mL compared with the control (double the MIC for Listeria and four times the MIC
for P. putida), (Figure 3E). Meanwhile terpinene-4-ol (concentration range: 1–8 mg/mL) eliminated both
bacteria from the biofilm at 8 mg/mL and had similar biofilm inhibitory effect to the parent oil.
3.3. SEM Observations
3.3.1. L. monocytogenes and E. coli
Cinnamon and trans-cinnamaldehyde were not used in these investigations due to their high
inhibitor effect. For Listeria and E. coli only thyme EO and thymol were chosen based on results
obtained for dual-species biofilm.
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Control samples showed the complex structure of the formed biofilm (Figure 4A), namely,
cells embedded in a large amount of possible extracellular polysaccharide (EPS) and forming a
three-dimensional structure. Treatment with thyme and thymol resulted in damaged, anamorph,
sparse micro-colonies and individual cells (Figure 4B–D).
 
Figure 4. Listeria monocytogenes and Escherichia coli biofilms observed using scanning electron microscope.
(A) control, (B) thyme EOs (0.5 mg/mL), and (C,D) thymol (0.1 mg/mL).
3.3.2. L. monocytogenes and S. aureus
Figure 5A,B present the findings for control samples of Listeria and Staphylococcus polymicrobial
biofilms. The three-dimensional structure embedded in the EPS layer can be observed with Listeria
cells are at the bottom, to which Staphylococcus clusters attach. After treatment with EOs, this structure
appears only in micro-colonies with a simple shape, the number of attached cells is decreased, and
mainly damaged cells are present. Samples treated with marjoram show split cocci, in agreement with
the fact that the EO’s target is the cell wall. In some cases, cell debris appears on the surface, which can
serve as a possible adhesion site for new cells (Figure 5C–F).
3.3.3. L. monocytogenes and P. putida
For Listeria and P. putida only thyme EO and thymol were chosen based on results obtained for
dual-species biofilm.
Figure 6A,B present the findings for control samples with nascent and fully formed cell-to-cell
connections and EPS material formation. Treatment with marjoram and its major component,
terpinen-4-ol, resulted in significant changes in the composition of these structures, leaving mainly
damaged cells and cell debris to be observed (Figure 6C,D).
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Figure 5. Listeria monocytogenes and Staphylococcus aureus biofilms observed using scanning electron
microscope. (A,B) control, (C) marjoram essential oil (EO) (1.6 mg/mL), (D) terpinen-4-ol (8 mg/mL),
(E) thyme EO (0.4 mg/mL), and (F) thymol (0.8 mg/mL).
 
Figure 6. Listeria monocytogenes and Pseudomonas putida biofilms observed using scanning electron
microscope. (A,B) control, (C) marjoram EO (1 mg/mL), and (D) terpinen-4-ol (1 mg/mL).
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Scanning electron microscopy images demonstrate the structural changes caused by EOs or
components during biofilm development [36]. The three-dimensional structure of matured biofilms
disappeared after EO treatment, the cells were damaged, and most of the treated cells had burst.
4. Discussion
In the present study we demonstrated that cinnamon, marjoram, and thyme EOs and main
components tested had good antibacterial and anti-biofilm forming effect on the investigated bacteria
associated with food spoilage and outbreaks. Trans-cinnamaldehyde and thymol were the best
inhibitors with MIC values below 1 mg/mL. As expected from the composition pattern of EO cinnamon,
the trans-cinnamaldehyde and the EO exhibited similar effect against the bacterial biofilms studied.
Besides this, thymol and trans-cinnamaldehyde are phenolics having the best antimicrobial activity
among the EO compounds. For comparison, the monoterpene terpiene-4-ol did not exceed the effect of
its parent oil marjoram.
Monoculture biofilms were significantly inhibited by the EOs and components in MIC/2
concentration which suggest that growth-reducing effect is not solely responsible for biofilm inhibition.
Sub-lethal damage of the cell wall can negatively influence bacterial attachment to surfaces which is
the first step in biofilm formation [29].
Dual-species biofilms responded to EOs differently. Contrary to our findings, Almeida et al. [37]
reported that, in dual-species (E. coli/L. monocytogenes) biofilms, cell densities were not altered. In
our case, L. monocytogenes outgrew E. coli in the control samples and most of the EOs eliminated this
bacterium from the biofilm. In line with this, the study of Giaouris et al. [9] concluded that Listeria
formed a stronger biofilm in mixed population, moreover, presence of other bacteria increased its
growth. Co-culturing of L. monocytogenes and S. aureus resulted a strong biofilm, which is in agreement
with the results of Millezi et al. [38]; only high concentrations of EOs (e.g., cinnamon EO: 1–2 mg/mL,
marjoram EO, and terpinene: 4–8 mg/mL) and components inhibited their formation. P. putida proved
to be more resistant to the oils and compounds than the Listeria and this bacterium was present in the
population even at high agent concentrations. This is in accordance with the results of Giaouris et al. [9]
who showed that co-culturing with L. monocytogenes within a dual-species biofilm increased the
community resistance of P. putida.
In most cases, anti-biofilm formation effect showed no concentration dependence above a certain
concentration, but the results of cell number determination were not congruent with this. In most cases,
dual-species biofilms were inhibited at lower concentration than the MIC of the individual bacteria,
but cell death occurred mainly at the higher MIC value or above. This discrepancy pointed to the fact
that absorbance and cell enumeration data can differ significantly. Biofilms, inhibited to a high degree
based on absorbance data, can still contain enough living cells to cause hygiene problems. Scanning
electron microscopic images demonstrated the structural changes caused by EOs or components during
biofilm development. Similarly to the altered biofilm structure visualized by confocal laser scanning
electron microscope in a recent study [39], our SEM pictures also showed that the three-dimensional
structure of matured biofilms disappeared after EO treatment and most of the treated cells have been
burst. Studying the mechanism of EOs in more detail, Zhang et al. [40] detected leakage of electrolytes
due to disruption of cell permeability after EO treatment which eventually lead to cell death. Along
with our findings these results also support the fact that EOs induce severe membrane damage [25,40].
In conclusion, the EOs and EO components examined in this study could represent alternatives
for elimination of E. coli, L. monocytogenes, P. putida, and S. aureus single and L. monocytogenes-E. coli/S.
aureus/P. putida dual biofilms in vitro with different efficiency. The use of EOs as antimicrobial agents in
real food systems is often limited due to their strong odor and taste. Therefore, our future investigations
aim at novel approaches, such as encapsulation of EOs, that could potentially reduce the organoleptic
impact and increase the antimicrobial activity [41].
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Abstract: This study proposes to exploit the in vivo metabolism of two probiotics (Bifidobacterium
longum subsp. infantis and Lactobacillus reuteri) which, upon adhesion on a solid surface, form a
biofilm able to control the growth of pathogenic and food spoilage bacteria. The results showed that
pathogenic cell loads were always lower in presence of biofilm (6.5–7 log CFU/cm2) compared to
those observed in its absence. For Escherichia coli O157:H7, a significant decrease (>1–2 logarithmic
cycles) was recorded; for Listeria monocytogenes, Staphylococcus aureus, and Salmonella enterica, cell load
reductions ranged from 0.5 to 1.5 logarithmic cycles. When tested as active packaging, the biofilm
was successfully formed on polypropylene, polyvinyl chloride, greaseproof paper, polyethylene
and ceramic; the sessile cellular load ranged from 5.77 log CFU/cm2 (grease-proof paper) to 6.94 log
CFU/cm2 (polyethylene, PE). To test the potential for controlling the growth of spoilage microorganisms
in food, soft cheeses were produced, inoculated with L. monocytogenes and Pseudomonas fluorescens,
wrapped in PE pellicles with pre-formed biofim, packed both in air and under vacuum, and stored
at 4 and 15 ◦C: an effective effect of biofilms in slowing the decay of the microbiological quality
was recorded.
Keywords: probiotic; biofilm; pathogen; spoilage bacteria; active packaging
1. Introduction
Despite that their use in foods is dated, in the last decades, Lactic Acid Bacteria (LAB) have
attracted much attention for their documented beneficial properties and for potential useful applications.
Among LAB, several strains are currently claimed as probiotics [1], i.e., live microorganisms that,
when administered in adequate amounts, confer a health benefit on the host [2]. According to
the consensus statement, there are some bacterial species with a long history of safe use and a
well-recognized health effect, such as Bifidobacterium adolescentis, B. animalis, B. bifidum, B. breve,
B. longum, Lactobacillus acidophilus, L. reuteri, L. casei, L. fermentum, L. gasseri, etc. [2]; some strains,
such as B. longum subsp. infantis and L. reuteri, are widespread due to the strong evidence of their effect
on health [3]. Probiotics are able to colonize, stably or transiently, host mucosal surfaces, including the
gut, where they may contribute to host health; the capacity of probiotics to colonize biotic and abiotic
surfaces by forming structured communities (i.e., biofilms), could have great potentials for human
Microorganisms 2020, 8, 177 www.mdpi.com/journal/microorganisms41
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health and food safety biotechnologies, although this aspect has is in fact barely been explored. It has
recently been shown that microbial biofilms may play several “useful” roles such as biodegradation of
toxic compounds and pollutants, bioremediation, toxic effluents treatment [4], despite being initially
considered only a negative phenomenon. These applications suggest that microbial biofilms could be
successfully used for new applications in the biomedical, industrial, food, and environmental field [4].
In the biomedical field, for example, a biofilm formed by probiotic microorganisms could be
potentially useful to hinder the development of microorganisms responsible for infections, especially
those caused by microorganisms of hospitals, typically resistant to common antibiotic treatments.
Indeed, it is widely accepted that in the development of direct and airborne transmission of nosocomial
infections, the hospital environment (infection reservoir) plays a key role [5]. In fact, it can be anticipated
that a probiotic biofilm left to form ad hoc on several surfaces (e.g., toilets, air conditioning systems)
could reduce the spread of pathogenic species that may harbor thereon. Other potential applications
in the biomedical field could be: preparations used in skin lesions for the healing processes to add
antibacterial capacity, the coating of implants and catheters, medical devices applied to the oral cavity
which might hinder the growth of bacterial species associated with caries and periodontal disease [6–9].
On the other hand, regarding potential applications in the food industry, biofilms can be used
to ensure the hygienic-sanitary safety of food products, as well as an extension of their shelf-life.
The formation of biofilms by “useful/probiotic” microorganisms may be stimulated on materials
commonly used to package food (plastic films, pellicles, combinations for packaging, paper, etc.) in
order to develop an innovative active packaging system. Although the scientific community is very
active in the production of research related to the ability of microorganisms to form biofilms, most
studies have focused on biofilm formation by pathogens and/or spoilage microorganisms (Enterobacter,
Listeria, Micrococcus, Streptococcus, Bacillus and Pseudomonas) [10–13]. It has been also shown that certain
species of LAB are able to form biofilms and some of them are capable of exhibiting antimicrobial
activity against pathogenic microorganisms [14–16]; some research was conducted on the possibility of
using new methods of sanitation, exploiting the principle of biological competition using probiotic
products [17], but this aspect needs to be explored further. In a previous study, we have described
the optimization of the production of a probiotic biofilm through intermediate steps by fixing some
valuable key points about the probiotics’ ability to adhere to surfaces and to form biofilms [18].
These results were used to file a patent covering the use of probiotic biofilms as a means to control
pathogen growth [19]. Even if some studies in literature present the use of LAB (mainly lactobacilli)
biofilms to control pathogen growth in food and superficies [20–27], most of them propose the use of
bio-surfactants and compounds with antimicrobial activity produced in greater quantities by lactobacilli
when growing in sessile form. Indeed, our study proposes a probiotic biofilm that exploits the in vivo
metabolism of two selected probiotic strains able to adhere rapidly on abiotic surfaces, and not the
substances secreted by them and subsequently recovered and used, as in the prior art. To the best of our
knowledge, only one study has previously proposed a similar approach evaluating the use of potential
probiotic LAB (isolated from Brazilian′s foods) biofilms to control Listeria monocytogenes, Salmonella
Typhimurium, and Escherichia coli O157:H7 biofilms formation and suggesting that LAB strains can be
excellent candidates to form protective biofilms to be used as biocontroller of contamination into the
food chain [28].
Besides the use as an innovative active packaging to ensure the safety of food products, as well
as an extension of their shelf-life, the proposed probiotic biofilm formed ad hoc on medical devices
(catheters, implants, braces, bite blocks or condoms) and on bathrooms’ surfaces (sink, bidet, toilet
bowl, water closet or piece of furniture) could be considered a tool against colonizing strains, since these
surfaces are often implicated in nosocomial infections. Our proposal could lead to the development of
a useful means to control the growth of pathogenic and spoilage bacteria for industrial and medical
applications. In the following, some specific applications of the developed probiotic biofilm are
described, focusing on two different aspects: 1) effect of probiotic biofilms on pathogen sessile growth;
2) application as potential active packaging.
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2. Materials and Methods
2.1. Effect of Probiotic Biofilms on Pathogen Sessile Growth
2.1.1. Surfaces and Microorganisms
Polycarbonate resin (Lexan, Fedele s.r.l., Rome, Italy) was the surface chosen for the adhesion
experiments. Before each experiment, the chips (2.5 × 5.0 × 0.05 cm) were prepared by washing in
acetone for a minimum of 30 min, rinsing in distilled water, and then soaking in 1 N NaOH for 1 h.
After a final rinse in distilled water, the chips were allowed to air dry. This cleansing procedure was
required to remove fingerprints, oils grease, and other soils that may have been on the materials.
The cleaned chips were finally autoclaved at 121 ◦C for 15 min prior to use.
The probiotic strains used for this study were Bifidobacterium longum subsp. infantis DSM20088
and Lactobacillus reuteri DSM20016, both purchased from Leibniz-Institut DSMZ (Deutsche Sammlung
von Mikroorganismen und Zellkulturen) and stored at −20 ◦C in MRS broth (Oxoid, Milan, Italy).
Before each assay, they were grown in their optimal media at their optimal conditions, until late
exponential phase was attained; namely, MRS broth added with cysteine 0.05% (w/v) (Sigma-Aldrich,
Milan, Italy) incubated at 37 ◦C for 24 to 48 h, under anaerobic conditions, and MRS broth (Oxoid)
incubated at 30 ◦C for 24 to 48 h, under anaerobic conditions, were used for B. infantis DSM20088 and
L. reuteri DSM20016, respectively.
Cells cultures were successively harvested by centrifugation for 10 min at 4500 rpm (4 ◦C) and the
pellets were washed twice with sterile saline solution (0.9% NaCl) at 4 ◦C and finally resuspended in
the same solution at a cell concentration of 1 × 108 CFU/mL.
As pathogen targets were chosen, four strains belonging to the Culture Collection of the Laboratory
of Predictive Microbiology (Department of the Science of Agriculture, Food and Environment, Foggia
University), and microorganisms with the media and growth conditions used, have been listed in
Table 1. The organisms were transferred to fresh Nutrient Agar (NA, Oxoid) periodically to maintain
viability and, prior to use, they were activated by two successive 24-h transfers of cells in Nutrient broth
(NB, Oxoid) at 37 ◦C. Inocula for experiments were prepared by centrifugation of the 24-h microbial
cultures at 3000× g for 15 min at 4 ◦C. After centrifugation, the obtained pellets were resuspended in
sterile saline solution at 4 ◦C to obtain approximately 108 CFU/mL for each microorganism.
Table 1. Pathogen strains used in the study with the indication of their source and optimal media and
growth conditions adopted.
Strains Source
Optimal Media and Growth
Conditions
Listeria monocytogenes *
Culture Collection of the Laboratory of
Predictive Microbiology, SAFE,
University of Foggia
Listeria selective agar base (Oxoid) plus
Listeria selective supplement-Oxoid
formulation, incubated at 37 ◦C for 48 h
Escherichia coli O157:H7 CECT 4267 Sorbitol MacConkey Agar (Oxoid),incubated at 37 ◦C for 24 h
Staphylococcus aureus ATCC 25923
Baird-Parker Agar Base (Oxoid) plus
Egg Yolk Tellurite Emulsion, incubated
at 37 ◦C for 24 h
Salmonella enterica ATCC 35664
Chromatic Salmonella Agar (Liofilchem,
Roseto degli Abruzzi, Teramo, Italy),
incubated at 37 ◦C for 24 h
* The strain was isolated from fish products and identified by sequencing the 16SrDNA.
2.1.2. Experiment
Biofilm formation was favoured by simultaneously inoculating the cocktail of identified probiotics
(B. infantis DSM20088 and L. reuteri DSM20016, about ~108 CFU/mL) and the pathogenic target
(~107 CFU/mL) on polycarbonate surfaces (Lexan® tiles, 25 mm × 75 mm, 0.5 mm thick) left at
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room temperature (20 ◦C) for 2 h. After this time interval, the tiles were transferred to aliquots of
peptone water (1% bacteriological peptone) and incubated at 15 ◦C for 48 h [18,19]. Specifically,
for each pathogen, two samples were prepared: an ACTIVE sample (ACT), containing a chip where
probiotics were left to form biofilm; a CONTROL sample (CNT), containing a chip without probiotics.
The pathogen sessile cell load was determined after 0, 4, 24, 30 and 48 h after inoculation. At these
times, chips were aseptically removed and rinsed with sterile distilled water, in order to eliminate the
unattached cells. As suggested in literature [29], sessile cells were detached from chips in a sterile test
tube containing 45 mL of sterile saline with a 20 Hz “Vibra Cell” sonicator (SONICS, Newcastle, Conn.,
USA) for 3 min. Viable and cultivable cells were enumerated by serial dilutions in 0.9% NaCl solution
and plating on appropriate media (Table 1).
2.2. Application as Potential Active Packaging
2.2.1. Probiotic Biofilm Formation on Different Materials
The materials assayed were polypropylene (PP), polyvinyl chloride (PVC), greaseproof paper (GP),
waxed paper (WP), polyethylene (PE) and ceramic; all materials were cut in rectangles of 2.5 × 5.0 cm and
cleaned by immersion in ethanol. Each individual chip was well rinsed with ultrapure water and dried at
room temperature. Probiotic biofilms were left to form for 96 h by simultaneously inoculating the cocktail
of probiotics (B. infantis DSM20088 and L. reuteri DSM20016, about ~108 CFU/mL) on chips of different
materials, left at room temperature (20 ◦C) for 2 h. After this time interval, the chips were transferred to
aliquots of peptone water (1% bacteriological peptone) and incubated at 15 ◦C for 96 h [19].
Biofilm cells were enumerated at 2, 24, and 96 h after inoculation. At these times, chips were
aseptically removed and rinsed with sterile distilled water, in order to eliminate the unattached cells.
Sessile cells were detached from chips in a sterile test tube containing 45 mL of sterile saline with a
“Vibra Cell” sonicator (SONICS, Newcastle, Conn., USA) at 20 kHz for 3 min. Viable and cultivable
cells were enumerated by serial dilutions in 0.9% NaCl solution and plating on MRS Agar (Oxoid).
2.2.2. Challenge Tests
Inoculations for experiments were prepared by centrifugation of the 24-h microbial cultures in
an ALC 4239R centrifuge (ALC, Milan, Italy) at 3000× g for 15 min at 4 ◦C. For the inoculations of
challenge tests, after centrifugation the pellets were resuspended in sterile isotonic solution (0.9%
NaCl) at a temperature of 4 ◦C and serial dilutions were made to obtain approximately 104 CFU/mL
for each microorganism. For biofilm formation, the probiotic pellet was resuspended in sterile isotonic
solution at a temperature of 4 ◦C and used on polyethylene films to form experimental pellicles with
pre-formed probiotic biofilm (EXP).
Miniature soft cheeses were made using pasteurized, whole and homogenized milk, purchased
in a local market. The milk had the following characteristics: lactose 5.0%, protein 3.2%, fat 3.6%,
pH 6.6. The cheeses were produced using a domestic cheese-maker (“Casaro”, Philips, Milan, Italy)
by pouring the milk into the single-wall cheese-maker vessel and heating to 85 ◦C. As soon as the
temperature reached 85 ◦C (after a few minutes), 4 g/L of sodium chloride was added and the salted
milk was immediately left to cool to 30 ◦C. Renneting was performed with 3 mL/L of liquid calf rennet
(concentrate extract of Liquid Rennet, CHR. Hansen s.p.a., Milan, Italy). After coagulation and curd
strengthening (approximately 40 min), the curd was cut and the whey discarded. Finally, miniature
soft cheeses of a round shape (25 g, 6 cm diameter) and regular smooth surfaces were made by hand
and placed in sterile boxes fitted with a grid to facilitate whey draining. The boxes were kept at room
temperature for 6 h until packaging.
To test the potential for probiotic biofilms to control the growth of microorganisms in soft cheese,
they were inoculated with L. monocytogenes (challenge test A) and Ps. fluorescens (challenge test B).
The inoculation (about 102 CFU/g) was carried out in the most homogeneous way possible, spreading
0.2 mL of the prepared microbial suspension across the entire surface of miniature cheese by means of a
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sterile spatula. After inoculation, all cheeses were wrapped in polyethylene films (EXP) and packed in
high-barrier plastic bags (Nylon/Polyethylene, 102 μm (Tecnovac, San Paolo D’Argon, Bergamo, Italy))
by means of S100-Tecnovac equipment. Control batches were prepared by wrapping cheeses in pellicles
without pre-formed biofilm (CNT). All samples were packaged in air and under vacuum. During the
storage at 4 and 15 ◦C for 28 and 14 days, respectively, microbiological analyses, determination of pH
and measurements of aw were made, details of which are given below.
2.2.3. Microbiological, Chemico-Physical and Sensorial Analyses
For microbiological analyses, mini-cheeses (25 g) were diluted with 225 mL of 0.1% peptone water
with salt (0.9% NaCl) in a Stomacher bag (Seward, London, England) and homogenized for 1 min in
a Stomacher Lab Blender 400 (Seward). Serial dilutions of cheese homogenates were plated on the
surface of the appropriate media in Petri dishes. The media and the conditions used were: Listeria
selective agar base (Oxoid) plus Listeria selective supplement-Oxoid formulation, incubated at 37 ◦C
for 48 h, for L. monocytogenes; Pseudomonas Agar Base (Oxoid) plus Pseudomonas CFC Supplement,
incubated at 25 ◦C for 48 h, for Ps. fluorescens; MRS agar (Oxoid), incubated at 30 ◦C for 4 days under
anaerobiosis, for mesophilic lactobacilli.
For each batch, the measurement of pH was performed twice on the first homogenized dilution of
the cheese samples during storage with a Crison pH meter model micro pH 2001 (Crison). aw was
measured by a hygrometer AQUALAB CX-2 (Decagon Device, Pullman, WA, USA).
During the storage at 4 and 15 ◦C, a sensory evaluation was also performed: the panel consisted of
15 panelists aged between 22 and 38 years (students and researchers of the Department of the Science
of Agriculture, Food and Environment (SAFE), University of Foggia). Using a scale ranging from 0 to
10 (where 10 stands for the most attractive attributes and 0 for the absolutely unpleasant attributes),
the sensorial overall quality of the samples was determined by evaluating colour, odour, texture and
overall acceptability. During the test sessions, cheese samples were coded by a letter and presented
individually to each panelist in plastic cups covered with a lid in random order. Sensory evaluation
was conducted in individual booths under controlled conditions of light (white light), temperature
(20 ± 2 ◦C), and humidity (70% to 85%).
2.2.4. Statistical Analyses
All experiments were performed twice with the analyses conducted twice.
Results about the effect of probiotic biofilms on pathogen sessile growth were expressed as log
CFU/cm2, presented as the average of replicates (n = 4) and analyzed through the Student’s t-test
(p < 0.05).
To highlight the effectiveness of probiotic biofilm, for each time of analysis the pathogen sessile
data were expressed as follows:
Biofilm Efficacy = CNT − ACT
where CNT and ACT were pathogen cell numbers (log CFU/cm2) in the control (without probiotic
biofilm) and in the active sample (with probiotic biofilm). These differences were analysed through
one-way ANOVA and Tukey’s test as the post-hoc comparison test (p < 0.05). Results about biofilm
formation on different materials were expressed as log CFU/cm2, presented as the average of replicates
(n = 4) and analyzed through one-way ANOVA and Tukey’s test as the post-hoc comparison test
(p < 0.05).
The microbiological data collected during the challenge tests were expressed as the average of
two replicates and the obtained mean values (one for experiment) were modelled according to the
Gompertz equation modified by Zwietering et al. [30]:
y = k + A ∗ exp{−exp[(μmax ∗ e/A) ∗ (λ− t) + 1]}, (1)
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where y is the concentration of the microorganism (Log CFU/ g), k is the initial level of the dependent
variable to be modelled, A is the difference between the decimal logarithm of the initial value of cell
concentration and the decimal logarithm of maximum bacteria growth attained at the stationary phase
(Log CFU/g), μmax is the maximal growth rate (1/day), λ the lag time (day) and t the time.
Following Castillejo Rodriguez et al. [31], the sanitary risk time for the growth of L. monocytogenes
in our samples was determined as the time (in days) that it took to observe an increase of 2 Log CFU/g
of the count of this microorganism in food as follow:
sanitary risk time [SRT] = 2/μ, (2)
where μ is the maximal growth rate.
For the growth of Ps. fluorescens, the maximum acceleration of microbial growth (dy2/dt2 (day)),
known as stability time, was also estimated with the Gompertz equation, following Riva et al. [32].
To determine whether significant differences (p < 0.05) existed among the parameters calculated
by using the Gompertz equation, a one-way analysis of variance (ANOVA), followed by Tukey’s test,
was conducted.
Modeling was performed through the software Statistica for Windows version 10.0 (Statsoft, Tulsa,
OK, USA).
3. Results and Discussion
3.1. Effect of Probiotic Biofilms on Pathogen Sessile Growth
In order to evaluate the effect of probiotic biofilms on the development of pathogenic
microorganisms, evidence was provided on the growth in sessile form of L. monocytogenes, E. coli
O157:H7, St. aureus and S. enterica. Table 2 shows the cellular loads in sessile form relating to the
targets studied; the data analysis shows how the pathogens studied were able to develop in all
samples, even if they exhibited a wide range in their ability to colonize the surface, with the highest
initial adhesion recovered for S. enterica (about 6 log CFU/cm2) against the lowest one (about 4 log
CFU/cm2) recovered for L. monocytogenes. However, cellular loads were always lower in ACT samples
(presence of probiotic biofilm, about 6.5–7 log CFU/cm2) compared to the CNT samples (absence of
probiotic biofilm), highlighting that the studied biofilm was able to control the growth of all inoculated
pathogenic targets. To quantify the effectiveness of probiotic biofilms in slowing down the pathogens’
adhesion, for each time of analysis the difference between the cellular loads recovered in CNT and
ACT samples was calculated. As it can be inferred from Table 2, for E. coli O157:H7, there was a
significant decrease in cell load compared to control of more than 1 and 2 logarithmic cycles after 4
and 48 h of incubation, respectively, and the biofilm efficacy increased over time. Similar results were
observed for St. aureus. On the contrary, for L. monocytogenes the effectiveness of probiotic biofilm was
maximum after 4 h (1.43 ± 0.28), but it decreased over time; this loss of efficacy was also recorded
for S. enterica, with cell load reductions ranging from 1 to 0.2 logarithmic cycles after 24 and 48 h,
respectively. As expected, biofilms were odorless and invisible to the naked eye. The idea to use
probiotics into the prevention of infections and other diseases has already been proposed [7], and is
also stimulated by the need of new alternative intervention strategies to combat bacteria pathogenesis
due to the increasing evidence of antibiotics resistance of many pathogens. Abdelhamid et al. [33]
observed that cell-free preparations of different probiotics belonging to Lactobacillus and Bifidobacterium
species were able to reduce the growth of E. coli, whereas Kaboosi [34] showed that probiotics from
yogurts had antibacterial effects against Gram negative bacteria such as E. coli, Salmonella Typhi and
Ps. aeruginosa, and Gram positive bacteria such as S. aureus. Similarly, Tejero-Sariñena et al. [35] found
that 15 strains of probiotics had antibacterial properties against gram negative Salmonella Typhimurium
and Clostridium difficile. However, most of these studies propose the use of compounds (mainly
bio-surfactants) with antimicrobial activity produced by probiotics, and contained in their cell-free
supernatants [20–27]; on the contrary, this study proposes the use of a probiotic biofilm that exploits
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the in vivo metabolism of two bacterial strains (Lactobacillus and Bifidobacterium) adhering on abiotic
surfaces and not the substances secreted by probiotics and subsequently recovered and used. In 2014
Schobitz et al. [36] proposed a biocontroller consisting of the thermally treated fermentate (TTF)
from two Carnobacterium maltaromaticum strains (ATCC PTA 9380 and ATCC PTA 9381), a strain of
Enterococcus mundtii (ATCC PTA 9382), plus nisin at a concentration of 1000 IU/mL, with all these
components entrapped in an alginate matrix supported by a mesh-type fabric. The strains used in our
study are different, and no bacteriocin or polymer is used, but the proposed probiotic biofilm should
be formed on different surfaces chosen according the purpose (an active packaging and/or a medical
device). Moreover, our solution, thanks to the maintenance of a continuous metabolism, should ensure
an uninterrupted and stronger activity of the active substances (mainly bacteriocins and/or other
LAB-produced antimicrobial compounds such as hydrogen peroxide, carbon dioxide, diacetyl, organic
acids), being the same in loco produced [37]. Similar to our study, Gomez et al. [28] used in situ
biofilms formed by potential probiotic LAB strains isolated from Brazilian′s foods (Lactococcus lactis
VB69, L. lactis VB94, Lactobacillus sakei MBSa1, Lactobacillus curvatus MBSa3, L. lactis 368, Lactobacillus
helveticus 354, Lactobacillus casei 40, and Weissela viridescens 113) to inhibit pathogenic growth: they
found the total inhibition in pathogens E. coli O157:H7, L. monocytogenes and Salmonella Typhimurium
biofilm formation, in 24, 48, and 72 h of exposure using L. lactis 368, Lactobacillus curvatus MBSa3 and
Lactobacillus sakei MBSa1. For the other strains, the inhibition was time-dependent and varied according
to the strain and target pathogen; for L. monocytogenes, reductions ranged from 4- to 7-log units over
24 and 48 h, and the inhibition was observed only within the first 24–48 h, after which the pathogen
was able to grow. In Salmonella Typhimurium and E. coli O157:H7 experiments, sessile cells were not
detected during 24 h of incubation in the presence of most LAB tested; during 48 and 72 h, reductions
between 5 and 3 log for E. coli O157:H7 and 4 log for Salmonella Typhimurium were achieved.
Table 2. Cellular loads (Log CFU/cm2) recovered for Listeria monocytogenes, Escherichia coli O157:H7,
Staphylococcus aureus and Salmonella enterica during their sessile growth with (ACTIVE, ACT) or without
(CONTROL, CNT) probiotic biofilms.
L. monocytogenes
Time (h) CNT ACT ** Biofilm Efficacy
0 4.21 ± 0.01 A,* 3.46 ± 0.12 B 0.75 ± 0.17 a,***
4 4.82 ± 0.16 A 3.39 ± 0.20 B 1.43 ± 0.28 b
24 4.83 ± 0.13 A 4.10 ± 0.10 B 0.73 ± 0.14 a
30 5.18 ± 0.25 A 4.31 ± 0.11 B 0.87 ± 0.16 a
48 4.91 ± 0.01 A 4.23 ± 0.10 B 0.68 ± 0.14 a
E. coli O157:H7
Time (h) CNT ACT Biofilm Efficacy
0 5.49 ± 0.01 A 5.20 ± 0.25 A 0.29 ± 0.35 a
4 5.43 ± 0.14 A 4.19 ± 0.22 B 1.24 ± 0.31 b
24 5.56 ± 0.41 A 4.10 ± 0.01 B 1.46 ± 0.01 b
30 6.13 ± 0.30 A 3.82 ± 0.01 B 2.31 ± 0.01 c
48 6.00 ± 0.25 A 3.80 ± 0.20 B 2.20 ± 0.28 c
St. aureus
Time (h) CNT ACT Biofilm Efficacy
0 5.07 ± 0.20 A 4.88 ± 0.01 A 0.19 ± 0.01 a,b
4 5.02 ± 0.03 A 4.70 ± 0.33 A 0.32 ± 0.47 b,c
24 5.57 ± 0.14 A 4.89 ± 0.19 B 0.68 ± 0.27 b,c
30 5.16 ± 0.01 A 3.86 ± 0.22 B 1.30 ± 0.31 c,d
48 5.16 ± 0.30 A 3.71 ± 0.05 B 1.45 ± 0.07 d
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Table 2. Cont.
Salmonella enterica
Time (h) CNT ACT Biofilm Efficacy
0 5.94 ± 0.10 A 4.37± 0.10 B 1.57 ± 0.14 a
4 5.38 ± 0.10 A 4.47 ± 0.16 B 0.91 ± 0.23 b
24 5.53 ± 0.15 A 4.54 ± 0.13 B 0.99 ± 0.18 b
30 5.35 ± 0.23 A 4.88 ± 0.05 B 0.47 ± 0.07 c
48 4.98 ± 0.30 A 4.77 ± 0.00 B 0.21 ± 0.00 c
* A, B, Values in the same lines with different letters are significantly different (Student′s t-test) (p < 0.05). ** Biofilm
Efficacy = CNT–ACT. *** a, b, c, d, Values in the same columns with different letters are significantly different
(one-way ANOVA and Tukey′s test) (p < 0.05).
3.2. Application as Potential Active Packaging
Once ascertained the effects on pathogens growth, the research focused on the formation
of the probiotic biofilm on different packaging materials, in order to individuate an innovative
packaging system.
The results obtained are shown in Table 3; after only 2 h, the probiotic biofilm was successfully
formed on all tested materials, except for waxed paper. The sessile cellular load ranged from 5.77 log
CFU/cm2 (grease-proof paper) to 6.94 log CFU/cm2 (polyethylene). After 96 h, polyethylene and ceramic
resulted the materials on which the highest adhesion was recorded (6.54 log CFU/cm2). In general,
any surface (plastic, rubber, glass, metal, paper, cement, stainless steel or wood, or food products
themselves) are vulnerable to biofilm development and each biofilm is different, thus suggesting that
every situation should be analysed individually and specifically [38].
Table 3. Cellular probiotic load in sessile form (log CFU/cm2) observed on common packaging materials
used in the food industry and on ceramic.
Materials Cellular Probiotic Load in Sessile Form (log CFU/cm2)
2 h 24 h 96 h
Polypropylene (PP) 6.64 ± 0.00 A 6.14 ± 0.48 A 5.88 ± 0.23 A
Polyvinyl chloride (PVC) 6.54 ± 0.14 A 5.65 ± 0.10 A 5.87 ± 0.30 A
Greaseproof paper (GP) 5.77 ± 0.23 B 5.24 ± 0.15 B 5.25 ± 0.06 B
Waxed paper (WP) No adhesion 4.61 ± 0.22 C 4.53 ± 0.13 C
Polyethylene (PE) 6.94 ± 0.00 A 6.03 ± 0.38 A 6.54 ± 0.14 D
Ceramic 6.86 ± 0.20 A 6.24 ± 0.23 A 6.54 ± 0.14 D
A, B, C, Values in the same columns with different letters are significantly different (one-way ANOVA and Tukey′s
test) (p < 0.05).
Once individuated in polyethylene (PE) the material able to ensure the greatest adhesion of
probiotics, in a second step, the attention was focused only on this material and it was used to test the
potential for probiotic biofilms to control the growth of microorganisms in soft cheeses. The products
were inoculated with L. monocytogenes (challenge test A) and Ps. fluorescens (challenge test B), wrapped
in PE pellicles with pre-formed probiotic biofim, packed both in air and under vacuum, and stored
at 4 and 15 ◦C. These model bacteria were chosen as main representatives of pathogen and spoilage
bacteria naturally contaminating soft cheese [39,40].
At 4 ◦C, the cellular load of L. monocytogenes remained lower than 3 log CFU/g for the entire
observation period (28 days), regardless the presence of the probiotic biofilm or the packaging.
On the other hand, at 15 ◦C (simulated thermal abuse), the λ length was always longer in samples
containing probiotic biofilms (EXP samples), if compared to CNT samples (without probiotic biofilms)
(Table 4): its value increased from 0.04 to 3.37 days (in air packaging, Figure 1A) and from 0.00 to
2.40 days (under vacuum, Figure 1B). The growth rate (μmax) was also influenced by the presence
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of probiotic biofilms, recording a decrease from about 0.7 to 0.4 Log(CFU/g)/day, in both packaging
conditions. The maximum cell load reached in the stationary phase (A + N0) was not influenced,
reaching approximately 5.6–5.7 log CFU/g, regardless of the presence or absence of probiotic biofilms.
The cellular load of lactic bacteria (LAB) was also monitored, as well as pH and water activity. At 4 ◦C,
the initial LAB count was 5.75 ± 0.18 log CFU/g in the control samples against 8.32 ± 0.20 log CFU/g in
the experimental cheeses; after 28 days, there were no statistically significant differences between the
samples (regardless of the presence of probiotic biofilms and the type of packaging), recording cellular
loads between 7 and 8 log CFU/g (data not shown).
Table 4. Kinetic parameters calculated by fitting Gompertz equation to the experimental data by
L. monocytogenes and Ps. fluorescens during their growth in soft cheeses with (EXP) or without (CNT)
probiotic biofilms, packed in AIR o under vacuum (UV) and stored at 15 ◦C. (A + No) is the maximum
bacterial load attained at the stationary phase, μmax is the maximal growth rate, λ is the lag time, TRS is










CNT AIR 5.66 ± 0.31 A 0.69 ± 0.14 A 0.04 ± 0.67 A 2.88
EXP AIR 5.37 ± 0.20 A 0.43 ± 0.19 A 3.37 ± 1.06 B 4.62
CNT UV 5.94 ± 0.85 A 0.68 ± 0.09 A 0.00 ± 0.00 A 2.95










CNT AIR 5.95 ± 0.33 A 0.41 ± 0.23 A 0.54 ± 0.61 A 2.54
EXP AIR 5.66 ± 0.18 A 0.33± 0.09 A 4.40 ± 0.74 B 6.59
CNT UV 6.00 ± 0.19 A 0.28 ± 0.05 A 0.00 ± 0.50 A 3.03
EXP UV 5.84 ± 0.25 A 0.26 ± 0.05 A 3.33 ± 0.76 B 6.35
A, B, Values in the same columns with different letters are significantly different (one-way ANOVA and Tukey′s
test) (p < 0.05). *, TRS, sanitary risk time, i.e., the time required (in days) to observe an increase of 2 log CFU/g in




Figure 1. Evolution of L. monocytogenes during the challenge test at 15 ◦C. EXP, cheeses stored with
probiotic biofilms; CNT, cheeses stored without probiotic biofilm. (A), AIR packaging; (B), under
vacuum packaging (UV).
Additionally, for the pH, no significant differences between the samples were observed;
this parameter decreased from 5.31–5.39 to 4.70–4.84 at the end of storage. In all samples, the value of
water activity remained constant (0.99–1.00) for the entire duration of the experimentation (data not
shown). Similar results were observed at 15 ◦C.
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During the experimentation, both at 4 and 15 ◦C, a gradual decrease of the score from 10 to
about 5.5–6 was recorded (end of storage), regardless of the presence of probiotic biofilms and the
type of packaging applied, showing that the probiotic microorganisms had no impact on the sensory
characteristics of cheeses; as an example, Figure 2 shows the sensorial scores for colour, odour, texture
and overall acceptability of cheeses recovered during storage at 4 ◦C.
Figure 2. Sensorial scores for colour (A), odour (B), texture (C) and overall acceptability (D) of cheeses
inoculated with L. monocytogenes stored at 4 ◦C. Mean values ± standard deviation. EXP, cheeses stored
with probiotic biofilms; CNT, cheeses stored without probiotic biofilm.
Figure 3; Figure 4 show the evolution of Ps. fluorescens during the growth on EXP and CNT
cheeses stored at 4 and 15 ◦C, respectively. The target microorganism was able to grow under all
tested conditions, regardless of the presence of probiotic biofilms and the type of packaging. At 4 ◦C
(Figure 3), the presence of the probiotic biofilm was able to influence the maximum cellular load
reached in the stationary phase (A + N0), which was significantly lower in the EXP samples (5.59–5.72
log CFU/ g) compared to the CNT samples (6.36–6.39 log CFU/g). No influence was observed about
the λ length and the maximum growth rate (μmax).
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Figure 3. Evolution of Ps. fluorescens during the challenge test at 4 ◦C. EXP, cheeses stored with
probiotic biofilms; CNT, cheeses stored without probiotic biofilm. (A), AIR packaging; (B), under
vacuum packaging (UV).
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Figure 4. Evolution of Ps. fluorescens during the challenge test at 15 ◦C. EXP, cheeses stored with probiotic
biofilms; CNT, cheeses stored without probiotic biofilm. (A), AIR packaging; (B), under vacuum
packaging (UV).
During storage at 15 ◦C (Figure 4), the presence of probiotic biofilms significantly slowed the
growth of the target microorganism: λ increased from 0.54 to 4.40 days and from 0.01 to 3.30 days,
in air and vacuum packaging, respectively. The maximum growth rate and the maximum cell load
reached in the stationary phase were also lower in the EXP samples (probiotic biofilms) than the control
samples, regardless of the packaging applied.
At both 4 and 15 ◦C, data on LAB, pH and water activity were similar to those observed in the
challenge test with L. monocytogenes (data not shown). Results of sensory analyses confirmed that
the probiotic microorganisms had no impact on the organoleptic characteristics of cheeses (data not
shown).
To highlight the effectiveness of probiotic biofilms to slow the decay of the microbiological quality
of soft cheeses at 15 ◦C, Table 4 shows the kinetic parameters of Gompertz equation accompained by
two other parameters (TRS and stability time). In a well-known study on the growth of L. monocytogenes
in food, Castillejo Rodriguez et al. [30] have proposed the sanitary risk time (TRS) for this pathogen as
the time required (in days) to observe an increase of 2 log CFU/g in its count, considering that, under
normal conditions, such a microorganism is present in foods in very low concentrations. As can be
seen, for soft cheeses wrapped in probiotic biofilms and packaged both in air and under vacuum,
the TRS was equal to 4.40–4.60 days; on the contrary, the same methods of packaging, applied to the
control samples, allowed L. monocytogenes to reach risky cell counts in shorter times (2.88–2.95 days)
(p < 0.05).
For the tests conducted with Ps. fluorescens at 15 ◦C, Table 4 also shows the stability time [31,41]
which represents the maximum acceleration of microbial growth and indicates how long the product
remains stable: after this time, an irreversible decay of the product begins. This parameter is generally
used as an alternative to shelf life: the underlying principle implies that microbial degradation has to
show a rate of the same order of magnitude as at the shelf life zero time. This condition is no longer met
when microbial growth attains its maximum acceleration, because beyond such a threshold the system
undergoes very fast changes with a rapid loss of the generally accepted safety or quality requirements.
This principle seems more reliable than the current practice that defines food stability according to
the ratio between attained and starting microbial population levels. The stability time increased by
more than 3 and 4 days, in vacuum packaging and in air, respectively, highlighting the effectiveness of
biofilms in slowing the decay of the microbiological quality of soft cheese.
Regarding the inhibitory effect of LAB against L. monocytogenes, some studies have already
explored the possibility to use a preformed biofilm to inhibit the pathogen growth [15,16,18,42].
Namely, Guerrieri et al. [15] showed the potential of a Lactobacillus plantarum strain to reduce the
pathogen growth over a 10-day period (about 4-log reduction). Mariani et al. [42] used the native
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biofilm microflora of wooden cheese ripening shelves to achieve a 1- to 2-log reduction over a 12-day
period. In previous studies, we have evaluated the use of LAB biofilms as a means to control the
growth of L. monocytogenes in soft cheeses [16] and in laboratory media [18], finding that sessile
LAB biofilms were able to delay the growth of L. monocytogenes. An anti-listerial activity was also
observed by Léonard et al. [43] during their studies on biopolymeric matrices based on alginate and
alginate-caseinate (an aqueous two-phase system) entrapping Lactococcus lactis subsp. lactis LAB3 cells
and by Barbosa et al. [44] who entrapped Lactobacillus curvatus in calcium alginate: the effect against
the pathogen was correlated to antimicrobial metabolites of proteinaceous nature.
4. Conclusions
This study has explored whether probiotic bacteria able to adhere on different surfaces (i.e.,
packaging materials, ceramic, plastic, paper, polymers, etc.) could be used as new biotechnological
solutions for industrial applications by biocontrolling the growth of pathogenic and spoilage bacteria.
The results obtained have shown the studied biofilm was able to delay the growth of some
pathogenic targets; in fact, cellular pathogenic loads were always lower in presence of probiotic biofilm
compared to its absence. For E. coli O157:H7, a significant cell load decrease (>1–2 logarithmic cycles)
was recorded, whereas for L. monocytogenes, St. aureus and S. enterica, cell load reductions ranged from
0.5 to 1.5 logarithmic cycles.
After only 2 h, the probiotic biofilm was successfully formed on polypropylene, polyvinyl chloride,
greaseproof paper, polyethylene and ceramic, with polyethylene and ceramic resultingly being the
material with the highest adhesion (6.54 log CFU/cm2). When testing as a tool to control the growth
of microorganisms in soft cheeses, the results highlighted the effectiveness of biofilms in slowing the
growth of L. monocytogenes by prolonging their microbiological stability at 15 ◦C by more than 3 and
4 days.
The results obtained suggest that the developed probiotic lactic acid bacteria biofilms have
a good potential to be used as biocontrol agents against pathogenic and food spoilage bacteria
through exclusion mechanisms: however, the mechanisms responsible for the inhibition have to be
deeply investigated.
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Abstract: Live probiotic bacteria obtained with food are thought to have beneficial effects on
a mammalian host, including their ability to reduce intestinal colonization by pathogens. To ensure
the beneficial effects, the probiotic cells must survive processing and storage of food, its passage
through the upper gastrointestinal tract (GIT), and subsequent chemical ingestion processes until
they reach their target organ. However, there is considerable loss of viability of the probiotic
bacteria during the drying process, in the acidic conditions of the stomach, and in the high bile
concentration in the small intestine. Bacillus subtilis, a spore-forming probiotic bacterium, can
effectively maintain a favorable balance of microflora in the GIT. B. subtilis produces a protective
extracellular matrix (ECM), which is shared with other probiotic bacteria; thus, it was suggested
that this ECM could potentially protect an entire community of probiotic cells against unfavorable
environmental conditions. Consequently, a biofilm-based bio-coating system was developed that
would enable a mutual growth of B. subtilis with different lactic acid bacteria (LAB) through increasing
the ECM production. Results of the study demonstrate a significant increase in the survivability of
the bio-coated LAB cells during the desiccation process and passage through the acidic environment.
Thus, it provides evidence about the ability of B. subtilis in rescuing the desiccation-sensitive LAB, for
instance, Lactobacillus rhamnosus, from complete eradication. Furthermore, this study demonstrates the
antagonistic potential of the mutual probiotic system against pathogenic bacteria such as Staphylococcus
aureus. The data show that the cells of B. subtilis possess robust anti-biofilm activity against S. aureus
through activating the antimicrobial lipopeptide production pathway.
Keywords: beneficial biofilm; bio-coating; B. subtilis; probiotics; extracellular matrix; pathogen
elimination
1. Introduction
Live probiotic microorganisms obtained often with food are thought to improve human health.
Thus, probiotics are usually defined as live microbial cells that provide a health benefit to the host
when administered in sufficient quantities [1]. Among most prominent probiotic microorganisms are
Gram-positive lactic acid bacteria (LAB), which mainly belong to the Lactobacillus and Bifidobacterium
genera [2]. The essential probiotic requirement in terms of the health benefits is a positive influence
on the digestion and immune systems [3]. Moreover, probiotics also have a protective role, directly
competing with pathogens through signaling interference [4], releasing antimicrobial substances [5] or
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metabolites such as acids [6–8]. Nevertheless, to exert its beneficial effects, any probiotic organism
must survive, establish, and multiply in the host.
Probiotic bacteria are usually delivered as dried cultures, but the process used to prepare them
may damage the cell’s structure, vitality, and functionality [9,10]. Drying processes involve the removal
of a large amount of fluid from the cell, which affects the cellular structure and may, therefore, cause
cell death [10,11]. Moreover, probiotic cells must survive shelf life and transit in the gastrointestinal
tract, including acid stress in the stomach [11], as well as degradation by enzymes and bile salt in the
intestine [12].
One of the main strategies of bacteria to deal with environmental stresses is the formation of
a complex structure called a biofilm [13]. In most natural settings, bacteria do not grow as free-living
cells but, instead, they form complex polymicrobial structures [14]. The biofilm structures contain less
than 10% microorganisms, while the other 90% is the extracellular matrix (ECM) produced by the
bacteria themselves. This ECM mainly consists of polysaccharides and other macromolecules such as
proteins, enzymes, surfactants, DNA, and lipids [15]. Thus, the biofilm structure is capable of resisting
extreme environmental conditions such as transit through the gastrointestinal tract or desiccation [16].
The ECM creates a microenvironment, which might lead to enhanced survival during desiccation [17].
Apparently, hygroscopic polysaccharides are thought to promote biofilm fluidity and resistance to
desiccation [18].
Bacillus subtilis, a spore-forming nonpathogenic Gram-positive bacterium, is commonly found
in the soil and the gastrointestinal tract (GIT) of some mammals [19]. This bacterium can effectively
maintain a favorable balance of microflora in the GIT of the mammalian host [20]. As one of the
physiological hallmarks, B. subtilis can form a robust biofilm through activation of a dedicated signaling
pathway to coordinate expression of genes encoding the ECM [21,22]. Its ECM relies mainly on
exopolysaccharides (EPS) synthesized by the epsA-O operon and amyloid fibers encoded by the tasA
located in the tapA–sipW–tasA operon [23].
According to recent studies, the use of Bacillus species and especially B. subtilis as probiotics gained
vast interest. Thus, Bacillus species were reported to be effective in preventing respiratory infections and
gastrointestinal disorders, and overcoming symptoms associated with irritable bowel syndrome [24,25].
However, the mechanism(s) via which Bacillus species act as probiotics remains unclear. It appears that
the presence of B. subtilis helps to maintain a favorable balanced microbiota in the gut and enhances
probiotic LAB cell growth and viability [26]. It was also suggested that these probiotic properties
are related to its ability to stimulate the immune system [24] and the production of antimicrobial
substances [27,28], or even inducing signaling interference against pathogenic microorganisms [4].
Cells of B. subtilis produce a vast diversity of antimicrobial substances, amongst them, relatively
well-characterized groups of lipopeptides, for instance, surfactins, iturins, and fengycins. These
compounds have a wide variety of biological activities such as anti-bacterial, anti-fungal, anti-viral,
and anti-tumor activities [29]. They can work in different mechanisms such as disrupting the structure
of bacteria members, decreasing the surface and interfacial tension of biofilms [30], and inhibiting
quorum sensing, which inhibits biofilm formation [4]. Furthermore, lipopeptides have an essential role
in signaling for biofilm formation in B. subtilis [31,32].
A model system was recently developed, which enhances biofilm formation by B. subtilis through
mutual growth with LAB [33]. This system seems to be beneficial for the protection of LAB during
heat treatment and through passage in the gastrointestinal tract [33]. The current study presents
a further development of the biofilm-based protective coating for probiotic cells via a process defined
as a bio-coating. Furthermore, this study provides evidence for two different probiotic functionalities
of B. subtilis: (i) protecting the LAB during their exposure to desiccation conditions and acid stress;
(ii) showing potent anti-microbial activity against pathogenic bacteria such as Staphylococcus aureus.
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2. Materials and Methods
2.1. Strains and Growth Conditions
Bacterial strains used in this study and their origins are summarized in Table S1 (Supplementary
Materials). The lactic acid bacteria (LAB) were routinely grown in either MRS broth (Man, Rogosa
& Sharpe) (Hy-labs, Rehovot, Israel) or MRS broth solidified using 1.5% agar (Difco, New-Jersy,
USA). In addition, the wild-type (WT) strain NCIB3610 of B. subtilis and its derivatives (Table S1,
Supplementary Materials) were regularly cultured in Lysogeny broth (LB containing: 10 g of tryptone,
5 g of yeast extract, and 5 g of NaCl per liter) (Difco) or LB solidified with 1.5% agar. Prior to generating
starter cultures, LAB and B. subtilis cells were grown on the agar-solidified plates for 48 h or overnight,
respectively, both at 37 ◦C. A starter culture of each strain was prepared using a single bacterial colony;
the cells of LAB were inoculated into 5 mL of MRS broth overnight without agitation, while the cells
of B. subtilis were inoculated into LB medium overnight at 30 ◦C, 150 rpm, until the cultures reached
an OD600 of approximately 1.5. For co-culture experiments, the modified MRS (MMRS) medium
(pH = 7) was used due to its biofilm-promoting capability and its suitability for co-culture cultivation
of B. subtilis and LAB [33]. Thus, B. subtilis cells were mixed with an equal amount of the LAB cells to
a final concentration of 108 cells/mL of each strain within MMRS. The cells in mixed cultures were
incubated aerobically at 37 ◦C at 50 rpm for 8 h [33]. Cells of S. aureus ATCC 25923 were regularly
cultured in tryptic soy broth (TSB) (Difco) solidified with 1.5% agar overnight at 37 ◦C. A starter culture
was prepared using a single bacterial colony inoculated into 10 mL of TSB medium overnight at 37 ◦C,
150 rpm.
2.2. Visualizing Biofilm-Forming Cells Using Confocal Laser Scanning Microscopy (CLSM)
Unlabeled cells of LAB and the CFP-tagged B. subtilis cells (YC189) were grown in co-culture into
MMRS broth as described above. Cell suspensions of each bacterium grown as mono-species culture
served as control samples. One milliliter of each culture was collected and centrifuged at 5000 rpm for
2 min. After removing supernatant, the cells were washed with 1 mL of DW (distilled water) and then
the following centrifugation (at 5000 rpm for 2 min) re-suspended in 100 μL of DW. A suspension of
5 μL from each sample was placed on a microscopy glass slide and visualized in a transmitted light
microscope using Nomarski differential interference contrast (DIC) and 458-nm laser for CFP excitation
(Leica, Wetzler, Germany).
2.3. Growth Curve Analysis of Lab During Growth in Co-Culture
Initially, B. subtilis and LAB cells were grown overnight in either LB or MRS as described above.
Afterward, the cells were introduced into the MMRS medium, and the co-culture was incubated for
8 h at 37 ◦C at 150 rpm. Mono-species cultures of LAB and B. subtilis were used as control. Every 2 h,
1 mL of each sample was collected for quantification of bacteria by the colony forming unit (CFU)
counting method on either MRS (for LAB) or LB (for B. subtilis) agar plates. The plates were incubated
aerobically at 37 ◦C for either 48 h (in case of LAB) or 24 h (for B. subtilis).
2.4. Analysis of Survival Rates Following Desiccation Treatment
The co-culture samples generated as described above were grown for 8 h aerobically at 37 ◦C and
50 rpm. The LAB cells grown as a mono-culture were used as a control. One milliliter of each sample
was harvested by centrifugation at 4000× g for 10 min, washed once with DW, and 50 μL of the sample
was placed into wells of a 96-well polystyrene plate (Greiner Bio-One, Monroe, North Carolina, USA).
The plate was left open in a dry cabinet (MRC, Holon, Israel), at 40% relative humidity and 25 ◦C for
20 to 40 h. The MRS agar plates were used to determine the cell counts before drying. For analysis of
the viable cell counts following desiccation, 100 μL of DW was added to each well, and the plates were
incubated for 5 min at room temperature, before resuspension of the samples by pipetting. Bacterial
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suspensions were serially diluted and underwent CFU counting on MRS agar plates. The CFU counts
were recorded following incubation for 48 h at 37 ◦C.
2.5. Visualizing Co-Culture Biofilm Following Desiccation Treatment Using Scanning Electron
Microscopy (SEM)
The co-culture and mono-culture samples were generated as described above. One milliliter of
each sample was harvested by centrifugation (at 4000× g for 10 min) and washed once with DW. Then,
5 μL of suspension from each sample was placed on polylysine-coated glass slides and left open in the
dry cabinet at 40% relative humidity and at 25 ◦C for 20 h. Before analysis in the SEM, the slides were
coated by gold/palladium coating (20:80), at 12 mA voltage and 1 nm thickness.
2.6. Analysis of Survival Rates Following Freeze-Drying
The co-culture and mono-culture samples were generated as described above. Afterward, the
samples were harvested by centrifugation at 4000× g for 10 min. One milliliter of each sample was
washed and resuspended with DW; the suspensions were then mixed with an equal volume of skim
milk (10%), to optimize the cell viability [34]. The samples were placed in a −80 ◦C freezer for 48 h
and subsequently freeze-dried in lyophilizer (Ilshin, Hialeah, FL, USA) for 24 h. The survival rates
following the freeze-drying are expressed as the number of CFUs/mL. The cell survivability (following
freeze-drying) was studied during incubation of the samples in pH 2 (with 1 M hydrochloric acid) at
37 ◦C, for either 1 h or 3 h, using the CFU counts.
2.7. Analysis of Survival Rates Following Transition within In Vitro Digestion System
To analyze the survivability of the LAB during the passage in the gastrointestinal tract, the
freeze-dried samples were resuspended in 5 mL of DW. Afterward, the samples were monitored for
four hours through an in vitro digestion system using the method described previously [35].
2.8. Determining the Effect of Conditioning Supernatant (CSN) on S. aureus Biofilm Formation
Cells of B. subtilis and Lactobacillus plantarum were grown either in monoculture or co-culture using
MMRS medium as described above for 24 h; B. subtilis cells were also grown in LB medium. Cultures
were then centrifuged at 13,000 rpm for 5 min, and the supernatants were sterilized by passing through
a 0.45-μm filter (Merck, Rockland, MA, USA). For analysis of the CSN effect on biofilm formation by
pathogenic bacteria, the S. aureus starter culture was generated through its growth into 10 mL of TSB
medium overnight at 37 ◦C and 150 rpm. The, S. aureus biofilm was grown into 1 mL TSB medium
(within a 24-well culture plate) supplemented by the CSN (10% v/v) harvested from the above probiotic
cultures. The TSB medium without supernatant was used as control. The plate was incubated for 24 h
at 37 ◦C.
2.9. Biofilm Quantitation Assay
Crystal violet staining was performed similarly as described previously [34]. Briefly, following
24 h of incubation at 37 ◦C, unattached cells were removed by washing the well plates two times using
DW. Then, 1% crystal violet (CV) solution was added to the wells. Following 2 min of incubation, the
excess CV was removed by washing with DW. Afterward, the fixed CV was released by 33% acetic acid
washing. Then, 100 μL of each sample was transferred to a new well plate for the absorbance detection
at 570 nm. To confirm the CV results, the CFU quantitation was performed for surface-attached cells.
Following 24 h of incubation at 37 ◦C, unattached cells were removed by washing the well plate two
times using DW. Then, 1 mL of DW was added to each well, and the cells attached to the surface were
scratched out using sterilized swab; the bacterial suspensions were serially diluted and underwent
CFU counting on LB agar plates.
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2.10. Effect of Cell-Free Culture Supernatant on S. aureus Growth
The, S. aureus starter culture was prepared into 10 mL of TSB medium overnight at 37 ◦C and
150 rpm. Then, 150 μL of the generated bacterial suspension was introduced into 15 mL of fresh
TSB medium. For the antibacterial test, the S. aureus suspension was supplemented by the cell-free
supernatant prepared as described above. The samples were incubated for 8 h at 37 ◦C at 150 rpm and
subjected to OD600 measurements every 1 h.
2.11. Confocal Laser Scan Microscopy (CLSM) Analysis
The, S. aureus biofilm was grown in a confocal microscopy dish (glass-bottom dish) (Bar-Naor,
Petach-Tikwa, Israel) with or without supplementation of the supernatant at the same conditions
as described above. After 24 h of incubation at 37 ◦C, the surface-unattached cells were removed
by washing the dish two times using DW. Next, the biofilm cells were stained using FilmTracer
LIVE/DEAD Biofilm Viability Kit (Molecular Probes, Eugene, OR, USA) and incubated for 30 min
in room temperature without exposure to light. Then, the stain was washed away and analyzed by
confocal laser microscopy (CLSM) (Olympus, Hamburg, Germany). Fluorescence emission from the
stained samples was measured with an SP8 CLSM (Leica) equipped with 488- and 552-nm lasers.
2.12. Real-Time PCR
To further analyze the potential antimicrobial effect of B. subtilis grown in MMRS medium,
we tested the expression of genes that could be affected during mitigating biofilm formation by
S. aureus. A starter culture of B. subtilis was prepared during overnight growth at 30 ◦C, 150 rpm,
in LB medium. For generating the antimicrobial substance producing a suspension of B. subtilis,
a portion of starter culture was introduced (by 1:100 ratio) into either MMRS or LB medium (as a control
medium for a low antimicrobial substance production). The samples were incubated for 6 h at 37 ◦C,
50 rpm. Next, 2 mL from each sample was collected and centrifuged at 5000× g for 10 min. The RNA
was harvested using the RNAeasy kit (QIAGEN, Hilden, Germany) following the manufacturer’s
protocol. The RNA concentration was measured by means of a Nanodrop 2000 spectrophotometer
(ThermoFisher Scientific, Waltham, MA, USA). A complementary DNA (cDNA) was synthesized from
1 μg of RNA in a reverse transcription reaction using a qScript cDNA Synthesis Kit (Quantabio, Beverly,
MA, USA) according to the manufacturer’s instructions. All cDNA samples were stored at −20 ◦C.
The RT-PCR reactions (final volume = 20.0 μL) consisted of 2 μL of cDNA template, 10 μL of fast SYBR
green master mix, 1 μL of suspension of each primer, and 7 μL of RNase free water. Forward and
reverse PCR primers (Table S2, Supplementary Materials) were designed using the Primer express
software and were synthesized by Hylabs (Rehovot, Israel). DNA was amplified with the Applied
Biosystems StepOne™ Real-Time PCR System (Life technologies, Foster, CA, USA) under the following
PCR conditions: initial denaturation for 2 min at 95 ◦C and subsequent 40 PCR cycles (95 ◦C for 3 s,
60 ◦C for 30 s, and 95 ◦C for 15 s). The RNA samples without reverse transcriptase were used as
negative control, to confirm that there was no DNA contamination in the RNA samples. The expression
levels of the tested genes (fenA, srfA) were normalized using the 16S ribosomal RNA (rRNA) and rpoB
genes as the endogenous controls (Table S2, Supplementary Materials).
2.13. Statistical Analysis
The results were subjected to either Student’s t-test or one-way analysis of variance at a significance
level of p < 0.05, to compare the control and tested samples. The results are based on three biological
repeats performed in duplicates.
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3. Results
3.1. Formation of Mutual Probiotic Biofilm of B. subtilis with Lactic Acid Bacteria (LAB)
The starting point of this investigation was generating the dual-species biofilms for the different
LAB strains together with robust ECM-producing bacterium B. subtilis. Thus, the bacterial cells were
incubated in the biofilm-promoting MMRS medium, which promotes increased biofilm formation by
B. subtilis through the KinD-Spo0A pathway [33]. To visualize the mutual biofilms, a transcriptional
fusion of the tapA promoter to the cfp gene (encoding cyan fluorescent protein) was used [35].
The observed upregulation in the CFP expression, during the mutual growth of B. subtilis with three
different species of the probiotic LAB, indicates that the tapA operon was activated and there that there
was notable matrix production by B. subtilis (Figure 1). This finding was quite noticeable following
a comparison of morphological changes that occurred during LAB growth in the presence of B. subtilis
(Figure S1, Supplementary Materials). In this regard, the LAB cells could not form any biofilm bundles
during their growth as a mono-species culture (Figure S1, Supplementary Materials), whereas a notable
incorporation of those cells was observed into biofilm bundles produces by B. subtilis cells (Figure 1).
Figure 1. Formation of dual-species biofilm bundles of B. subtilis with LAB. Bacterial biofilms were
generated during co-culture growth of B. subtilis cells with either Lactobacillus plantarum, Pediococcus
acidilactici, or L. rhamnosus cells in modified MRS (MMRS) medium at 37 ◦C for 8 h. The biofilm samples
were prepared as described in Section 2 and analyzed using a confocal laser scanning microscope
(CSLM, Leica, Germany). B. subtilis cells express CFP under the control of the tapA operon, which is
responsible for the matrix production. LAB cells are not stained. Scale bar = 10 μm.
To confirm that there are no antagonistic interactions between the LAB and B. subtilis cells, the
bacterial growth was analyzed in this mutual growth system. Consequently, there was no significant
inhibition in either of the bacterial species following their mutual growth (Figure 2), meaning that the
LAB and B. subtilis cells can grow together without interference through generating the mutual probiotic
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biofilm. In addition, the growth in dual-species biofilm did not change the medium acidification rate
by the LAB cells (Figure S2, Supplementary Materials).
 
Figure 2. Co-culture growth of B. subtilis with the LAB bacteria does not influence growth rate. Growth
curve analysis of LAB cells in presence or absence of B. subtilis. The blue line represents the growth rate
of a single-species culture of LAB, whereas the orange line represents the growth rate of (A) L. plantarum,
(B) P. acidilactici, and (C) L. rhamnosus in co-culture with B. subtilis. (D) Growth curve of B. subtilis cells
in the presence of LAB species compared to single culture. The cells were analyzed during growth for
8 h in 37 ◦C, 150 rpm.
3.2. Growth in Mutual Biofilm Increases the Survivability of the LAB during Desiccation
It was hypothesized that the growth in the mutual biofilm system could provide a relative
protection of LAB during the desiccation process, which might indicate about the relative improvement
in survivability of the bio-coated cells through industrial processing and storage conditions. Therefore,
the LAB cells grown in the mutual biofilm were exposed to desiccation conditions for either 20 or
40 h. The LAB cells grown in mono-species culture were used as a control sample. It was found that
L. plantarum cells grown in mutual biofilm showed increased survival (relatively to mono-species
culture) of around 1.12 log·CFU/mL and 1.52 log·CFU/mL, following 20 and 40 h of desiccation,
respectively. Surprisingly, L. rhamnosus cells grown in the mutual biofilm demonstrated an even
more significant increase in survivability, of around 3.12 log·CFU/mL, during 20 h of desiccation.
Even more profoundly, the bio-coated cells of L. rhamnosus demonstrated around a five-log increase
in their survivability after 40 h of desiccation. Concerning the cells of P. acidilactici, the bio-coated
cells showed a relatively moderate increased survival following 20 and 40 h of desiccation of around
0.71 log·CFU/mL and 2.09 log·CFU/mL, respectively (Figure 3).
To reinforce our assumption about the ECM protection of the LAB cells, the dual- and mono-species
biofilms were visualized using SEM imaging, after desiccation treatment. It was found that L. plantarum
cells grown in the presence of B. subtilis were surrounded with the coating substance(s), which could
be interpreted as the biofilm matrix (Figure 4).
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Figure 3. Growth in dual-species biofilm increases survivability of LAB during exposure to drying
process. Mono and dual-species cultures of B. subtilis and LAB cells were generated in MMRS medium
during bacterial growth for 8 h in 37 ◦C, 50 rpm. Survival rates of the LAB cells (grown in presence or
absence of biofilm forming B. subtilis) were determined based on CFU counts following desiccation
conditions (40% relative humidity (RH)) for 20–40 h. Error bars represent standard deviation (SD).
* p < 0.05 comparison of the control and tested samples. (A) L. plantarum survival rates, (B) P. acidilactici
survival rates, and (C) L. rhamnosus survival rates.
Figure 4. Bio-coating of L. plantarum cells by extracellular polymeric substance(s) produced by B. subtilis.
Mono and dual-species cultures of B. subtilis and L. plantarum cells were generated in MMRS medium
during bacterial growth for 8 h in 37 ◦C, 50 rpm. (A) SEM images of the mono-species culture of
L. plantarum and (B) dual-species culture of L. plantarum with B. subtilis following desiccation conditions
(40% RH) for 20 h. Images were taken at a magnification of 20,000×with a JEOL, JSM 7800F, Japan.
3.3. Growth in Mutual Biofilm Increases the Survivability of the LAB during Acid Stress Following
Freeze-Drying
It was further investigated whether the mutual biofilm could also protect the cells of LAB during
freeze-drying, which is considered as the most common technique for drying and storage of probiotic
bacteria for a long time [10,36]. Since, after consumption, the LAB cells are usually exposed to
additional stress (acidic stress during the passage in the gastrointestinal tract), the survivability of the
bio-coated cells during their exposure to acid stress was tested, following freeze-drying. To mimic
the acid stress conditions, the bio-coated cells were freeze-lyophilized and exposed to pH 2. It was
found that the bio-coated L. plantrum cells showed increased survivability of around 0.45 log·CFU/mL,
compared to the control, following freeze-drying (Figure 5). In the case of the bio-coated L. rhamnosus
cells, an increase of about 0.49 log·CFU/mL was observed, while, in the case of P. acidilactici, there was
no significant change in the number of viable cells following freeze-drying (Figure 5). Concerning acid
stress tolerance, the freeze-dried LAB cells were exposed to low pH (pH 2) for 1–3 h. As shown in
Figure 5, the encapsulated LAB consistently demonstrated increased survival (up to around a one-log
increase) following their exposure to this stress, especially after three hours of exposure to the low pH.
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Figure 5. Bio-coating increases the survivability of the LAB during acid stress following freeze-drying.
Mono- and dual-species cultures of B. subtilis and the LAB cells were generated in MMRS medium
during bacterial growth for 8 h in 37 ◦C, 50 rpm. Survival rates of LAB cells were determined based
on CFU counts following freeze-drying and an exposure to low pH (HCl 1 M, pH = 2) for 1–3 h.
* p < 0.05 for comparison of the control and tested samples. Error bars represent standard deviation
(SD). BFD—before freeze-drying; AFD—after freeze-drying; AC1—freeze-dried and exposed for 1 h
to acid conditions; AC3—freeze-dried and exposed for 3 h to acid conditions. The survival rates are
shown for (A) L. plantarum, (B) P. acidilactici, and (C) L. rhamnosus.
3.4. Bio-Coating Retains the LAB Survivability during In Vitro Gastrointestinal Digestion Following
Freeze-Drying
It was further tested whether bio-coating could also provide protection of the LAB cells during
passage through an in vitro GIT system. This unique system included two phases: a gastric phase
characterized by low pH and stomach proteolytic enzymes and, the intestinal phase, characterized
by neutral pH, intestinal proteolytic enzymes, and bile salts. The bio-coated LAB cells were
freeze-lyophilized and tested through this system. It was found that the bio-coated cells of L. plantarum
and L. rhamnosus showed increased survivability of around 0.5 log following freeze-drying, which
remained at the augmented level during the transition of those cells through the GIT system (Figure 6).
Nonetheless, in the case of P. acidilactici, there was no significant increase in the survivability of the
cells in the tested conditions.
3.5. Antagonistic Effect of Probiotic Cells against the Biofilm-Forming, S. aureus
Next, it was hypothesized that the probiotic cells (from the mutual biofilm) could antagonize
pathogenic bacteria, for instance, S. aureus, which is known as a robust biofilm-forming bacterium,
especially a submerged type of biofilm. It was consequently found that the conditioning supernatant
(CSN) obtained during the growth of the probiotic cells strongly inhibited biofilm formation by S. aureus
(Figure 7A). This result indicates that there might be an induction in producing an antimicrobial
substance(s) during the generation of the mutual biofilm. Interestingly, it seems that a major impact of
this inhibitory effect was related to B. subtilis cells, although there was a modest contribution by the cells
of L. plantarum. A further quantitation of the surface-adhered cells confirmed a potent inhibitory effect
of the CSN against biofilm formation by pathogenic S. aureus (Figure 7B). Moreover, the microscopic
visualization of the augmented biofilm phenotypes confirmed once again the anti-staphylococcal
properties of the CSN (Figure 7C). Importantly, it was further confirmed that the CSN did not cause
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growth inhibition of S. aureus (Figure 7D), which indicates the biofilm-specific mode of action of CNS
against this pathogenic bacterium.
Figure 6. Bio-coating maintains LAB survivability during gastrointestinal digestion in vitro following
freeze-drying. Mono- and dual-species cultures of B. subtilis and LAB cells were generated in
MMRS medium during bacterial growth for 8 h in 37 ◦C, 50 rpm. Survival rates of LAB cells were
determined based on CFU counts following freeze-drying and during gastro-intestinal digestion in vitro.
* p < 0.05 for comparison of the control and tested samples. Error bars represent standard deviation
(SD). BFD—before freeze-drying; AFD—after freeze-drying; GP—gastric phase; IP—intestinal phase.
The survival rates are shown for (A) L. plantarum, (B) P. acidilactici, and (C) L. rhamnosus.
Figure 7. Conditioning supernatant (CNS) of the B. subtilis culture inhibits biofilm formation by
Staphylococcus aureus. S. aureus biofilm formation was determined after growth in TSB medium with
10% CNS at 37 ◦C for 24 h. (A) S. aureus biofilm formation quantification by crystal violet method.
(B) Quantification of live bacteria attached to surface using CFU method. * p< 0.05 for comparison of the
control and tested samples. Error bars represent standard deviation (SD). (C) Confocal laser microscopy
(CLSM) images of S. aureus biofilms formed onto polystyrene surfaces containing 10% CNS. Live cells
(SYTO-9, green) and dead cells (propidium iodide, red). Scale bar = 50 μm. (D) S. aureus growth curve
in TSB medium supplemented by the 10% CNS generated from the B. subtilis growth medium.
It was further hypothesized that the growth media would affect the ability of the CSN to inhibit
S. aureus biofilm formation. Therefore, the antibiofilm activity of the CNS produced by B. subtilis cells
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in the MMRS medium was compared with that produced in LB medium. Apparently, growth of the
Bacillus cells in the MMRS induced the antibiofilm effect of the CSN (Figure 8). Thus, a significantly
higher inhibition on S. aureus biofilm formation was found by the CSN from the MMRS medium
compared to that produced in the LB medium. Accordingly, the CSN from MMRS medium showed
around a three-log reduction in the S. aureus adherence onto the surface compared to that from
LB (Figure 8A). The inhibitory effect of the CSN was further confirmed microscopically by testing
a submerged biofilm of S. aureus cells using live–dead staining (Figure 8B).
Figure 8. Type of growth medium governs the inhibitory effect on the S. aureus biofilm formation.
(A) quantification of the S. aureus cells attached to the surface using CFU method, and (B) the CLSM
imaging of the S. aureus biofilm formation in the presence or absence of the CSN, following growth in
TSB medium with 10% supernatant at 37 ◦C for 24 h. * p < 0.05 for comparison of the CSN from LB to
control; ** p < 0.05 for comparison of CSN from MMRS vs. LB. Error bars represent standard deviation
(SD). Live cells are stained green (SYTO-9) and dead cells are stained red (propidium iodide). Scale
bar = 50 μm.
According to recent findings, B. subtilis could affect S. aureus biofilm formation via signaling
interference [4]. It was, thus, hypothesized that the production of either fengycins [4] or surfactin [37]
could explain the antibiofilm activity of the CSN produced by B. subtilis. Both factors are produced
by B. subtilis, and they could affect the S. aureus cells through interfering with inter- or intra-cellular
signaling. It was subsequently found that expression of the genes encoding for these factors by B. subtilis
was notably upregulated in the MMRS compered to LB medium (three- and two-fold induction in
the expressions of fenA and srfA, respectively) (Figure 9). This result suggests the involvement of the
regulatory pathways associated with those genes in the observed antibiofilm phenotype.
Figure 9. Relative expression of B. subtilis genes related to antagonistic activity during growth in the
different media. The real-time (RT)-PCR analysis was performed for quantitation of fenA and srfA
gene expression in B. subtilis cells grown in either LB or MMRS medium as described in the Methods.
* p < 0.05 compared to control. Error bars represent standard deviation (SD).
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4. Discussion
The importance of healthy commensal microbiota for the mammalian host is evident; thus, there
is widespread use of probiotics for preventing and treating various health problems in humans, as well
as in animals. Nonetheless, maximizing the survivability of probiotic cells during their formulation,
as well delivery, remains a significant challenge. Probiotic bacteria are supposed to go through a long
route starting with processing, through shelf life and the passage through the GIT, which includes
dealing with extreme conditions [38]. Since these processes may affect cell survivability, an effective
way(s) of delivering probiotic bacteria to the mammalian host would be highly useful.
It is now well established that biofilm formation represents one of the most favorable microbial
lifestyles within often challenging natural environments [39]. The biofilm provides bacterial cells
protection against challenging environmental conditions such as changes in shear forces, extreme
temperatures, desiccation, extreme pH, and antimicrobial agents [40–42]. It was, therefore, proposed to
generate a protective bio-coating system for probiotic cells for a possibility of a more efficient delivery
to the mammalian host. The most appropriate candidate for this mission appeared to be the robust
biofilm-forming B. subtilis, since it naturally colonizes the mammalian gut and is considered to be
harmless to mammals including humans [19,20]. It was confirmed that there are no antagonistic
interactions during the generation of this complex multispecies system; thus, no antagonism was
observed between B. subtilis cells and LAB, or during the formation of symbiotic biofilm bundles
through inducing the expression of tapA operon (involved in the matrix production) by B. subtilis.
It should be emphasized that the tested LAB strains belong to different genera with a different origin.
Nonetheless, it was possible to generate cooperating and protected multispecies biofilms, which
indicates the feasibility of using this bio-coating system for a wide range of probiotic species.
As suggested throughout the study, the generated bio-coating system increased the LAB
survivability during drying processes, which points to the feasibility of using this system for processing
probiotic cells for further food or biotechnological applications. The drying process is commonly used
as a means for storage and distribution, which lowers the expense and inconvenience of using a cool
chain. Although water is essential for bacteria living and the drying processes damage cell structure
and viability, the long-time preservation and retention of viability during storage is often enhanced
by lowering the water activity [34]. The robust biofilm matrix, produced by B. subtilis, contains
polysaccharides (PS) that presumably have an important role in protecting bacteria during drying
processes. The PS could provide bacteria a hydrated microenvironment. Thus, through the drying
process, the PS layers may serve as a barrier on the cell surface and prevent water removal [18,43].
In the case of L. rhamnosus, which could not survive the 40 h of desiccation, the bio-coating process
enabled a very significant increase in survivability during the desiccation process. This finding highly
suggests the possibility of protecting desiccation-sensitive probiotic cells using this bio-coating system.
Freeze-drying is the most common drying method for long-term preservation of microorganisms,
in the microbiological industry, thanks to optimal protection of cell viability [36]. Usually, before the
freeze-drying process, protective agents like skim milk, sucrose, or other sugar types are added to
the drying medium to prevent cell damage during the drying process and storage of freeze-dried
cells [44]. Some studies showed that biofilm PS can also be used as a protective agent [43,45], which is
in agreement with the findings of current study. We observed higher survivability during freeze-drying
for L. plantarum and L. rhamnosus cells following their growth through the bio-coating system. However,
we did not observe a significant increase in survival rates for P. acidilactici following freeze-drying.
One of the possible explanations for this result could be related to the possible resistance of this
environmental isolate to desiccation stress due to its adaptation to the udder environment (from where
it was isolated).
In addition to the protective capability, B. subtilis demonstrated potent antimicrobial activity
against pathogenic S. aureus. This result was not surprising since B. subtilis was recently explored for its
probiotic functionality on many levels. It was shown that B. subtilis could stimulate an immune response
in humans, as well as maintain a favorable balanced microbiota, and decrease infection and diarrhea via
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the synthesis of antimicrobial agents [46]. Production of antimicrobial agents is one of the antagonistic
properties of probiotic bacteria, and indeed B. subtilis produces a wide diversity of substances, which
influence a broad spectrum of pathogens via different mechanisms [27]. Several studies suggested
either the growth inhibition or depression of Staphylococcal virulence by the antagonistic activity
of B. subtilis [4,47]. In agreement with the literature, the current study showed that most of the
antimicrobial activity of the multispecies biofilm system was due to substances produced by B. subtilis.
Importantly, this activity was specific to the mitigation of biofilm formation by S. aureus rather than
inhibition of its growth. Notably, the relatively modest effect of the CSN derived from L. plantarum on
biofilm formation by S. aureus cells might still have an important role in mitigating this problematic
pathogen. The synergistic activity of substances produced by different probiotic species might provide
a further antimicrobial effect against such persistent pathogens.
Findings of this study further indicated that the inhibitory effect of the CSN is associated with
the production of secondary metabolites, for instance, lipopeptides by B. subtilis. In this regard, the
inhibitory effect could be related to their chemical structure [30] or to their ability to inhibit quorum
sensing [4]. Lipopeptides produced by B. subtilis function firstly as quorum-sensing interrupters
(fengycins), by inhibiting the quorum-sensing regulatory system [4], and surfactin, by regulating the
autoinducer-2 (AI-2) activity [38]. Thus, these lipopeptides could inhibit quorum sensing via a different
mechanism. The other antimicrobial mode of action of lipopeptides is related to the similarity of their
chemical structure to surface-active agents, which might impair the ability of cells to attach to the
surface and form a biofilm structure [30]. According to the results presented in this study, it appears
that the growth of B. subtilis in the MMRS medium triggers the production of antimicrobial lipopeptides.
This finding is indeed conceivable since the MMRS medium notably induces biofilm formation in
B. subtilis [33], which is highly related to the production of antimicrobial lipopeptides [32].
Taken together, the data shown in this study suggest of the robust probiotic functionality of
B. subtilis (i) in protecting the probiotic LAB during their exposure to unfavorable environmental
conditions, such as desiccation and acid stresses, and (ii) strong anti-biofilm activity against pathogenic
bacteria such as S. aureus.
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Abstract: Hydrophobic zein-based functional films incorporating licorice essential oil were
successfully developed as new alternative materials for food packaging. The lotus-leaf negative
template was obtained using polydimethylsiloxane (PDMS). The complex surface patterns of the lotus
leaves were transferred onto the surface of the zein-based films with high fidelity (positive replica),
which validates the proposed proof-of-concept. The films were prepared by casting method and fully
characterized by Scanning Electron Microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR)
and Differential Scanning Calorimetry (DSC). The grammage, thickness, contact angle, mechanical,
optical and barrier properties of the films were measured, together with the evaluation of their
biodegradability, antioxidant and antibacterial activities against common foodborne pathogens
(Enterococcus faecalis and Listeria monocytogenes). The zein-based films with the incorporation of
licorice essential oil presented the typical rugosities of the lotus leaf making the surfaces very
hydrophobic (water contact angle of 112.50◦). In addition to having antioxidant and antibacterial
properties, the films also shown to be biodegradable, making them a strong alternative to the
traditional plastics used in food packaging.
Keywords: lotus-effect; water contact angle; food packaging; licorice essential oil; antioxidant
properties; antibacterial activity; foodborne pathogens
1. Introduction
Food packaging is designed to protect food from external factors, such as temperature, light or
humidity that can lead to degradation [1]. Moreover, packages also protect its content from other
environmental influences, namely, odors, microorganisms, shocks, dust, vibrations and compressive
forces [1].
The production and application of synthetic materials in food packaging has grown quickly over
the past few decades, resulting in serious environmental concerns due to the resistance to degradation
of these synthetic materials [2,3]. In recent years, the replacement of synthetic plastics by natural
polymers in packaging materials has been an intense research field [3,4]. Particularly, bio-based natural
polymers (mainly polysaccharides and proteins) have been given increasing attention to be used in food
packaging films because of their abundance, biodegradability, biocompatibility, and non-toxicity [3,4].
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However, natural polysaccharides have their weak points in making hydrophobic films because
most of them are hydrophilic and water absorbing, resulting in rapid solubilization in aqueous
environments [5].
Protein-based films have several advantages over other types of edible materials. Proteins are
constructed of nearly 20 different amino acids, and usually have good film forming capability [6].
Moreover, protein-based films are generally good gas barriers, possess good mechanical properties,
and can also be regarded as nutrients [6].
Zein, a by-product obtained from corn starch processing, is prepared from corn protein flour.
Zein is particularly rich in hydrophobic and neutral amino acids as well as some sulfur-containing
amino acids, but lacks polar or ionizable amino acids [7]. Due to its large number of hydrophobic
groups, zein is soluble in aqueous ethanol, yet insoluble in pure water. Since it possesses well-known
film-forming ability caused by its unique amino acid composition, it is widely used in food packaging
materials [7]. Pure zein films have good water barrier properties, but their mechanical properties are
relatively poor. In order to overcome these deficiencies, blend zein films with other biodegradable
biopolymers has been widely studied, and the zein provided good potential to produce blend films [7].
Superhydrophobic surfaces are used by several living organisms, both animals and plants.
The most famous case from the plant kingdom (Plantae) is the lotus leaf (Nelumbo nucifera) [8].
The extreme water repellency of lotus leaves stems from the combination of low surface energy with
the hierarchical topology present on the leaf surface [9]. Water droplets roll freely on these surfaces and
remove dirt, keeping the leaves clean, even in the muddy waters where these plants tend to grow [9].
This extreme water repellency and self-cleaning performance of the lotus leaf is usually known as the
“lotus effect” [10]. Recently, researchers have focused on recreating these surfaces, structured at the
micro and nanometric scale, with new functionalities, replicating or mimicking the hierarchical surface
morphology of the lotus leaf [11].
Licorice (Glycyrrhiza glabra L.) is a plant belonging to the Fabaceae family. Its sweet flavor makes
it a popular ingredient in the production of candies and sweets in Europe [12]. The antioxidant and
antibacterial properties of the licorice essential oil (EO) have already been demonstrated, together with
its incorporation on carboxymethyl xylan films with potential to be used as novel food packaging
materials [13].
Therefore, the aim of this work was to develop hydrophobic zein-based films incorporating
licorice EO while biomimicking the lotus leaf surface, which is the innovation of this work. The films
obtained were then characterized, and their bioactive properties evaluated.
2. Materials and Methods
2.1. Reagents
Polydimethylsiloxane (PDMS)—Sylgard® 184 Silicone Elastomer was obtained from Dow Corning
(Midland, MI, USA). Zein from maize (CAS Number: 9010-66-6), presenting a molecular weight
of 22–24 kDa, was supplied by Sigma-Aldrich (Saint Louis, MO, USA). Glycerol (anhydrous extra
pure) was purchased from Merck (Darmstadt, Germany). The licorice EO (Glycyrrhiza glabra L.)
(Leguminosae/Fabaceae) was obtained from Best Formula Industries (BF1, Kuala Lumpur, Malaysia).
The EO (Pure Essential) was isolated from trunks of the plant by steam distillation and was stored
at −20 ◦C in the dark until analysis and further use. The purity of the EO was tested and its
quality ensured to be consistent with the standards described in the European Pharmacopoeia, being
suitable to be used in products for human consumption. The chemical composition, analyzed by Gas
Chromatography coupled to Mass Spectrometry (GC-MS, Perkin Elmer Clarus 600, Shelton, CT, USA),
and the bioactivities, namely antioxidant ant antibacterial, of this EO were previously published [13].
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2.2. Lotus Leaves
The fresh lotus leaves (Nelumbo nucifera) were collected in Autumn 2018 (September-October) and
were kindly provided by the Jardim Botânico of Universidade de Coimbra. The hierarchical surface
morphology of the lotus leaf was observed by Scanning Electron Microscopy (SEM, Hitachi, Chiyoda,
Japan). For that, pieces of lotus leaves were fixed with 5% (v/v) glutaraldehyde at 4 ◦C for 12 h. After that,
samples were washed once with phosphate buffer saline (PBS) and the dehydration was carried out
in ethanol series for 1 h each (30, 50, 70, 80, 90% (v/v), and absolute) at room temperature [14,15].
The samples were then allowed to dry overnight in a desiccator. Finally, samples were coated with
gold and analyzed by VP SEM Hitachi S-3400N (Hitachi, Chiyoda, Japan) using a voltage of 20.0 kV
and 100.0 μA emission.
2.3. Negative Template Fabrication
PDMS was used to produce the lotus leaf negative template. The lotus leaves were gently cut
and glued to glass Petri dishes. Then, molten paraffin was placed on the edges of the Petri dishes
to seal the samples and prevent the polymer from dripping. Initially, the mixture of PDMS and its
catalyzer (10:1; w/w) were weighed and mixed by hand for 5 min in order to improve homogeneity.
Then, this mixture was degassed under vacuum until visible air bubbles formed during the mixing
procedure had disappeared (30 min) [16]. Finally, the mixture was cast on the previously prepared
Petri dishes with the lotus leaves [17]. The Petri dishes were then placed into a ventilated oven for
a curing time of 4 h at 60 ◦C and then were left for more 48 h at room temperature [16] (Figure 1a).
The negative template produced was visualized by SEM. Small pieces of the negative template were
directly mounted on stubs and then coated with gold and analyzed by VP SEM Hitachi S–3400N using
a voltage of 20.0 kV and 100.0 μA emission.
2.4. Preparation of Zein-Based Films
The film-forming solution was prepared by dissolving zein powder in 80% (v/v) ethanol-water
solution (10%; w/v) under magnetic stirring for 30 min at 80 ◦C and 250 rpm. Glycerol at 25%
(g glycerol/g dry zein powder) was added to the solution as plasticizer agent and stirred for 8 min at
80 ◦C and 250 rpm [18]. Then, licorice EO at 30% (g EO/g dry zein powder) was incorporated and was
stirred again (8 min, 80 ◦C, 250 rpm) [13,18]. Films were then obtained by casting. For this purpose,
the film-forming solution was spread on polystyrene Petri dishes in which the lotus leaf negative
template was mounted as described above (Figure 1a), allowing the obtention of zein-based films with
similar hierarchical surface morphology to that of the lotus leaf (positive replica). Films were also
obtained by spreading the film-forming solution on simple polystyrene Petri dishes. Finally, the Petri
dishes were placed into a ventilated oven to dry the mixture (24 h, 40 ◦C). The positive replica films
obtained were observed by SEM as described for the negative template.
2.5. Characterization of Films
The control film (without EO) and the film with EO, both casted on simple polystyrene Petri
dishes and on lotus negative template, were further characterized.
2.5.1. Fourier-Transform Infrared Spectroscopy (FTIR)
FTIR spectra of the films were obtained between 4000 and 600 cm−1 using a Nicolet iS10 smart
iTRBasic (Thermo Fisher Scientific, Waltham, MA, USA) model, with 64 scans and a 4 cm−1 resolution [19].
2.5.2. Differential Scanning Calorimetry (DSC)
DSC analysis of the films was performed on a calorimeter (Netzsch DSC 204, Selb, Germany)
operating in the following conditions: heating rate of 2 ◦C/min, inert atmosphere, and temperature
range from 22 to 350 ◦C. For all the analyses, the respective baselines were firstly obtained [20].
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2.5.3. Grammage, Thickness and Mechanical Properties
The grammage of the films was calculated based on the ratio between their mass and area
(g/m2), according to ISO 536:1995. The thickness (μm) was measured according to ISO 534:2011 using
a micrometer (Adamel Lhomargy Model MI 20, Veenendaal, Netherlands), with several random
measurements being considered. Tensile strength (MPa), elongation (%) and elastic modulus (MPa)
of the films were obtained using a tensile tester (Thwing-Albert Instrument Co., West Berlin, NJ,
USA), at 23 ± 2 ◦C and 50 ± 5% relative humidity (RH), as per ISO 1924/1 with a single modification.
The initial grip was set at 50 mm and the crosshead was set at 10 mm/min [21].
2.5.4. Optical Properties
The color and transparency of the films were evaluated using a Technidyne Color Touch 2
spectrophotometer (New Albany, IN, USA). Measurements were performed on at least three random
positions of the films using the D65 illuminant and 10◦ observer. Color coordinates L* (lightness),
a* (redness; ±red-green) and b* (yellowness; ±yellow-blue) were obtained. The transparency of the
films was calculated according to the equation defined in ISO 2289 [21].
2.5.5. Barrier Properties: Water Vapor Permeability
Water vapor permeability (WVP; g/(Pa.day.m)) and water vapor transmission rate (WVTR;
g/(m2.day)) were determined according to the standard protocol ASTM E96-00. The films, which had
been equilibrated at 23 ± 2 ◦C and 50 ± 5% RH for 72 h, were fixed on the top of equilibrated cups
containing a desiccant (15 g of anhydrous CaCl2, dried at 105 ◦C for 2 h before being used). The test
cups were placed in a cabinet at 23 ± 2 ◦C and 50 ± 5% RH. The weight changes were monitored for
every 2 h over 48 h. The gradient was calculated from the slope of a linear regression of the weight
increase versus time [22,23]. WVTR and WVP were calculated according to the following equations:
WVTR = (Δm/Δt)/A, where Δm is the weight changes of test cups (g), A is the test area (m2) and t
is test time (day).
WVP =WVTR/Δp = (WVTR/[p(RH1 − RH2)]) × e, where p is the vapor pressure of water at 23 ◦C
(Pa), RH1 is the RH of the cabinet (50%), RH2 is the RH inside the cups (0%) and e is the thickness (m)
of the films.
2.5.6. Contact Angle Measurement
Contact angle measurements were performed using the sessile drop method with distilled water as
test liquid (OCAH 200, DataPhysics, Filderstadt, Germany). At least eight measurements were made for
each film [21]. Moreover, the contact angle was measured for both sides (upper and lower) of each film.
2.5.7. Water Solubility
The films solubility in water was defined by the content of dry matter solubilized after 24 h of
immersion in water. The initial dry matter content of each film was determined by drying to constant
weight in an oven at 105 ◦C. Two disks of films (2 cm of diameter) were cut, weighed and immersed in
50 mL of water. After 24 h of immersion at 20 ◦C with occasional magnetic stirring, the pieces of films
were taken out (by filtration) and dried to constant weight in an oven at 105 ◦C, in order to determine
the weight of dry matter which was not solubilized in water [24]. The measurement of solubility of the
films was determined as follows:
S(%) = [(mi − mf)/(mi)] × 100%, where S is the solubility, mi is the initial mass and mf the
final mass.
2.5.8. Antioxidant Activity
The antioxidant activity of the films was evaluated by the 2,2-diphenyl-1-picrylhydrazyl (DPPH)
free radical scavenging assay and the β-carotene bleaching test.
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For the DPPH free radical scavenging assay, 3 disks of the film (6 mm of diameter) were added to
2.9 mL of a DPPH methanolic solution (0.1 mM). Then, the absorbances were measured at 517 nm
every 30 min, for 5 h, against a blank of methanol [13].
For the β-carotene bleaching test, 500 μL of a β-carotene solution (20 mg/mL in chloroform) were
added to 40 μL of linoleic acid, 400 μL of Tween 40 and 1 mL of chloroform. The chloroform was then
evaporated under vacuum, and 100 mL of oxygenated distilled water were added to the mixture to
form an emulsion. Then, 5 mL of this emulsion were pipetted into test tubes containing 3 disks of the
film (6 mm of diameter). Finally, the tubes were shaken and placed at 50 ◦C in a water bath for 1 h.
The absorbances of the samples were measured at 470 nm [13].
2.5.9. Antibacterial Properties
The antibacterial properties of the films against two foodborne pathogens (Enterococcus faecalis
ATCC 29212 and Listeria monocytogenes LMG 16779) were evaluated by solid diffusion assay. For this
test, inoculums were prepared by suspending bacteria in a sterile saline solution (NaCl; 0.85%; w/v) to
a cell suspension of 0.5 McFarland (1–2 × 108 colony-forming units/mL (CFU/mL)). Disks of the films
(6 mm of diameter) were prepared under aseptic conditions. Then, the Müeller-Hinton agar (MHA)
plates were inoculated and allowed to dry, being the disks of films placed over the inoculated culture
medium. Finally, the plates were incubated at 37 ◦C for 24 h. After the incubation, all the plates were
visually checked for inhibition zones, being their diameters measured using a pachymeter. This assay
was performed three independent times [13,21].
2.5.10. Biodegradability
Soil burial degradation test was carried out to evaluate the biodegradability of the films.
Small pieces of films (dimensions 2 × 7 cm) were buried in natural soil at a depth of 10 cm (23 ± 2 ◦C
and 50 ± 5% RH). After 10 days, the samples were collected, washed several times with distilled water
and then allowed to dry in an oven at 50 ◦C for 24 h [25]. The weight loss was monitored and the FTIR
spectra of the degraded films were also recorded as described above.
2.6. Statistical Analysis
The results were expressed as mean ± standard deviation (SD). The data were analyzed using the
statistical program IBM SPSS Statistics 25 (https://www.ibm.com/analytics/spss-statistics-software).
The significant difference among means was analyzed by Student’s T-test (assuming the normal
distribution of the continuous variables). A level of p-value < 0.05 was considered significant. Linear
regression was also performed for antioxidant activity of the films measured by DPPH scavenging
assay considering the % Inhibition as a function of time.
3. Results and Discussion
3.1. Proof-of-Concept: Negative Template and Positive Replica
This work intended to develop zein-based films incorporating licorice EO with potential
applications in food packaging materials. Considering that these bio-based films are usually hydrophilic,
and considering the “lotus effect”, it was decided to try to mimic the hierarchical surface morphology
of the lotus leaves in these films.
Firstly, the surface of the leaves was analyzed by SEM (Figure 1b), where it was possible to notice
the common pattern of lotus leaves with its micro and nanostructures, measuring between 7 and 8 μm.
Then, to prepare a negative template of the lotus leaves, a mixture of PDMS and its catalyzer was
nano-casted on fresh lotus leaves. After solidification of PDMS, the negative template was lift off and
visualized by SEM (Figure 1c). The PDMS-negative template presents the holes corresponding to the
structures observed in the lotus leaves surface, which means that a complementary topographic surface
structure of the original template (lotus leaves) was successfully obtained. Finally, the zein-based
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films (with and without licorice EO) were casted on the PDMS-negative template to replicate the
hierarchical surface morphology of the lotus leaves in the films. The films obtained were once again
visualized by SEM (Figure 1d), ant it was possible to observe that the complex surface patterns of
the lotus leaves were transferred to the surface of the zein-based films with high fidelity (positive
replica), which validated the original concept behind this study. Moreover, the structures obtained in
both types of zein-based films presented similar dimensions (≈7–8 μm), measured by SEM, indicating
that the incorporation of the licorice EO in the films did not interfere with the nano-casting process.





































Figure 1. Flowchart for negative template fabrication and films preparation (a). SEM images of lotus
leaf surface (b), PDMS-negative template (c), and zein film-positive replica (d). (Magnification: 500×).
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3.2. FTIR and DSC Analyses of The Films
The spectra of zein-based films with or without licorice EO, and both casted on simple polystyrene
Petri dishes and on lotus negative template were recorded. It was observed that all the films without
incorporation of licorice EO presented analogous FTIR spectra. Similar results were found for the
films with licorice EO, indicating that the support material where the films were casted (polystyrene or
PDMS) did not influence the chemical interactions between the components of the films. In addition,
both sides of each film presented similar FTIR spectra, which means that the topographic surface
structure did not affect the chemical composition of the films. Figure 2a shows the FTIR spectrum of
the zein film without licorice EO, while Figure 2b presents the spectrum of the film incorporating the
EO. The licorice EO is mainly constituted (71.8%) by isopropyl palmitate [13], also shown in Figure 2b.
The large absorption at 2960 cm−1 in the zein film with licorice EO was attributed to the stretching
vibration of the aliphatic compounds, and the peak at 1740 cm−1 was ascribed to the stretching
vibration of the ester compounds. Isopropyl palmitate possesses an aliphatic chain with several methyl
groups (CH), while being also an ester presenting a carbonyl group (C = O) [13]. These molecular
features of the main compound of the EO are responsible for the peaks visible in the FTIR spectrum
of the zein-based film incorporating licorice EO, when compared to the spectrum of the control film,










Figure 2. FTIR spectra of the films: control film (without EO) (a), film with EO (b), and films after
10 days of soil burial (c).
The thermal profiles of zein films with or without the licorice EO incorporated were evaluated
by DSC. Similar to what was observed in FTIR analysis, the support material where the films were
casted did not influence the DSC curves. Figure 3a shows the DSC curve of a zein film without EO
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and Figure 3b shows the DSC curve of a zein-based film incorporating licorice EO. Both thermograms
show endothermic peaks in the range of temperature of 50 ◦C to 150 ◦C. The presence of such peaks
is attributed to the loss of volatile components, like water, or the possibility of chain relaxation.
Additionally, in this range of temperature, the breakdown of hydrogen bonds that are present in
the zein structure and other molecular associations also happens [20]. Proteins have some features
associated to their different tridimensional structure, such as the denaturation process. The DSC curve
of zein-based film without EO (Figure 3a) exhibited endothermic peaks at 311 ◦C and 318 ◦C, which
can be interpreted as the protein unfolding, similar to what was previously observed [20]. Moreover,
through the DSC curve of the control film, at the 174 ◦C mark, a slight modification on the linear profile
of the zein curve appears, which is linked to the zein glass transition temperature (Tg), since above this
temperature the protein chains of zein enter in a flexible stage [20]. When incorporating licorice EO
in the zein films, the DSC curve (Figure 3b) changed, having observed a lower value of Tg (165 ◦C),
which is probably related to the loss of some flexibility in the films with the EO [20]. This fact can be
explained by the interactions among zein and the compounds of licorice EO after the preparation of
the films, as it was also observed by the FTIR analysis. Similar results were previously obtained by
other authors dealing with zein-based films [29].
 
Figure 3. DSC curves of the films: control film (without EO) (a), and film with EO (b).
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3.3. Grammage, Thickness, Mechanical and Optical Properties of The Films
The grammage and thickness were significantly higher (p-value < 0.05) in the films incorporating
licorice EO casted on the lotus negative template (Table 1), which is probably due to the imprisonment
of air microbubbles during the casting. The film-forming solution must fill all the holes of the lotus
negative template, which are full of air that can become entrapped in the film matrix. Moreover,
the incorporation of the EO in the films most likely increases their apparent density, which is also
reflected in higher values of grammage.
Table 1. Grammage, thickness, mechanical and optical properties of the films.
Properties
Films
p-ValuesPolystyrene Petri Dishes Lotus Negative Template
Without EO a With EO b Without EO c With EO d
















































(Results expressed as mean ± SD) a, b, c and d correspond to each type of film; Significant p-values are highlighted
in bold.
Concerning the mechanical properties, zein films are brittle, and thus, plasticizers are needed to
improve their flexibility [30]. In general, tensile strength and elongation are key factors in packaging
materials, which keep their integrity during packaging, transport, storage and sales [7]. The tensile
strength of the films casted on lotus negative template was significantly lower (p < 0.05) when
compared to the films casted in simple polystyrene Petri dishes (Table 1), incorporating (or not) licorice
EO. This means that it is not the licorice EO that affects tensile strength, but the support material
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where the films were casted, probably because of the same effect of air microbubble entrapment,
as explained above.
Nevertheless, elongation and elastic modulus were similar within all the films (Table 1). Finally,
the mechanical properties of the zein-based films developed in this work, using glycerol as plasticizer,
are very close to the ones obtained previously for zein films using oleic acid as the plasticizer
agent [29,30], but improved upon than the ones obtained using other plasticizers (buriti oil, macadamia
oil and olive oil) [29].
The optical properties (L*, a* and b*) of the films with EO were only slightly affected (Table 1),
since zein is a yellow powder and the licorice EO is yellow-brownish. On a previous work, the licorice
EO was incorporated in carboxymethyl xylan films (white) and the optical properties were significantly
changed by the EO, particularly transparency [13]. In the present work, the color of the EO is not a
problem since zein is also yellow.
3.4. Barrier Properties: Water Vapor Permeability
The barrier properties of the films, and particularly water permeability, plays a critical role in
evaluating the practical applications of functional films. It was expected that the films with licorice
EO presented lower water permeability since the hydrophobic nature of the EO was known to
contribute to the decrease of WVP [22]. Furthermore, in the present work, the WVP was significantly
higher (p-value < 0.05) in the zein films casted on lotus negative template, compared to the ones
casted on simple polystyrene Petri dishes (Table 2). The WVP of the films casted on polystyrene
is near 2.74 × 10−6 g/(Pa.day.m) while for the films casted on lotus negative template it is about
3–4 × 10−6 g/(Pa.day.m), indicating that the water barrier properties of the films were weakened.
The support material where the films were casted seems to influence the WVP, probably because of the
higher values of thickness obtained for the films casted on lotus negative template. The zein-based
films developed in the present work presented strong water barrier properties than the ones obtained
previously with chitosan-zein edible films incorporated with anise, orange and cinnamon essential oils
(250 ppm) [31].
Table 2. Barrier properties of the films: water vapor permeability.
Properties
Films
p-ValuesPolystyrene Petri Dishes Lotus Negative Template
Without EO a With EO b Without EO c With EO d











(Results expressed as mean ± SD) a, b, c and d correspond to each type of film; Significant p-values are highlighted
in bold.
3.5. Contact Angle and Water Solubility
Understanding the wettability of the films is often carried out by measuring the contact angle
formed between a liquid drop and the film [32]. Additionally, the water contact angle measurements
provide information about the hydrophobicity/hydrophilicity of the surface of the films. A hydrophobic
surface is a surface in which the water contact angle is higher than 90◦ [5]. Table 3 summarizes the
water contact angle measured in both sides of the films (with and without the licorice EO), casted on
polystyrene and on lotus negative template. The addition of licorice essential oil increases significantly
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(p-values < 0.05) the contact angle of the films (Table 3). In films casted on simple polystyrene
Petri dishes, the contact angle raises from 48.27◦ (without EO) to 71.80◦ (with EO). These results
may be explained by the chemical composition of the licorice EO, mainly constituted by isopropyl
palmitate, which presents an octanol/water partition coefficient (logP) of 8.16, an indicator of its strong
hydrophobic character [13]. Licorice is usually taken as a hydrophobic component of edible films and
coatings [33]. More interestingly was the effect observed in the films casted on lotus negative template.
The upper side of the films (without the hierarchical surface morphology of the lotus leaves), presented
contact angles of 65.15◦ (without EO) and 58.04◦ (with EO); contrariwise to what was verified in the
lower side of the films (with the hierarchical surface morphology of the lotus leaves) that presented
significantly higher (p-value < 0.05) contact angles than the ones obtained for the films casted on
polystyrene (Table 3). The film without EO that presents the complex surface patterns of the lotus
leaves (positive replica) had a contact angle of 81.95◦; significantly higher (p-value < 0.05) contact
angle was obtained for the film with EO, which is also a lotus positive replica (112.50◦) (Table 3).
Here, the strong hydrophobic effect of licorice/isopropyl palmitate was noticed, in addition to the
“lotus effect”, which confirms the initial idea behind this work. Combining the “lotus effect” with
the incorporation of the licorice EO resulted in a near superhydrophobic surface (water contact angle
superior than 150◦) [5]. To the best of our knowledge, it was the first time that zein-based films were
obtained with such high water contact angle.
Water solubility is a measure of the resistance of the films to water [24]. The results obtained
showed that all the films presented a water solubility of about 20% (Table 3), indicating the lower
affinity to water of these films, which also corroborates the water contact angles obtained for the films.
3.6. Antioxidant and Antibacterial Properties
Figure 4 shows the antioxidant activity of the films measured by DPPH scavenging assay over
time. All the films presented the ability to scavenge the free radicals in a time-dependent manner,
as demonstrated by the linear regressions (p-values < 0.05). After 5 h of reaction, the films presented
near 90% of inhibition of DPPH free radicals (Figure 4). Although the licorice EO is a potent
antioxidant [13], the films without it also presented the capacity to scavenge free radicals, which is
due to zein. The antioxidative nature of zein was previously reported, being frequently used in food
packaging (edible films and coatings) without adding any other antioxidant during processing [34].
Some studies have reported the benefits of using zein films as packaging material for cooked turkey
and fresh broccoli [34]. The capacity of the films to inhibit lipid peroxidation was also evaluated
(Table 4). The results showed that the films with licorice EO have significantly higher (p-value < 0.05)
percentages of inhibition than the control films. Both types films (polystyrene and lotus negative
template) incorporating the EO presented similar capacity to inhibit the lipid peroxidation measured
by the β-carotene bleaching test (20–30%), contrariwise to what was obtained with the control films
(3–5%) (Table 4). This capacity can be attributed to isopropyl palmitate, the major compound of licorice
EO, which is generally used in cosmetic and food industries due to its binder and fragrant properties,
together with skin-conditioning and emollient activities. The Food and Drug Administration (FDA)
considers that this compound is not ecotoxic and classifies it as not expected to be potentially toxic or
harmful, presenting a low human health priority [35].
Also, licorice is generally recognized as safe (GRAS) by the FDA, indicating that there is no
evidence, in the available information on licorice, that identifies a hazard to the public when it is used
at levels that are now current and in the manner now practiced [36].
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Figure 4. Antioxidant activity of the films measured by DPPH scavenging assay.




p-valuesPolystyrene Petri Dishes Lotus Negative Template
Without EO a With EO b Without EO c With EO d
% Inhibition







Without EO a With EO b Without EO c With EO d p-values











(Results expressed as mean ± SD) a, b, c and d correspond to each type of film; Significant p-values are highlighted
in bold.
The antibacterial properties of the films were evaluated against two well-known foodborne
pathogens (E. faecalis ATCC 29212 and L. monocytogenes LMG 16779). E. faecalis is a commensal of
the human gastrointestinal tract that can persist in the external environment and is a leading cause
83
Microorganisms 2019, 7, 267
of several infections. Given its diverse habitats, the organism has developed numerous strategies
to survive a multitude of environmental conditions [37]. L. monocytogenes is a foodborne pathogen
responsible for a disease called listeriosis, which is potentially lethal in immunocompromised people
and can provoke septicemia, meningitis and fetal infection or abortion in infected pregnant women [38].
The results of the antibacterial activity studied by solid diffusion assay are presented in Table 4.
Both types of zein films incorporating licorice EO presented significantly higher (p-value < 0.05)
diameters of inhibition zones for the two bacterial species. Moreover, the anti-biofilm potential of zein
films against the same foodborne pathogens was evaluated by SEM, forming the bacterial biofilms
directly on the surface of the films (results not shown). It was possible to verify that in the films
presenting the hierarchical surface morphology of the lotus leaves, the bacterial adhesion did not occur.
More than inhibiting the bacterial growth, the films inhibited the adhesion. The anti-bio adhesion of
surfaces with lotus-leaf-like rugosities is well described in the literature [39].
Since zein-based films incorporating licorice EO were able to scavenge free radicals to inhibit lipid
peroxidation and the growth of foodborne pathogens, they can potentially be used as alternative food
packaging systems, particularly in foods with high contents of lipids.
3.7. Biodegradability
The biodegradability of the films was studied by soil burial degradation test for 10 days. The weight
loss of zein-based films was about 50–60% (Table 3), which is a clear reflection of the biodegradation
process performed by the microorganisms and moisture present in the soil. Moreover, at the end of
the biodegradability test, the films were thin and appeared disrupt (Figure 5b) when compared to
the initial samples (Figure 5a). The FTIR spectra of the films after the soil burial degradation test
(Figure 2c) showed peaks absorption and decrease in intensities as biodegradation took place, as other
authors also reported [25]. These results clearly show the biodegradable nature of the zein-based films
now developed.
 
Figure 5. Biodegradability: soil burial degradation test of the films. Film without EO — polystyrene
Petri dishes (1), film without EO — lotus negative template (2), film with EO —polystyrene Petri dishes
(3), and film with EO —lotus negative template (4); initial films at 0 days (a), and films after soil burial
degradation test (10 days) (b).
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4. Conclusions
In this work, a simple and rapid method to mimic the lotus leaf surface was developed and
applied to the production of zein-based films. The licorice EO was also incorporated into the films as a
bioactive agent. The zein films produced using the lotus negative template presented lotus-leaf-like
rugosities, resulting in very hydrophobic surfaces (water contact angle of 112.50◦). The zein films with
licorice essential oil are biodegradable and possess antioxidant and antibacterial properties against
known foodborne pathogens, making them potential alternatives to the conventional plastics used in
food packaging solutions, reducing environmental pollution and increasing the shelf-life of foods.
Future research is needed to identify ways to produce on a large scale films with the hierarchical
surface morphology of the lotus leaf.
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Abstract: Although spice extracts are well known to exhibit antibacterial properties, there is lack of
a comprehensive evaluation of the antibacterial effect of spices against antibiotic-resistant bacteria.
In the present study, ethanolic extracts from a total of 67 spices were comprehensively investigated for
their in vitro antibacterial activities by agar well diffusion against two common food-borne bacteria,
Staphylococcus aureus and Salmonella enteritidis, with multi-drug resistance. Results showed that
S. aureus was generally more sensitive to spice extracts than S. enteritidis. Of the 67 spice extracts,
38 exhibited antibacterial activity against drug-resistant S. aureus, while only four samples were
effective on drug-resistant S. enteritidis. In addition, 11 spice extracts with inhibition zones greater
than 15 mm were further verified for their broad-spectrum antibacterial properties using another
10 drug-resistant S. aureus strains. It was found that five spice extracts, including galangal, fructus
galangae, cinnamon, yellow mustard seed, and rosemary, exhibited the highest antibacterial capacity.
Further cytotoxicity of these 11 spices was determined and LC50 values were found to be more than
100 μg/mL except for galangal, rosemary, and sage, whose LC50 values were 9.32 ± 0.83, 19.77 ± 2.17,
and 50.54 ± 2.57, respectively. Moreover, the antioxidant activities (ferric-reducing antioxidant power
(FRAP) and trolox equivalent antioxidant capacity (TEAC) values) and total phenolic content (TPC)
of spice extracts were determined to establish possible correlations with the antibacterial activity.
Although the antibacterial effect was positively correlated with the antioxidant activities and TPC,
the correlation was weak (r < 0.5), indicating that the antibacterial activity could also be attributed to
other components besides antioxidant polyphenols in the tested spice extracts. In conclusion, dietary
spices are good natural sources of antibacterial agents to fight against antibiotic-resistant bacteria,
with potential applications as natural food preservatives and natural alternatives to antibiotics in
animal feeding.
Keywords: spice extracts; drug resistant bacteria; antibacterial activity; antioxidant activity; total
phenolic content; correlation
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1. Introduction
Food poisoning caused by food-borne bacteria is one of the critical threats to human health all
over the world [1]. The emergence of multi-drug resistant bacteria induced by the abuse of antibiotics
cause greater obstacles for the treatment of food-borne diseases [2]. Antibiotic-resistant bacteria,
such as Staphylococcus (S.) aureus and Salmonella (S.) enteritidis, have frequently been reported to cause
contamination of different foods like raw pork, beef, and poultry [3,4]. Many attempts, such as the
use of synthetic preservatives, have been used to control microbial growth and ensure food safety.
However, there have potential carcinogenic and toxicological properties, as well as side effects like food
allergies and sensitivities that are harmful to human health [5]. To counter these problems, much effort
has gone into the search for “naturally derived” alternative antimicrobials since plants are known to
produce diverse secondary metabolites that are associated with anti-infective mechanisms against
the invasion of pathogenic microorganisms [6,7]. Among them, plant-derived spices and extracts
containing a mixture of active ingredients have received growing attention, not only for their effective
antibacterial activity but also for the relative difficulty in developing resistance to them. Moreover,
spice and their major components are generally recognized as safe (GRAS) with no historical records
of detrimental impacts and with modern toxicological verification [8].
Although spices have been widely used in rituals, and as flavorings and coloring agents since
ancient times [9], recent literature has increasingly reported on the antibacterial activity of spices against
common Gram-positive and Gram-negative bacteria responsible for human infectious diseases and food
safety problems [10–13]. Examples of such spices are cinnamon, oregano, nutmeg, basil, pepper, thyme,
clove, rosemary, ginger, cumin, etc. However, few studies have focused on the inhibitory effects of
these spices on antibiotic-resistant bacteria. The methanolic and ethanolic extracts of cinnamon, which
was the most studied spice, were reported to have inhibitory effects on high level gentamicin-resistant
(HLGR) enterococci, multi-drug resistant Escherichia coli AG100, methicillin-resistant S. aureus (MRSA),
as well as β-lactamase producing multi-drug Klebsiella pneumonia and Pseudomonas aeruginosa [14–16].
Moreover, the antibacterial properties of spices are mostly attributed to lipophilic essential oils in
most previous studies [17]. However, spices are also rich in hydrophilic antioxidants [18], such as
polyphenols, many of which possess excellent antioxidant activity, and also exhibit good antibacterial
activity [19]. Considering that microbial contamination and lipid oxidation are the two major factors
resulting in food spoilage [20], spice hydrophilic extracts with good antibacterial and antioxidant
activities can be promising natural food preservatives. For instance, extracts of cinnamon, oregano,
and especially clove, were confirmed to be effective for retarding lipid oxidation and reducing pathogen
numbers in real food matrices like cheese and raw pork [21,22]. More importantly, probiotic bacteria
like lactic acid bacteria (LAB) were less influenced by the presence of these phenolic rich spice extracts,
indicating that spice extracts could be applied in foods not only to prolong shelf-life but also enhance
health benefits of foods [23].
Therefore, the aim of this study was to evaluate systemically and compare the in vitro antibacterial
activity of the ethanolic extracts of 67 spices, mainly focusing on their effects on antibiotic-resistant
bacteria, and to analyze the correlation among antibacterial activity, antioxidant activity, and total
phenolic content (TPC) in spices. Overall, this study can shed light on the control of antibiotic-resistant
bacteria using dietary spices, which should have broad applications in food industry to help assure
food safety.
2. Materials and Methods
2.1. Chemicals and Reagents
2,2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) and
2,4,6-tri(2-pyridyl)-s-triazine (TPTZ) was from Sigma/Aldrich (St. Louis, MO, USA). Gallic
acid was from Energy Chemical (Shanghai, China). Dimethyl sulfoxide (DMSO) was from
Beyotime (Shanghai, China), Folin–Ciocalteu reagent was from Macklin (Shanghai, China),
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6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (trolox) was from Fluka Chemika AG (Buchs,
Switzerland). Hydrochloric acid, iron (III) chloride hexahydrate and Iron (II) sulfate heptahydrate
were from Sinopharm Chemical Reagent (Shanghai, China), acetic acid and sodium acetate were
from Molbase (Shanghai, China). Potassium persulphate and ethanol were obtained from Titanchem
(Shanghai, China). Sodium carbonate and methanol were purchased from J&K (Beijing, China).
Luria Bertani (LB) broth, agar bacteriological, and Mueller–Hinton (MH) broth were purchased from
Oxiod (Basingstoke, England). Antibiotics, including ampicillin, cefazolin, ciprofloxacin, clindamycin,
erythromycin, gentamicin, oxacillin, penicillin, streptomycin, sulfisoxazole, and tetracycline were
purchased from Meilune (Dalian, China). All chemicals used in the experiment were of analytical grade.
2.2. Spice Materials
The 67 dried edible spice materials were purchased from the local markets in Shanghai, China.
The basic information (scientific name and common name) of these spices is detailed in Table 1.
2.3. Microorganisms and Culture
Two strains of Salmonella enteritidis (drug-resistant S. enteritidis SJTUF 10987 and the standard
strain S. enteritidis ATCC 13076) and 12 strains of Staphylococcus aureus, including 11 drug-resistant
strains S. aureus SJTUF 20745, S. aureus SJTUF 20746, S. aureus SJTUF 20755, S. aureus SJTUF 20758,
S. aureus SJTUF 20772, S. aureus SJTUF 20827, S. aureus SJTUF 20841, S. aureus SJTUF 20862, S. aureus
SJTUF 20973, S. aureus SJTUF 20978, and S. aureus SJTUF 20991, as well as the standard strain S. aureus
ATCC 25923 were used in this study. These strains were stored at −80 ◦C. To prepare the inocula,
a single colony of the bacteria grown on the LB agar plate was selected and transferred into the LB broth
to culture overnight in a rotary incubator (37 ◦C, 150 rpm). The bacterial suspension was then diluted
to approximately 1 × 106 colony-forming units (CFU)/mL for subsequent antibacterial experiments.
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2.4. Verification of the Drug-Resistant Bacteria
The verification assay was undertaken using the agar dilution method following the testing
procedures of the Clinical and Laboratory Standards Institute, USA (CLSI M100-S28, 2018). Briefly,
tested strains were cultured in MH broth overnight, then centrifuged (1000× g, 1 min) and transferred
to a custom 96-well microtitre plate using 1 mL of 0.85% sodium chloride solution. The absorbance of
bacterial resuspension at OD 600 was adjusted to 0.5, followed by further 100 fold dilution to make a
final concentration of 1 × 106 CFU/mL. Subsequently, bacterial suspensions were incubated to the MH
agar plates which were supplemented with antibiotics under prescribed breakpoint concentrations
stated by CLSI using the multipoint incubator (HM1-12-001, Hen Gao Technology Development Co.,
Ltd., Tianjin, China), and the plates were cultured at 37 ◦C for 20 h. In addition, the oxacillin agar
dilution method was used for the detection of MRSA (CLSI, 2018). Isolates were considered to be
multi-drug resistant if they were resistant to at least three different categories of antibiotics, based on
their growth condition on the MH plates.
2.5. Preparation of Spice Ethanolic Extracts
The clean dietary spices were air-dried in a ventilated oven at 40 ◦C for 24 h, then ground into
fine powders by a miller (S025, IKA, Staufen, Germany). Powdered samples (4.0 g) were extracted
with 80 mL of 80% (v/v) ethanol in a shaking bath (MQT-50, Shanghai Min Quan Co., Ltd., Shanghai,
China) at room temperature (23 ± 1 ◦C) for 24 h. In this study, 80% ethanol was used for the extraction,
since ethanol is of relative low toxicity among several organic solvents, and 80% ethanol was efficient
to extract antioxidant and antibacterial components from spices and herbs based on our previous
study [22]. Afterwards, the mixture was centrifuged at room temperature (900× g, 15 min) and the
collected supernatant was concentrated by a rotatory vacuum evaporator (RE-52AA, Shanghai Ya Rong
Co., Ltd., Shanghai, China) at 40 ◦C, then the concentrated extract was dried by a vacuum freeze-dryer
(SJIA-5FE, Ningbo Shuang Jia instrument Co., Ltd., Ningbo, China). The freeze-dried samples were
stored at −20 ◦C in small vials for further use.
2.6. Determination of Antibacterial Activity
The inhibitory effects of 67 spices were estimated according to the agar diffusion method as
previously reported with slight modification [24]. The freeze-dried extracts were dissolved in DMSO to
a final concentration of 100 mg/mL and filtered through 0.22 μm sterilizing filters. Briefly, all bacteria
were diluted to about 1 × 106 CFU/mL with sterile LB medium, and then 100 μL of each bacterial
suspension was evenly spread onto the surface of LB agar plate by sterile glass beads (6 mm in
diameter). Oxford cups (sterilized hollow cylinder with an inner diameter of 6 mm, outer diameter
of 7.8 mm, and height of 10 mm) were placed lightly on the agar surface, and then 60 μL of the
prepared samples (100 mg/mL) were delivered into the cups. DMSO (60 μL/cup) was used as a negative
control. The plates were incubated at 37 ◦C for 24 h for bacterial growth in an incubator (BI-150A,
Shanghai Stik Co., Ltd., Shanghai, China). The diameters of the inhibitory zones (DIZs) formed around
the Oxford cups were measured to evaluate the antibacterial activity and expressed in millimeter
(mm). All experiments were performed in triplicate. DIZ values less than 8 mm were considered as
“no inhibition zone (NIZ)”.
2.7. Minimum Inhibitory Concentration (MIC) and Minimum Bactericide Concentration (MBC) Assays
Minimum inhibitory concentration (MIC) and minimum bactericide concentration (MBC) were
determined according to the method described by Elshikh et al. with minor adjustment [25]. Briefly,
100 μL of MH broths were added into 96-well plate and then another 100 μL of dissolved samples,
whose initial concentrations were 100 mg/mL, were added in first wells. Serial two-fold dilutions were
made with final concentrations ranging from 50 mg/mL to 0.39 mg/mL. Afterwards, 100 μL of the
standardized bacteria suspensions (1 × 106 CFU/mL) was added to each test well, so that the final
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volume in each well was 200 μL. Plates were incubated at 37 ◦C for 24 h. After incubation, 30 μL of the
freshly prepared resazurin (0.015%) was added to all test wells, and further incubated for 2 h to allow
the viable microorganism to metabolize the blue resazurin dye into pink resorufin. MIC was defined as
the concentration at which the corresponding well showed no color change. Afterwards, the contents
of wells with concentrations equal or higher than MIC values were directly incubated onto the MH
plate, and the lowest concentration at which there was no colony growth was defined as MBC.
2.8. Cytotoxicity of Spice Extracts
Human foreskin fibroblast (HFF) cells were grown in DMEM medium supplemented with 10%
fetal bovine serum (FBS), and maintained at 37 ◦C in a humidified 5% CO2 incubator. The toxicity of
spice extracts was evaluated by 3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay as described by Mosmann with slight modification [26]. HFF cells were seeded at a density of
5× 104 cells/mL into the 96-well plate and incubated overnight to adhere the cells. The cells were treated
with various concentrations (5–100μg/mL, and the concentration of DMSO was diluted below 0.1%) of
different extracts and incubated at 37 ◦C in a humidified 5% CO2 incubator for 24 h. The untreated cells
were included as control. After the incubation period, MTT (20 μL of 5 mg/mL) was added into each
well and incubated for 4 h. The formazan crystals were dissolved with DMSO (100 μL). The absorbance
was measured at 570 nm using a microtitre plate reader (SpectraMax iD3, Molecular Devices, Silicon
Valley, NC, USA). The LC50 value was calculated as the concentration of the extract that resulted in
50% reduction of absorbance compared to control cells [27].
2.9. Determination of Antioxidant Capacity
2.9.1. Ferric-Reducing Antioxidant Power (FRAP) Assay
The ferric-reducing antioxidant power (FRAP) assay was carried out according to the procedures
described by Gan et al. [28]. Briefly, the FRAP working solution was freshly prepared before the
experiment, with sodium acetate solution (300 mM, pH = 3.7), TPTZ (10 mM solved with HCl) and
ferric chloride solution (20 mM) mixedin a volume ratio of 10:1:1, respectively. The FRAP working
solution was then incubated at 37 ◦C before use. The proper dilutions (100 μL) of samples were added
to 3 mL of the FRAP working solution and their absorbance at 593 nm was determined after incubation
for 4 min at room temperature (23 ± 1 ◦C). Ferrous sulfate solution (0.1–1 mM) was used as the standard
for the calibration curve, and the results were expressed as mmol Fe(II)/g dry weigh (DW) extract
powder. All tests were performed in triplicate.
2.9.2. Trolox Equivalent Antioxidant Capacity (TEAC) Assay
The trolox equivalent antioxidant capacity (TEAC) assay was carried out to determine the free
radical scavenging capacity using ABTS+ according to the method previously reported [28]. ABTS stock
solution was prepared by mixing 7 mM ABTS and 2.45 mM potassium persulfate in a ratio of 1:1 (v/v)
and then incubated at room temperature (23 ± 1 ◦C) in the dark for at least 16 h. The ABTS working
solution was prepared by dilution of the stock solution with 80% ethanol before use, and then the
absorbance at a wavelength of 734 nm was adjusted to 0.7 ± 0.05. The blank control is a mixture of
3.9 mL ABTS working solution and 0.1 mL of 80% ethanol. The spice extract sample (0.1 mL) was
diluted with 80% ethanol to provide 20–80% inhibition of the blank absorbance, and then the properly
diluted samples were added to 3.9 mL ABTS working solutions and mixed thoroughly. The absorbance
of reactive mixture was determined at 734 nm after incubation at room temperature (23 ± 1 ◦C) for
6 min. Quantitative results were determined from the standard curve of trolox (0.05–0.8 mM) and were
expressed as mmol trolox/g dry weight (DW) extract powder. All tests were performed in triplicate.
95
Microorganisms 2019, 7, 157
2.10. Determination of Total Phenolic Content (TPC)
TPC was determined by the Folin-Ciocalteu method reported previously with some
modification [29]. The appropriate dilutions of samples (200 μL) were mixed with 1 mL of 0.5 M
Folin–Ciocalteu reagent at room temperature (23 ± 1 ◦C) for 4 min, and then reacted with 800 μL of
saturated sodium carbonate solution (75 g/L) in dark for 2 h. Finally, the absorbance of the reaction
mixtures was measured at 760 nm with a spectrophotometer (181712007PC, Shanghai Jing Hua Co. Ltd.,
Shanghai, China) and quantified on the base of the standard curve of gallic acid (0.01–0.1 mM).
The results were expressed as milligram gallic acid equivalent (mg GAE)/g DW extract powder. All
tests were performed in triplicate.
2.11. Statistical Analysis
All the measurements were performed in triplicate, and the results were expressed as mean ±
standard deviation (SD). Statistical analysis was performed using Microsoft Excel 2016 (Microsoft,
Seattle, MA, USA) and SPSS 22.0 (IBM SPSS Statistics, IBM Corp, Somers, NY, USA). Pearson linear
correlation analysis and principal component analysis (PCA) were performed to analyze relationships
among parameters, and p value less than 0.01 was defined as statistical significance.
3. Results
3.1. Verification of Drug-Resistant Bacteria
The antibiotic-resistant strains of S. aureus and S. enteritidis were isolated from food samples
in our lab previously. In order to confirm their antibiotic resistance, we first tested their resistance
to 11 common antibiotics from different categories. The breakpoint concentration of each antibiotic
defined by CLSI and corresponding bacterial resistance spectra are shown in Table 2. All tested
bacteria were resistant to antibiotics. Except for S. aureus SJTUF 20827 and S. aureus SJTUF 20973,
the remaining bacteria were identified as multi-drug resistant bacteria, resistant to at least three
antibiotics. These bacteria showed the highest resistance rate to erythromycin, reaching up to 83.3%,
followed by ciprofloxacin (75%), Clindamycin (75%), gentamicin (50%), and streptomycin (50%).
However, no strain resistant to oxacillin (methicillin-resistant Staphylococcus aureus, MRSA) was
detected. Overall, it was confirmed that all selected bacteria were antibiotic-resistant, most of which
were multi-drug resistant.
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3.2. Antibacterial Activity against Antibiotic-Resistant Bacteria
The agar diffusion method was used to evaluate systematically the antibacterial activity of 67 spice
extracts on antibiotic-resistant S. aureus SJTUF 20978 and S. enteritidis SJTUF 10987, with each standard
strain used as the comparison. The results of DIZ were presented in Table 1. A significant variation in
the antibacterial activity reflected by different DIZ values was observed, depending on the type of
spice extracts and the subject bacteria.
For antibiotic-resistant S. aureus SJTUF 20978, a significant proportion of the spices (38,
approximately accounting for 56.7% of the total tested samples) exhibited antibacterial activity,
with DIZ in the range of 8.7–25.6 mm. Besides, 11 of these spice extracts (accounting for 16.4%)
showed a relatively superior antibacterial activity, with DIZ values greater than 15 mm. Among
there, galangal, the rhizome of Alpinia galanga (L.) Willd., showed exceptional antibacterial capacity,
with the DIZ reaching 25.6 mm, followed by cinnamon, fructus galangae (ripe fruit from galangal),
yellow mustard seed, rosemary, and marjoram, with DIZ values of 20.7, 20.2, 18.6, 18.3, and 17.2 mm,
respectively. Moreover, the MIC and MBC results of these 11 samples were determined and were
shown in Table 3. The MIC values ranged from 0.40–6.25 mg/mL, and MBC values ranged from
0.40–12.5 mg/mL, which were one or two times higher than MICs. Among them, clove fruit, sage,
rosemary, and liquorice had the lowest MIC value (0.40 mg/mL), and fructus galangae, galangal,
and yellow mustard seed showed a relatively high value (6.25 mg/mL). However, for drug-resistant
S. enteritidis SJTUF 10987, the overall antibacterial effects of tested spice extracts were relatively low,
and only four samples showed inhibitory activity, including cinnamon (DIZ = 16.0 mm), male clove
(DIZ = 11.0 mm), thorn amomum villosum (DIZ = 8.6 mm), and female clove (DIZ = 8.5 mm).
Table 3. Minimum inhibitory concentration (MIC) and minimum bactericide concentration (MBC)
values of selected 11 spice extracts with good antibacterial activity.
Scientific Name Common Name MIC (mg/mL) MBC (mg/mL)
Alpinia galangal (L.) Willd. Galangal 6.25 6.25
Alpinia galanga Willd. Fructus galangae 6.25 6.25
Cinnamomum cassia (L.) J. Presl Cinnamon 0.8 1.6
Glycyrrhiza uralensis Fisch. Liquorice 0.4 0.8
Origanum majorana L. Marjoram 1.6 1.6
Rosmarinus officinalis L. Rosemary 0.4 0.4
Salvia japonica Thunb. Sage 0.4 0.8
Sinapis alba L. Yellow mustard seeds 6.25 12.5
Syzygium aromaticum (L.) Merr. et L. M. Perry Male clove (flower) 0.8 1.6
Syzygium aromaticum (L.) Merr. et L. M. Perry Female clove (fruit) 0.4 0.4
Thymus vulgaris L. Thyme 1.6 1.6
In general, the antibacterial activity of spice extracts against antibiotic-resistant bacteria was
somewhat less effective compared to corresponding standard strains S. aureus ATCC 25923 and
S. enteritidis ATCC 13076 (data shown in Table 1). Besides, spice extracts showed much better
antibacterial activity against Gram-positive S. aureus than Gram-negative S. enteritidis. Therefore,
we further tested whether spice extracts had a broad spectrum antibacterial effect on drug-resistant
S. aureus. 11 spice extracts with DIZ more than 15 mm on drug-resistant S. aureus SJTUF 20978 were
selected to verify their antibacterial capacity against another 10 antibiotic-resistant strains of S. aureus.
As shown in Figure 1, all selected spice extracts exhibited inhibitory effects against the validated
antibiotic-resistant strains of S. aureus. Among them, galangal (DIZ = 25.6–31.1 mm), fructus galangae
(DIZ = 21.2–27.8 mm), and cinnamon (DIZ = 18.3–25.1 mm) showed the strongest antibacterial effects,
followed by yellow mustard seed (DIZ = 18.0–21.4 mm) and rosemary (DIZ = 16.2–19.9 mm). Overall,
selected spice extracts possessed a broad spectrum antibacterial effect against antibiotic-resistant
S. aureus.
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S. aureus
Figure 1. The antibacterial activity of selected spice extracts on 10 antibiotic-resistant strains of S. aureus.
3.3. Cytotoxicity of Spice Extracts
Spices were generally considered to be non-toxic or less toxic because of their natural origin and
long use as food additives and medicine for ailment treatments. Meanwhile, some studies on the
efficacy and safety of plants pointed out that some phytochemicals displayed certain cytotoxicity,
genotoxicity, and carcinogenic effects when used chronically [30]. Therefore, it was necessary to
determine the cytotoxicity of the selected 11 spice extracts with good activity against multi-drug
resistant S. aureus. The cytotoxicity of these chosen 11 spices were determined by using the in vitro
assay with HFF cells, and LC50 values were calculated. Of 11 spices tested, eight spice extracts did
not show any cytotoxicity against HFF cells after 24 h of treatment with the highest concentration
tested (100 μg/mL), suggesting that their LC50 values higher than 100 μg/mL. However, other three
spices, including galangal, rosemary, and sage, were able to inhibit the growth of HFF cells at the
LC50 of 9.32 ± 0.83, 19.77 ± 2.17, and 50.54 ± 2.57 μg/mL, respectively, indicating their potential safety
issue. Overall, the results found that most spice extracts with high antibacterial effect were low toxic,
and could be used as potential antimicrobial agents in food industry.
3.4. Antioxidant Activity of Spice Extracts
The antioxidant activity of spice extracts was determined using FRAP and TEAC assays, and the
results are shown in Table 4. The strongest antioxidant activity determined by FRAP assay was found
in the extract of female clove, followed by male clove, allspice, red pepper, and fructus amomi, showing
the FRAP values about 6682 ± 68.6, 5453 ± 23.9, 4404 ± 23.9, 4137 ± 147 and 3605 ± 201 mmol Fe (II)/g
DW extract powder. In addition, the antioxidant activity measured by TEAC method was also highest
in the extract of female clove, followed by male clove, semen alpiniae katsumadai, allspice, and fructus
amomi. The TEAC values were 3415 ± 53.1, 3131 ± 177, 2662 ± 83.7, 2184 ± 43.9, and 2153 ± 370 mmol
Trolox/g DW extract powder, respectively. Besides, the lowest antioxidant activity was found in the
extract of dried lemon, with FRAP and TEAC values about 50.3 mmol Fe (II)/g DW extract powder and
17.4 mmol Fe (II)/g DW extract powder, respectively.
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3.5. TPC of Spice Extracts
The TPC in spice extracts was analyzed through the Folin-Ciocalteu method, and varied from 7.35
to 485 mg GAE/g DW extract powder (Table 4). The highest TPC was observed in the extract of female
clove, followed by semen alpiniae katsumadai, male colve, red pepper, and fructus amomi, and the
TPC values were 485 ± 18.5, 473 ± 8.67, 424 ± 14.9, 378 ± 3.52, and 360 ± 6.80 mg GAE/g DW extract
powder, respectively. Additionally, the lowest TPC was found in the extract of dried lemon (7.35 mg
GAE/g DW), consistent with the results of antioxidant activity.
3.6. Correlation Analysis
In order to shed light on the potential antibacterial components in spice extracts, the correlations
among antibacterial activity on S. aureus (indicated by the DIZ values), antioxidant activity (indicated
by the FRAP and TEAC values), and TPC were analyzed. As shown in Table 5, a strong positive
correlation was found between TPC and FRAP/TEAC values (r > 0.9, p < 0.01), suggesting that
polyphenols mainly contributed to the antioxidant activity of spice extracts. However, regarding the
relationship between DIZ values and FRAP/TEAC values, a significant but weak positive correlation
(r < 0.5, p < 0.01) was observed, indicating that antioxidant activity of spice extracts was only slightly
related to their antibacterial capacity. Besides, DIZ values were also found to be weakly correlated
with TPC (r = 0.541 and 0.568, p < 0.01), suggesting that polyphenols were only partly responsible for
the antibacterial activity of spice extracts on S. aureus, and some other substances should exist in spice
extracts to contribute to their overall antibacterial activity.
Table 5. Correlation analysis among antibacterial activity, antioxidant activity, and total phenolic content.
Pearson Correlation Coefficient (r) DIZ Value
(S. aureus ATCC 25923)
DIZ Value
(S. aureus SJTUF 20978) TPC FRAP TEAC












TPC 1 0.919(p < 0.001)
0.931
(p < 0.001)
FRAP 1 0.924(p < 0.001)
Pearson correlation analysis was performed to analyze the relationships among the means of parameters. p < 0.01
was defined as statistical significance.
3.7. Principal Component Analysis
To further analyze the relationships among antibacterial activity, antioxidant activity, and TPC of
spice extracts and to select suitable spice extracts with good antioxidant and antibacterial activities as
food preservative candidates, principal component analysis (PCA) was performed to cluster factors,
including TPC, FRAP, TEAC, and DIZ values against both S. aureus ATCC 25923 and S. aureus SJTUF
20978 (Figure 2). According to the results of Kaiser–Meyer–Olkin (KMO) and Bartlett’s test (KMO
value = 0.725, p < 0.05), as well as the communalities of factors with extraction >0.94, the data met
the requirements of PCA. In addition, the cumulative variance contribution rate of the two main
components (C1 and C2) extracted was 96.3%, with C1 counting for 55.6% and C2 being 40.7%.
According to the rotated component matrix, C1 included the factors TPC, FRAP, and TEAC, suggesting
that TPC was closely related to the antioxidant capacity. On the other hand, C2 contained DIZ values
of S. aureus ATCC 25923 (DIZ1) and drug-resistant S. aureus SJTUF 20978 (DIZ2). More interestingly,
C1 and C2 were clearly divided into two separate clusters (Figure 2), indicating there was no evident
relationship of antibacterial capacity with antioxidant ability and TPC. These results were generally in
agreement with those of the correlation analysis.
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Figure 2. The results of principal component analysis (PCA). C1 included the factors total phenolic
content (TPC), ferric-reducing antioxidant power (FRAP), and trolox equivalent antioxidant capacity
(TEAC), suggesting that TPC was closely related to the antioxidant capacity. C2 contained DIZ values
of S. aureus ATCC 25923 (DIZ1) and drug resistant S. aureus SJTUF 20978 (DIZ2). C1 and C2 were clearly
divided into two separate clusters, suggesting that there was no evident relationship of antibacterial
capacity with antioxidant ability and TPC.
Next, the general score (GS) of each sample was calculated based on the factor scores of the two
principal components, following the equation GS = (C1 × 0.556 + C2 × 0.407)/0.963, and the results
are shown in Table S1. Spice extracts with higher GS usually exhibited higher phenolic contents,
antioxidant, and antibacterial activity. Based on the results listed in Table S1, clove extracts, prepared
from both fruit and flower of clove, as well as cinnamon showed the highest GS values, indicating
that they could be used as potential promising food preservatives by means of reducing microbial
contamination and lipid spoilage oxidation simultaneously.
4. Discussion
In this study, 38 out of 67 tested spices displayed various degrees of antibacterial activity against
antibiotic-resistant strain of S. aureus, while only four were effective against drug-resistant strain
of S. enteritidis. The antibacterial activity seemed to be bacteria-dependent, and Gram-positive
bacteria were more susceptible to the tested spice extracts than Gram-negative bacteria, which was in
accordance with many previous studies [31,32]. Different from Gram-positive bacteria, Gram-negative
bacteria have an outer membrane rich in lipopolysaccharides, as well as a unique periplasmic space.
The complex composition and spatial structure of lipopolysaccharides form a barrier for penetration of
antimicrobial agents, besides, the presence of enzymes in periplasmic space may break down intrusive
molecules, preventing the antibacterial drugs entering intracellular environment [29]. Additionally,
the antibacterial activity of certain spice extracts tested in our study was also reported by previous
studies. For instance, chilli, lemongrass, bay leaf, cumin, cinnamon, clove, parsley, basil, sage, thyme,
rosemary, and mint, were all demonstrated to show antibacterial capacity against S. aureus [33–36].
However, considering the difference in extraction solvent, extraction method, and dosage of samples,
it is difficult to directly compare these results with the results of our present study. More importantly,
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the inhibitory effects of spice extracts on multi-drug resistant bacteria were relatively less reported.
Gull et al. revealed that eight drug-resistant bacteria were inhibited by ginger extract at a concentration
of 100 mg/mL, with the DIZ ranging from 11 to 15 mm [37]. Mandal et al. reported that the DIZ
value obtained from ethanol extracts (20 μL, 10 mg/mL) of cinnamon, clove, and cumin against
methicillin-resistant S. aureus was in the range of 22–27 mm, 19–23 mm, and 9–15 mm, respectively [38].
Similarly, Revati et al. found that high level gentamicin-resistant enterococci isolates were sensitive to
ethanol extracts (50 μL, 100 mg/mL) of cinnamon, ginger, clove, and cumin, with the DIZ values of
31–34, 27–30, 25–26, and 19–20 mm, respectively [14]. Even though, most of the previous investigations
were carried out with a limited number of antibiotic-resistant bacterial isolates as well as the tested spice
samples, thus the broad antibacterial spectra of spice extracts could not be demonstrated. In addition,
we did not set a positive control, such as antibiotics, mainly with two reasons. On the one hand,
the antibiotic resistance of bacterial strains used in our study was determined using 11 different
antibiotics (Table 2). On the other hand, we were not intended to compare the antibacterial activity
of these 67 spice extracts with antibiotics, since the effects of the crude extracts were generally not
comparable to pure antibiotics. Besides, in our study, we used the stock concentration of extracts at a
relatively high concentration, 100 mg/mL, for the DIZ evaluation, since our samples were dissolved in
DMSO, which also possessed an antibacterial effect at a relatively high concentration, such as more
than 5%. To rule out the interference of DMSO during subsequent MIC and MBC assays, it was
necessary to increase the stock concentration of extracts to reduce the concentration of DMSO in the
final working solution of samples.
In our present study, we further chose 11 spices whose DIZ values were higher than 15 mm to
verify their antibacterial effects on another ten antibiotic-resistant strains of S. aureus, since tested spice
extracts exhibited much better antibacterial activity on Gram-positive S. aureus than Gram-negative
S. enteritidis, and found that galangal, fructus galangae, cinnamon, yellow mustard seed, and rosemary
overall had the best antibacterial effect, and could probably be developed into antimicrobial agents.
Our study may be the first large-scale investigation on the antibacterial effect of spice hydrophilic
extracts on antibiotic-resistant bacteria. Therefore, this study can give a clear comparison of the
antibacterial activity of spice extracts, especially against antibiotic-resistant bacteria. To provide useful
information like safety for further use of these spice extracts, HFF cells were used to evaluate the
cytotoxicity of them by MTT assays. All spices except galangal, rosemary, and sage were with low
toxicity with LC50 values higher than 100 μg/mL. It was worth noting that galangal, which exhibited
excellent antibacterial activity among tested spices was also found to show some cytotoxicity against
HFF cells in vitro, while its toxicity should also be evaluated in in vivo studies in the future before
reaching the conclusion on its toxicity. Discarding crude extracts with good antimicrobial activity
only based on the in vitro cytotoxic experiments should involve caution, since cytotoxic compounds
might not necessarily be the same antibacterial compounds in some cases [27]; therefore, the main
antibacterial and cytotoxic compounds of galangal ethanol extracts should be further isolated and
identified in the future before a final conclusion can be made.
In addition to microbial contamination, lipid oxidation is another major cause of food spoilage,
therefore, we also measured the antioxidant capacity of 67 spice extracts. The antioxidant activity of
tested 67 spice extracts determined by both FRAP and TEAC assays were in the range of 50.3–6682 mmol
Fe(II)/g DW and 17.4–3415 mmol trolox/g DW extract powder, respectively. Among them, clove showed
the highest antioxidant capacity, even comparable to butylated hydroxyanisole (BHA), an antioxidant
commonly applied in food industry preservation due to its excellent hydrogen-donating capacity
and metal-chelation ability [39]. Additionally, the results of PCA analysis showed that the extract of
clove (both fruit and flower) and cinnamon were spotlighted as potential good candidates as natural
food preservatives due to their excellent antibacterial and antioxidant properties. Several other spice
extracts like coriander, cinnamon, oregano, mustard, holy basil, and green pepper were also reported
to be potent food preservatives [40–44]. Indeed, some studies demonstrated the potential application
of clove extracts in raw chicken meat and raw pork during storage to extend shelf-life, in terms of
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reducing microbes, maintaining natural color, and retarding lipid oxidation [40]. The antimicrobial and
antioxidant activities of clove were mainly attributed to the presence of secondary metabolites. A study
conducted by Suleiman et al. revealed that the ethanolic extract of clove flower bud appeared to be rich
in flavonoids (26.8%), phenolic acid (20.8%), and tannins (4.9%) [45], whose antioxidant effects were
already well-known, similar to another phytochemical screening of clove made by Upadhyaya et al. [46].
In addition, the extract of clove flower bud with stronger antimicrobial capacity was also found to
exhibit higher phenolic content [47], indicating that phenolic compounds that contributed to the
antioxidant activity also displayed antibacterial capacity. Moreover, some components mainly existing
in volatile oil also participated in the contribution of antibacterial activity, such as eugenol, isoeugenol,
eugenyl acetate, caryophyllene, and humulene. Eugenol was even classified as a substance generally
regarded as safe by Food and Drug Administration (FDA). Compared with male clove (flower bud),
there were limited studies on female clove (fruit). Although they were derived from the same plant,
chemical components were significantly different, and the phytochemicals in clove fruit were identified
as eugenol, 2-hydroxy-4, 6-dimethoxy-5-methylacetophenone, and cyclohexane, which might exert
antibacterial and antioxidant effects [48].
The antimicrobial activity of spice extracts is mainly attributed to their phytochemicals. Phenolic
compounds, such as phenolic acids, flavonoids, and tannins are among the most abundant and widely
distributed groups of secondary metabolites in edible plants [49,50]. Moreover, phenolic compounds
have been reported to be highly responsible for the antioxidant activity in spices [9], which is also
agreement with our results, showing strong correlation between TPC and FRAP/ABTS values (r = 0.918
and 0.931, respectively, p < 0.01). Thus, TPC can serve as a bridge connecting the antibacterial and
antioxidant activity of spice extracts. In a previous study, Shan et al. showed that there was a
strong positive linear relationship among antibacterial activity, antioxidant activity, and TPC values in
spices [29]. Indeed, in some spices like sage, higher antibacterial activity could be observed in spices
containing higher TPC [51]. Moreover, some phenolic compounds identified in spices showed good
bacterial inhibitory efficiency. Taking oregano as an example, its antibacterial activity was strongly
linked to the presence of phenolic compounds like carvacrol and thymol [52]. Besides, the phenolic
compounds identified in many spices like curcumin in turmeric, eugenol in cloves, thymol in thyme,
and gingerol in ginger, as well as caffeic acids and ferulic acids in thyme, cinnamon, and galangal have
also been demonstrated to exhibit evident antibacterial capacity [8,50,53–56]. Moreover, the number
and position of phenolic hydroxyl groups are also considered to be tightly related to the toxicity towards
microorganisms [6]. The antibacterial activity of these phenolic compounds involves many modes
of action, such as destroying cell membrane morphology, altering membrane fatty acids, depleting
proton motive force, causing reactive oxygen damage, impairing enzymatic mechanisms for energy
production and metabolism, disrupting normal functionality of proteins, and inhibiting nucleic acid
synthesis [6,29,57].
In our study, however, we found a significant but weak correlation of antibacterial activity with
TPC and antioxidant activity, indicating that polyphenols were only partially contributed to the
antibacterial activity of spice extracts. The Pearson correlation coefficient (r = 0.541) tested between
TPC and DIZ values of S. aureus in our study was overall consistent with a previous study [24],
reporting that the TPC of 28 pigmented edible bean coats were weakly correlated (r = 0.540) with DIZ
values of S. aureus. In addition, Weeakkody et al. found a similarly poor correlation (r2 < 0.30) between
the antimicrobial activity of seven edible spice extracts and phenolic compound levels [58]. Our study
and these studies suggest that in addition to polyphenols, there should be other substances responsible
for the overall antibacterial activity of spice extracts. For instance, in our study, although the TPC of
galanga was lower than some other spices, its antibacterial activity was highest among tested spices,
indicating that other nonphenolic constituents, like 5-hydroxymethyl furfural (accounting for 59.9% in
methanol extract), might have the capacity to act as antimicrobial agents [59,60]. Besides, alkaloids,
such as piperine from black pepper, were also found to be effective against Escherichia coli, Klebsiella
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penumonia, Salmonella enterica, and S. aureus [61]. Therefore, polyphenols combined with other bioactive
compounds should contribute to the overall antibacterial activity of spice extracts.
5. Conclusions
This study investigated systematically the antibacterial activity, antioxidant activity, and TPC of
67 spice extracts. The antibacterial activity of the spice extracts was partially ascribed to polyphenols,
while detailed contributions of other antibacterial components should be elucidated in future work.
Five selected spice extracts showed the strongest antibacterial activity against different strains of
antibiotic-resistant S. aureus, and they have potential for use as antibiotic alternatives in animal feeding.
Moreover, the clove, exhibiting both excellent antioxidant and antibacterial activities, has great potential
as a natural food preservative in the food industry.
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Abstract: Kombucha tea is a refreshing beverage that is produced from the fermentation of tea leaves.
In this study, kombucha tea was prepared using 1% green tea, oolong tea, and black tea, and 10%
sucrose with acetic acid bacteria and yeast. The pH values of the kombucha tea were found to be
in a range of 2.70–2.94 at 15 days of fermentation. The lowest pH value of 2.70 was recorded in the
kombucha prepared from black tea. The total acidity of kombucha prepared from black tea was the
highest by 16.75 g/L and it was still maintained after heat treatment by boiling and after autoclaved.
Six organic acids: glucuronic, gluconic, D-saccharic acid 1,4-lactone, ascorbic, acetic, and succinic
acid in kombucha tea were detected by HPLC with the optimization for organic acids detection using
isocratic elution buffer with C18 conventional column. The highest level of organic acid was gluconic
acid. Kombucha prepared from green tea revealed the highest phenolic content and antioxidation
against DPPH radicals by 1.248 and 2.642 mg gallic acid/mL kombucha, respectively. Moreover,
pathogenic enteric bacteria: Escherichia coli. E. coli O157:H7. Shigella dysenteriae, Salmonella Typhi,
and Vibrio cholera were inhibited by kombucha and heat-denatured kombucha with diameter of the
inhibition zones ranged from 15.0 ± 0.0–25.0 ± 0.0 mm. In addition, kombucha prepared from green
tea and black tea demonstrated toxicity on Caco-2 colorectal cancer cells. Therefore, kombucha tea
could be considered as a potential source of the antioxidation, inhibition of pathogenic enteric bacteria,
and toxicity on colorectal cancer cells.
Keywords: antibacteria; antioxidation; Caco-2 cancer cells; kombucha tea; pathogenic bacteria
1. Introduction
Kombucha tea is a slightly acidic beverage that is produced from the fermentation of tea leaves
(Camellia sinensis) and infusion with a consortium culture of acetic bacteria including Acetobacter
xylinum, A. xylinoides, or Bacterium gluconicum and yeasts such as Saccharomyces cerevisiae, S. ludwigii,
Zygosaccharomyces bailii, Z. rouxii, Schizosaccharomyces pombe, Torulaspora delbrueckii, Brettanomyces
bruxellensis, B. lambicus, B. custersii, Candida sp., or Pichia membranaefaciens [1]. Normally, a traditional
substrate used in kombucha fermentation is comprised of 10 g/L of black tea infusion that has been
sweetened with.5–8% (w/v) sucrose. Notably, cellulose is produced during the fermentation by A. xylinum
and appears as a thin film on top of the fermented tea where the cell mass of bacteria and yeast is
attached. Yeast and bacteria in kombucha are involved in metabolic activities that utilize substrates in
different pathways. Yeast cells hydrolyze sucrose into glucose and hydrolyze fructose using invertase
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enzymes. Moreover, ethanol is also produced and further utilized by acetic acid bacteria to generate
organic acids and other substances such as acetic, gluconic acid, glucuronic acid, citric acid, lactic
acid, malic acid, succinic acid, saccharic acid, pyruvic acid, sugars, vitamins, and amino acids [2].
Thus, the pH value of kombucha is known to decrease during the process of fermentation due to the
production of organic acids. Kombucha beverages also contain other substances such as phenolic
compounds in a quantity of about 30% (w/w) of the dry mass of the tea leaves [3]. These substances vary
considerably depending on the variety of tea and the processing procedures. Moreover, kombucha
fermentation is dependent upon the source of kombucha culture (tea fungus), which is affected by a
variety of properties for each kombucha beverage. When compared to unfermented tea, the enhanced
beneficial activities of kombucha tea indicate that some changes are related to the origin of the microbial
community that is present during the fermentation process [4–6].
Non-fermented tea such as green tea contains major polyphenolic catechins, such as epigallocatechin
gallate (EGCG), epigallocatechin (EGC), epicatechin gallate (ECG), and epicatechin (EC) [7]. Black tea is
considered a fully fermented form of tea since the production process creates a small particle size of the
tea leaves and a greater surface area for enzymatic oxidation. During black tea fermentation, quinones
react with catechins and produce new compounds; theaflavins and thearubigins [8]. In addition,
catechins present in green tea are also partially converted to theaflavins [9]. Oolong tea is classified
as semi-fermented tea and prepared during a limited period of oxidation. Thus, the fermentation
process of oolong tea is shorter than that of black tea. Notably, oolong tea contains approximately
half the amount of catechins when compared to green tea [10]. The compounds that are produced
during the production processes of different types of tea markedly affect the composition and total
phenolic content that are found in kombucha tea. The major polyphenolic components, catechin and
epicatechin, are known to possess antioxidant activity [11]. Moreover, the antimicrobial activity of
kombucha from black tea against pathogenic Vibrio strains was observed [12].
Although kombucha has been used for long time but scientific report on properties of kombucha
has not been clarified. In this study, different biological properties of kombucha tea from various
kinds of tea leaves including green, oolong, and black tea were determined for the useful properties of
kombucha and application as supplementary beverage for health benefits. Hence, the aim of this study
was to investigate the antioxidant and antibacterial properties of kombucha that was obtained from
different types of C. sinensis, including green tea, oolong tea, and black tea, and the degree of toxicity it
displays against the colorectal cancer cell line.
2. Materials and Methods
2.1. Starter Culture of Kombucha Tea
Tea leaves and starter culture were also provided from Tea Gallery Group (Thailand) Co., Ltd.,
Chiang Mai, Thailand. Kombucha tea was prepared using the same method of the industry standard.
The formulation of kombucha tea production consisted of 1% of tea leaf and 10% of sucrose. The starter
culture of kombucha tea was used as a consortium culture combining yeast and acetic acid bacteria.
The stock culture of kombucha tea contained a total count of bacterial colony at 7.79–7.81 log CFU/mL
and the yeast colony was recorded at 7.53–7.75 log CFU/mL.
2.2. Preparation of Kombucha Tea Obtained from Camellia Sinensis Tea Leaves
Kombucha tea was prepared using different types of tea; green, oolong, and black tea. The tea
leaves were obtained from the Tea Gallery Group (Thailand) Co., Ltd. Dry tea leaves at 1.0% (w/v)
were added to 500 mL of sterilize distilled water and then boiled for 15 min. Sucrose was filtered into
sterilized glass bottles and 10% (w/v) sucrose was then dissolved in the hot tea. A starter culture made
from the fermentation broth of the tea fungus at 10% (v/v) was inoculated into a mixture of tea and sugar,
and it was further incubated at room temperature for 15 days. Subsequently, the kombucha tea was
analyzed for its chemical and microbiological properties at 0, 3, 6, 9, 12, and 15 days of fermentation.
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2.3. pH and Total Acidity Determination
The pH of kombucha tea was measured using an electronic pH meter (Denver Instruments,
Bohemia, NY, USA). The total acidity of kombucha tea was measured according to the procedure of
Srihari and Satyanarayana [13]. Kombucha tea was titrated with 0.1 M NaOH. The volume of the
NaOH solution was calculated in terms of grams of acetic acid per liter of the sample.
2.4. Total Soluble Solids (ºBrix) and Alcohol Content
The total soluble solids (ºBrix) were measured using a refractometer (RHB-62ATC, JEDTO, Halden,
Norway) and the alcohol content of the kombucha tea was measured using an Ebuliometer (Dujardin
Salleron, France).
2.5. Microbiological Determination
The total count of yeast cells in the kombucha tea was determined using the spread plate technique
on yeast malt (YM) agar with the addition of chloramphenicol. Determination of the total count
of acetic acid bacteria was performed on yeast peptone mannitol (YPM) agar with amphotericin B
(CAISSON, USA). The plates were incubated at 30 ◦C, for at least 3 days [14].
2.6. HPLC Analysis of Organic Acids
The predominant organic acids found in kombucha tea were determined by high performance
liquid chromatography (HPLC). Six organic acids including glucuronic acid (Sigma-Aldich, Darmstadt,
Germany), gluconic acid (Merck, Darmstadt, Germany), d-saccharic acid 1,4-lactone (Sigma-Aldich,
Germany), acetic acid (Merck, Germany), ascorbic acid (Merck, Germany), and succinic acid (Merck,
Germany) in kombucha tea were optimized for detection by isocratic HPLC systems with a conventional
C18 column. The kombucha tea samples were filtered through a 0.22 μm sterile microfilter and 50 μL of
the filtrate was injected into the HPLC system (Agilent technologies 1200 series, Santa Clara, CA, USA).
The C-18 column (4.6 × 150 mm, 5 μm; GL Sciences, Tokyo, Japan) employing a UV detector (210 nm)
was used for the analysis. Moreover, the HPLC system was controlled with a flow rate of 0.8 mL per
minute and a running time of 40 min at 25 ◦C. Six organic acids in kombucha tea were separated by
20 mM KH2PO4 elution buffer at pH 2.4 and the standards of organic acids were used for comparison
with kombucha tea. The peak area of each organic acid was calculated by Agilent ChemStation level-5
program, and then standard graphs of each organic acid were generated. Thus, the content of each
organic acid in kombucha tea was calculated from the standard graph of each organic acid.
2.7. DPPH Radical Scavenging Assay of Kombucha Tea
The radical scavenging activity of kombucha tea was determined against DPPH free radical
content [15]. The kombucha tea was diluted with methanol by 10-fold serial dilution. Each concentration
of the kombucha tea (0.5 mL) was incubated with 1.5 mL of 0.1 mM DPPH solution (Sigma-Aldich,
Germany). Absorbance at 517 nm was measured by spectrophotometer (Genesys 20, Thermo Scientific,
Dreieich, Germany) after the solution mixture was kept in the dark at room temperature for 20 min.
Methanol was used as a blank solution, while DPPH without kombucha tea was used as a control.
The absorbance of the DPPH solution A1, and the absorbance of kombucha tea mixed with the DPPH
solution A2, were measured. The percentage of DPPH free radical inhibition was calculated as follows:
percentage inhibition = {(A1–A2)/A1} × 100.
The antioxidant activity of kombucha tea was assessed by comparing the samples to standard
gallic acid and was expressed as milligrams of gallic acid per milliliter of kombucha tea (mg GAE/mL
kombucha tea).
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2.8. Total Phenolic Content of Kombucha Tea
Total phenolic content of kombucha tea was determined by Folin-Ciocalteu reagent [16]. Kombucha
tea (250 μL) was mixed with 125 μL of 50% Folin-Ciocalteu reagent (Merck, Germany) and 250 μL of
95% ethanol. The mixture was incubated in the dark at room temperature for 5 min. Subsequently,
250 μL of 5% sodium carbonate was then added, and the mixture was incubated in the dark at room
temperature for 60 min. Blue molybdenum–tungsten complex was formed and detected at 725 nm by
spectrophotometer (Genesys 20, Thermo Scientific, Germany). Total phenolic content was calculated
by comparing the substance to standard gallic acid and was expressed as milligrams of gallic acid per
milliliter of kombucha tea (mg GAE/mL kombucha tea).
2.9. Pathogenic Enteric Bacteria Used in the Study
The pathogenic enteric bacteria that were used for the antimicrobial activity test included E. coli
O157:H7 DMST 12743, Shigella dysenteriae DMST 1511 and Salmonella Typhi DMST 22842. Escherichia
coli and Vibrio cholera were kindly obtained from the Microbiology Section, Department of Medical
Technology, Faculty of Associated Medical Science, Chiang Mai University, Chiang Mai, Thailand.
The bacterial strains were stored in glycerol stock at −20 ◦C and then grown on Mueller–Hinton (MH)
agar (Difco™, Detroit, MI, USA) plates at 37 ◦C for 18–24 h.
2.10. Antimicrobial Activity of Kombucha Tea
A single colony of the tested bacteria; Escherichia coli, E. coli O157:H7, Shigella dysenteriae, Salmonella
Typhi, and Vibrio cholera, was transferred into Mueller–Hinton (MH) broth (Difco™, USA) and incubated
at 37 ◦C for 18–24 h. The antimicrobial activity of kombucha tea after 15 days of fermentation was
investigated using the agar well diffusion method. The turbidity of the bacterial culture was adjusted
to McFarland standard no. 0.5 and swabbed on Mueller–Hinton (MH) agar (Difco™, USA). Wells
of 10 mm in diameter were prepared on the agar plate with a sterile cork borer. Kombucha samples
were sterilized by filtering them through a sterile microfilter (0.22 μm pore size), and they were then
transferred into the wells in the agar plates. The plates were further incubated at 37 ◦C for 18–24 h.
The zones of bacterial growth inhibition were then determined [17,18].
The antimicrobial activity of kombucha tea was compared to the non-fermented tea, and acetic acid
was recorded at the same concentration of the kombucha tea after 15 days of fermentation. Moreover,
kombucha tea was neutralized at pH 7.0 by adjusting the pH with 1 M HCl or 1 M NaOH. Heat
denatured kombucha tea was prepared by treatment at 100 ◦C for 20 min and at 121.5 ◦C, at 15 pounds
per square inch for 15 min by being autoclaved. After treatment, the kombucha tea was then sterilized
by filtration and tested for its antimicrobial activity, as has been described previously.
2.11. Cytotoxicity Test of Kombucha Tea on Human Colorectal Carcinoma (Caco-2) and NIH/3T3 Cells
The cytotoxicities of kombucha tea were tested using MTT assay. NIH/3T3 cells were used as normal
cell control. Human colorectal carcinoma (Caco-2) and NIH/3T3 cells were cultured in Dulbecco’s
modified Eagle medium (DMEM; Gibco, Grand Island, NY, USA) that had been supplemented with 10%
(v/v) heat-inactivated fetal bovine serum (HyCloneTM, Pittsburgh, PA, USA), 100 Units/mL penicillin
and 100 μg/mL streptomycin (CAISSON, Smithfield, UT, USA). After incubation at 37 ◦C in a 5%
CO2 incubator (SHEL LAB, USA), the cells were washed twice with phosphate buffer saline (PBS,
pH 7.4) and trypsinized with 0.05% (v/v) trypsin-EDTA solution (CAISSON, USA). The Caco-2 and
NIH/3T3 cells were plated in 96-well plates and incubated at 37 ◦C in a 5% CO2 incubator for 24 h.
After incubation, each concentration of kombucha tea was then added. The plates were incubated at
37 ◦C in a 5% CO2 incubator for 48 h. The MTT solution (Bio Basic Inc., Amherst, NY, USA) was then
added and the solution was incubated for 4 h. Finally, blue formazan crystals were dissolved with
dimethyl sulfoxide and the absorbance was measured at 540 and 630 nm by micro plate reader (EZ
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Read 2000, Biochrom, Cambridge, UK). The percentage of cell viability was calculated by comparing
the relevant values to the cell control [19].
2.12. Statistical Analysis
All experiments were performed in three independent treatments. All data acquired from the
treatments and the control groups were compared and analyzed and are presented as mean ± SD using
t-test and ANOVA analysis.
3. Results
3.1. Appearance of Kombucha Tea during Fermentation
Kombucha tea was prepared from green, oolong, and black teas using 1% (w/v) tea leaves and
10% (v/v) fermentation broth in the preparation of tea fungus as a starter culture. After 15 days of
fermentation, the kombucha tea prepared from black tea appeared as a dark-brown color, while the
kombucha tea that was prepared from the green tea and oolong tea displayed a brown color. During
the fermentation period of kombucha preparation over 3–15 days, a thin film appeared on top of the
culture medium, which was identified as the cellulose produced by the acetic acid bacteria (Figure 1).
Figure 1. Appearance of kombucha prepared from green tea (A), oolong tea (B), and black tea (C) at
the beginning of the fermentation process and after 15 days of fermentation.
3.2. Microbial and Chemical Changes that Occur During Kombucha Tea Fermentation
Microorganisms in kombucha tea utilize a carbon source and begin to produce cellulose which
appears as a thin layer on top of the culture medium. The different types of tea; green, oolong, and black
tea, that were used in this study did not affect the growth of the tea fungus. The total counts of
bacterial and yeast cells during kombucha tea fermentation are shown in Figure 2. After inoculation
of the 10% (v/v) starter culture, total counts of acetic acid bacterial colonies at the beginning of the
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kombucha tea fermentation process for green, oolong, and black teas were 5.72, 5.81, and 5.54 log
CFU/mL, respectively. Moreover, the total counts of yeast cells at the beginning of kombucha tea
fermentation were 5.68, 5.89, and 5.79 log CFU/mL in the kombucha tea prepared from green, oolong,
and black teas, respectively. After increasing the fermentation time, the number of bacterial and yeast
cells were found to be significantly higher than when observed at the beginning of the fermentation
period (Figure 2A,B). After 15 days of fermentation, a total count of 7.80 log CFU/mL was found in
the kombucha that had been prepared from green tea and black tea. The acetic acid bacterial colonies
were significantly higher in the kombucha prepared from green and black teas than in the kombucha
prepared from oolong tea (7.54 log CFU/mL). In addition, the total counts of the yeast cells in the
kombucha tea prepared from green tea (7.64 log CFU/mL), oolong tea (7.74 log CFU/mL) and black tea
(7.78 log CFU/mL) were not significantly different in each type of kombucha tea.
Figure 2. Alteration of the total count of acetic acid bacteria (A), total count of yeast cells (B), pH (C),
total acidity (D), and total soluble solids (E) during fermentation of kombucha prepared from green tea
(  ), oolong tea (), and black tea (). * The values were significantly different between the beginning
of the fermentation and the end of 15 days of the fermentation period (p < 0.05). ** The values were
significantly different for each type of kombucha tea at the end of 15 days of fermentation (p < 0.05).
The results are presented as mean ± SD of three independent experiments.
The blank control without acetic acid and yeast was performed. However, after incubation for
2–3 days the contamination from other microorganisms was presented because the blank control
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showed pH around 4.57–5.25. However, pH of 3.73–3.92 was determined after inoculation of starter
culture at 0 day of fermentation time (Figure 2C). This acidic condition of kombucha tea inhibited other
contaminated microorganisms in kombucha tea.
The alteration of pH values during kombucha tea fermentation with significantly different initial
pH values is shown in Figure 2C. At the end of the 15-day fermentation period, the pH value of
kombucha tea that had been prepared from black tea was the lowest at a pH value of 2.70. Kombucha
that was prepared from green tea and oolong tea revealed pH values of 2.94 and 2.89, respectively.
On the other hand, changes in titratable acidity that occurred during the fermentation process were
significantly increased, which indicated a concentration of these organic acids (Figure 2D). The total
acidity of the kombucha prepared from black tea was significantly higher (16.75 g/L) than that of the
kombucha prepared from oolong (12.24 g/L) and green teas (11.72 g/L). In contrast, total soluble solids
of kombucha prepared from green, oolong and black tea were significantly decreased from 10 ◦Brix to
6 ◦Brix at 15 days of fermentation (Figure 2E). In addition, no alcohol content was detected during the
process of kombucha tea fermentation.
3.3. Organic Acids in Kombucha Tea
The organic acids in kombucha tea were analyzed by HPLC assay. The HPLC system was
optimized for the detection of several organic acids in kombucha tea with a conventional C18 column.
HPLC conditions were optimized and 20 mM KH2PO4 with a pH value of 2.4 in the isocratic elution
buffer was used with a 210 nm UV detector. Six organic acids including glucuronic acid, gluconic acid,
D-saccharic acid 1,4-lactone (DSL), acetic acid, ascorbic acid, and succinic acid were clearly separated.
Chromatograms of six standard organic acids, including glucuronic acid, gluconic acid, DSL, acetic
acid, ascorbic acid, and succinic acid, were eluted at different retention times (Figure 3).
Figure 3. HPLC chromatograms of running time 40 min (A) and the six organic acids (B) are presented
as standards; glucuronic acid (Peak 1), gluconic acid (Peak 2), D-saccharic acid 1,4-lactone (DSL)
(Peak 3), acetic acid (Peak 4), ascorbic acid (Peak 5), and succinic acid (Peak 6).
After 15 days of kombucha fermentation, the amounts of each type of organic acid that were
present in the kombucha prepared from green, oolong, and black teas were analyzed by HPLC.
The chromatograms and production values of organic acids at 15 days of fermentation are shown
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in Figure 4 and Table 1. The highest content of gluconic acid was found in the kombucha that was
prepared from green, oolong, and black teas, followed by acetic acid, DSL, ascorbic acid, and glucuronic
acid. In contrast, succinic acid was detected in the kombucha that had been prepared from black tea,
but it was not detected in the kombucha prepared from green tea and oolong tea. Therefore, kombucha
prepared from black tea revealed the highest amounts of organic acid content: glucuronic acid (1.58 g/L),
gluconic acid (70.11 g/L), DSL (5.23 g/L), ascorbic acid (0.70 g/L), acetic acid (11.15 g/L), and succinic
acid (3.05 g/L), when compared to both oolong tea and green tea.
Figure 4. HPLC chromatograms of kombucha prepared from green tea (A), oolong tea (B), and black tea
(C) at 15 days of fermentation. Peak (1)—glucuronic acid; Peak (2)—gluconic acid; Peak (3)—D-saccharic
acid 1,4-lactone (DSL); Peak (4)—acetic acid; Peak (5)—ascorbic acid; Peak (6)—succinic acid, respectively.
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Table 1. Organic acid content of kombucha tea prepared from green tea, oolong tea, and black tea at
15 days of the fermentation process.
Kombucha
Organic Acids Content (g/L)
Glucuronic Gluconic DSL Ascorbic Acetic Succinic
Green tea 1.37 ± 0.01 c 41.42 ± 0.02 c 3.44 ± 0.03 c 0.61 ± 0.00 a 10.42 ± 0.00 b ND d
Oolong tea 0.07 ± 0.01 b 48.75 ± 0.03 b 4.02 ± 0.02 b 0.60 ± 0.00 a 10.48 ± 0.00 ab ND d
Black tea 1.58 ± 0.01 a 70.11 ± 0.01 a 5.23 ± 0.01 a 0.70 ± 0.00 a 11.15 ± 0.00 a 3.05 ± 0.01 a
a, b, c The data of different superscript letters (a, b, c) are presented as mean ± SD of three independent experiments
and revealed significantly different values for each type of kombucha tea (p < 0.05). d ND: organic acid in kombucha
tea was not detected.
3.4. DPPH Scavenging Ability and Total Phenolic Content during Kombucha Fermentation
The DPPH scavenging ability of kombucha prepared from green, oolong, and black tea significantly
increased during the fermentation process to 2.642, 2.582, and 0.435 mg GAE/ml kombucha tea,
respectively (Figure 5). The maximum increase of DPPH scavenging activity was presented after
15 days in the kombucha that was prepared from green tea. Kombucha prepared from oolong tea
showed the highest DPPH scavenging activity after 9 days of fermentation and was remarkably stable
after 12–15 days of fermentation. Moreover, the DPPH scavenging ability of the kombucha prepared
from black tea was at the highest incremental value after 3 days of the fermentation process.
Figure 5. DPPH scavenging ability (A) and total phenolic content (B) during fermentation of kombucha
prepared from green tea (  ), oolong tea (), and black tea (). * The values were significantly different
between the beginning of the fermentation and on each day of the fermentation period (p < 0.05).
The results are presented as mean ± SD of three independent experiments.
Total phenolic content is shown in Figure 5. After fermentation for three days, the kombucha that
was prepared from green, oolong, and black teas revealed maximum levels of total phenolic contents
at 1.248, 1.011, and 0.455 mg GAE/mL kombucha tea, respectively. After 3–6 days of fermentation,
the amounts of phenolic compounds decreased and then appeared to be stable at 15 days of the
fermentation process. Thus, kombucha prepared from green tea revealed the highest amounts of
antioxidant activity and total phenolic content.
3.5. Total Acidity and Antibacterial Activity of Kombucha Tea
The antibacterial activities of the kombucha tea that was fermented under different conditions
were investigated against pathogenic enteric bacteria. The fermented tea was tested at 15 days
in terms of acidity and then after neutralization (pH 7.0). Moreover, the samples were heated to
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analyze the thermostability of the active components. Kombucha tea prepared from green, oolong,
and black tea showed antibacterial activity against all tested enteric bacteria; Escherichia coli, E. coli
O157: H7 DMST 12743, Shigella dysenteriae DMST 1511, Salmonella Typhi DMST 22842, and Vibrio
cholerae. The diameter of the inhibition zones of the kombucha prepared from green tea ranged from
20.0 ± 0.0–24.7 ± 0.6 mm. The diameter of the inhibition zones of kombucha prepared from oolong
tea ranged from 19.3 ± 0.6–24.7 ± 0.6 mm and the diameter of the inhibition zones of black tea ranged
from 20.0 ± 0.0–21.3 ± 0.6 mm. The antibacterial activity of each type of kombucha tea was similar to
that of the acetic acid at the same total acidity content of each type of kombucha tea. In this study,
gentamicin (1 mg/mL) was used as a positive control and presented the diameters of the inhibition
zones ranged from 19.3 ± 0.6–23.3 ± 0.6 mm. after testing with E. coli, E. coli O157:H7, S. dysenteriae,
S. Typhi, and V. cholera (Table 2).





a Inhibition Zone Diameter (mm) of Target Bacteria
E. coli E. coli O157: H7 S. Dysenteriae S. Typhi V. Cholera
Green tea
b Fermented tea 24.7 ± 0.6 24.3 ± 0.6 21.7 ± 0.6 23.7 ± 0.6 20.0 ± 0.0
c Unfermented tea 0 0 0 0 0
d Neutralized kombucha 0 0 0 0 0
e Heat-denatured Kombucha M1 25.0 ± 0.0 23.0 ± 0.0 21.0 ± 0.0 23.0 ± 0.0 19.0 ± 0.0
f Heat-denatured Kombucha M2 15.3 ± 0.6 22.3 ± 0.6 19.7 ± 0.6 20.7 ± 0.6 17.3 ± 0.6
g Acetic acid (11.72 g/L) 20.3 ± 0.6 22.0 ± 0.0 20.0 ± 0.0 21.0 ± 0.0 22.0 ± 0.0
Oolong tea
Fermented tea 23.7 ± 0.6 20.3 ± 0.6 19.3 ± 0.6 24.7 ± 0.6 20.0 ± 0
Unfermented tea 0 0 0 0 0
Neutralized kombucha 0 0 0 0 0
Heat-denatured Kombucha M1 20.0 ± 0.0 19.3 ± 0.6 19.3 ± 0.6 24.0 ± 0.0 16.7 ± 0.6
Heat-denatured Kombucha M2 15.7 ± 0.6 15.0 ± 0.0 17.0 ± 0 19.7 ± 0.6 15.7 ± 0.6
Acetic acid (12.24 g/L) 21.0 ± 0.0 20.0 ± 0.0 21.0 ± 1.0 20.3 ± 0.6 22.0 ± 0.0
Black tea
Fermented tea 21.0 ± 0.0 21.3 ± 0.6 21.0 ± 0.0 20.0 ± 0.0 21.0 ± 0.0
Unfermented tea 0 0 0 0 0
Neutralized kombucha 0 0 0 0 0
Heat-denatured Kombucha M1 20.3 ± 0.6 20.3 ± 0.6 20.0 ± 0.0 18.0 ± 0.0 20.0 ± 0.0
Heat-denatured Kombucha M2 18.0 ± 0.0 16.3 ± 0.6 19.7 ± 0.6 17.3 ± 0.6 18.0 ± 0.0
Acetic acid (16.75 g/L) 20.0 ± 0.0 20.0 ± 0.0 20.7 ± 0.6 21.0 ± 0.0 21.7 ± 0.6
Gentamycin (1 mg/mL) 20.3 ± 0.6 19.3 ± 0.6 23.3 ± 0.6 22.3 ± 0.6 20.0 ± 0.0
a Inhibition zone diameter is presented as mean ± SD of three independent experiments. b Fermented tea: kombucha
tea fermented at 15 days without any treatment. c Unfermented tea: broth culture contained only 1% of tea leaves.
d Neutralized kombucha: kombucha tea neutralized with NaOH (1 M) at pH 7.0. e Heat-denatured kombucha M1:
kombucha tea treated at 100 ◦C for 20 min. f Heat-denatured kombucha M2: kombucha tea treated at 121.5 ◦C for
15 min. g Acetic acid: acid prepared at the same total acidity content of kombucha for each type of tea leaf.
On the other hand, the antibacterial activity of kombucha after neutralization to pH 7.0 did not
reveal any inhibition of all of the tested enteric bacteria. Kombucha tea was also treated by being boiled
(100 ◦C for 20 min) and autoclaved (121.5 ◦C for 15 min) to determine the activity of the thermostability
of its components. The total acidity of the kombucha tea prepared from green, oolong, and black
teas were titrated after thermal treatments, while the total acidity of kombucha tea prepared from
green, oolong, and black teas after treatment by boiling was 10.93, 11.61, and 15.67 g/L, respectively.
In addition, the total acidity of kombucha tea from green, oolong and black teas after treatment by
being autoclaved was 8.12, 9.16, and 12.16 g/L, respectively. Thus, the total acidity level of kombucha
tea after treatment by boiling was maintained since the total acidity was significantly higher than that
of the kombucha tea that was treated by being autoclaved. The results indicated that the antibacterial
activity of kombucha tea after treatment by boiling revealed significantly higher inhibitory activity on
the tested enteric bacteria than in the kombucha tea that had been treated by being autoclaved (Table 2).
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3.6. Cytotoxicity Test of Kombucha Tea Against Caco-2 and NIH/3T3 Cells
The inhibition of the kombucha in different types of tea leaves was investigated against Caco-2
cancer cells and NIH/3T3 cells by MTT assay (Table 3). Kombucha tea prepared from green, oolong and
black teas at 15 days of fermentation inhibited Caco-2 cancer cells with 50% inhibitory concentrations
(IC50) of 2.603%, 1.899%, and 6.077%, respectively. Moreover, Kombucha from green, oolong and
black teas inhibited NIH/3T3 cells with 50% inhibitory concentrations (IC50) of 2.851%, 1.922%,
and 6.697%, respectively.
Table 3. Cytotoxicity of kombucha prepared from green, oolong, and black teas on Caco-2 colorectal





Caco-2 Cells NIH/3T3 Cells
Green tea
b Fermented tea 2.603 ± 0.072 * 2.851 ± 0.052 *
c Unfermented tea 3.661 ± 2.228 3.819 ± 0.122
d Neutralized kombucha 8.621 ± 0.685 8.915 ± 0.715
e Heat-denatured kombucha M1 1.758 ± 0.065 * 1.916 ± 0.011*
f Heat-denatured kombucha M2 1.309 ± 0.117 1.518 ± 1.202
g Acetic acid (11.72 g/L) 33.155 ± 2.834 35.206 ± 0.625
Oolong tea
Fermented tea 1.899 ± 0.242 1.922 ± 0.186
Unfermented tea 2.097 ± 0.305 2.519 ± 0.024
Neutralized kombucha 4.194 ± 0.081 4.671 ± 1.205
Heat-denatured kombucha M1 1.179 ± 0.041 1.219 ± 0.012
Heat-denatured kombucha M2 1.515 ± 0.138 1.641 ± 0.220
Acetic acid (12.24 g/L) 12.610 ± 0.341 12.817 ± 0.452
Black tea
Fermented tea 6.077 ± 0.222 * 6.697 ± 0.030 *
Unfermented tea 6.082 ± 0.191 6.244 ± 0.659
Neutralized kombucha 16.339 ± 0.833 17.066 ± 1.568
Heat-denatured kombucha M1 6.083 ± 0.053 * 6.702 ± 0.156 *
Heat-denatured kombucha M2 5.699 ± 0.008 5.819 ± 0.209
Acetic acid (16.75 g/L) 8.720 ± 0.047 8.810 ± 0.142
a Results are presented as mean ± SD of three independent experiments. b Fermented tea: kombucha tea fermented
at 15 days without any treatment. c Unfermented tea: broth culture contained only 1% of tea leaves. d Neutralized
kombucha: kombucha tea neutralized with NaOH (1 M) at pH 7.0. e Heat-denatured kombucha M1: kombucha
tea treated at 100 ◦C for 20 min. f Heat-denatured kombucha M2: kombucha tea treated at 121.5 ◦C for 15 min.
g Acetic acid: acid prepared at the same total acidity content of kombucha for each type of tea leaf. * The values
were significantly different between the cytotoxicity of Caco-2 cells and NIH/3T3 cells (p < 0.05).
The effect of kombucha tea on cancer cells showed cytotoxicity values higher than cytotoxicity on
normal cells. However, kombucha tea prepared from green tea and black tea significantly showed
toxicity against cancer cells when compared to normal cells. Moreover, cytotoxicity of kombucha
prepared from green tea and black tea after boiling (100 ◦C for 20 min) also showed significantly
toxicity against cancer cells.
Moreover, all unfermented tea containing 1% (w/v) of tea leaf-infusion also displayed toxicity
toward Caco-2 cancer cells. In contrast, kombucha that was neutralized with 1 M NaOH at a pH
value of 7.0 revealed levels of toxicity on Caco-2 cells that were lower than those in the heat-denatured
kombucha. Acetic acid was used for acidic activity control and was prepared with the same total
acidity content of kombucha for each type of tea. After treatment of Caco-2 cancer cells with acetic
acid, IC50 values of the kombucha prepared from green, oolong, and black teas were 33.155%, 12.610%,
and 8.720%, respectively. Thus, the toxicity of the acetic acid on cancer cells was lower than in the
fermented kombucha that had been prepared from each type of tea leaves.
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4. Discussion
Kombucha tea was prepared from green, oolong, and black teas. The microbial community and
chemical properties presented during kombucha fermentation were demonstrated in this study. In this
study, the starter culture of kombucha tea was used as a symbiosis culture of acetic acid bacteria
including Acetobacter xylinum and yeast cells. Therefore, cellulose production from A. xylinum was
present on the surface of the kombucha tea during 3–15 days of fermentation. The production of the
cellulose of this species is important for kombucha tea fermentation since a floating cellulose pellicle
provides benefits to microorganisms by enhancement of the association between the bacteria and yeast
cells and allows for the exposure of the microorganisms to atmospheric oxygen [20]. Moreover, caffeine
and other related xanthines that are found in tea showed the ability to stimulate cellulose production
by way of the bacteria that is present [3].
Normally, kombucha tea was completely fermented when fermentation time was 12–21 days
and the inoculation size of starter culture was 5–10%. Thus, a period of kombucha fermentation of
15 days was selected in this study since the highest level of acidity was demonstrated during this
fermentation process [11,21–23]. Moreover, yeast cells are known to convert sucrose into glucose and
fructose by invertase enzymes. Additionally, ethanol was also produced. Glucose in kombucha was
further utilized by acetic acid bacteria to produce gluconic acid, whereas ethanol was used to produce
acetic acid. The different types of tea: green, oolong, and black tea that were used in this study did not
affect the growth of the tea fungus. After increasing the fermentation time, the total counts of acetic
acid bacterial and yeast cells were found to be significantly higher than were observed at the beginning
of the fermentation period. After 15 days of fermentation, the total counts of acetic acid bacteria in
the kombucha prepared from green tea and black tea were significantly higher than in the kombucha
prepared from oolong tea. Additionally, the total counts of yeast cells in each kombucha tea were not
significantly different. Therefore, the increasing amounts of bacteria present in kombucha during the
fermentation process is dependent upon the different types of tea that are used as a substrate [3].
The pH values of the kombucha prepared from green, oolong, and black teas decreased due to
the production of organic acids during the fermentation process. The lowest pH value was recorded
in the kombucha that had been prepared from black tea, followed by that of oolong tea and green
tea. The total acidity of kombucha prepared from black tea showed the highest total amount of acids,
which related to the low pH value of the kombucha. Moreover, microorganisms were able to use
sucrose as the major substrate to produce many organic acids that resulted in the decrease of total
soluble solids during fermentation of each kombucha tea. These different values of pH and total
acidity correspond to the different types of tea used and affected the degree of organic acid production.
Notably, green tea is considered a non-fermented type of tea, whereas black tea and oolong tea are
classified as fully fermented tea and semi-fermented tea, respectively. The process of tea preparation
resulted in different oxidation levels of catechins. Green tea was found to possess the highest total
phenolic content, and black tea showed the highest content of polyphenol oxidation products after the
fermentation process [24].
Moreover, this study has enabled researches to optimize new conditions of HPLC for detection
of several organic acids including glucuronic, gluconic, DSL, ascorbic, acetic, and succinic acid in
kombucha tea. All organic acids were clearly separated by isocratic elution buffer using the C18
conventional column. Moreover, an elution buffer of 20 mM KH2PO4, pH 2.4, and a UV detector of
210 nm were suitable for the separation of each organic acid. Low molecular weight organic acids with
high levels of polarity produced the greatest level of separation using mobile phase 20 mM KH2PO4
as an elution buffer. In addition, a low pH buffer was used to ensure that all acidic groups were
protonated, which allowed for protection of the change from organic acids to the neutral form, thus
allowing the best interaction between the organic acids and the C18 stationary phase [25]. The HPLC
result revealed that gluconic acid and acetic acid were identified as the major organic acids in the
kombucha tea that was prepared via the fermentation of green, oolong, and black tea for a period of
15 days.
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In addition, kombucha prepared from black tea presented higher values of organic acid content in
terms of glucuronic, gluconic, DSL, ascorbic, acetic, and succinic acid, when compared to oolong tea
and green tea. The highest level of organic acid content in kombucha tea was found to be gluconic acid.
The glucuronic acid present in kombucha has been associated with a number of benefits to the liver.
Glucuronic acid plays an important role in liver detoxification and in the process associated with the
excretion of exogenous chemicals known as glucuronidation [26].
The DPPH scavenging abilities of the kombucha prepared from green, oolong, and black teas
significantly increased from the beginning of fermentation. During kombucha fermentation, many
compounds with radical scavenging properties were obtained from the tea leaves and were considered
by-products of the metabolic pathway of microorganisms. Catechins belong to polyphenols in green
tea and they display high levels of antioxidant properties. Catechins also have the ability to scavenge
free radicals and reactive oxygen species [13]. Notably, the increase of antioxidant potential against
DPPH radicals from kombucha tea significantly reduced oxidative injuries in rats [27]. Moreover,
kombucha tea prepared from green, oolong, and black teas showed significantly high amounts of total
phenolic contents on day 3 of fermentation. After 3–6 days of kombucha tea fermentation, the amounts
of phenolic compounds could maintain stability and then continued to be stable during 15 days of the
fermentation process. The kinetics of microorganisms in kombucha fermentation increased around
3 days after beginning inoculation, which might be the reason for the enhancement of the phenolic
compounds [28]. Many enzymes are produced during kombucha fermentation, such as phytase,
α-galactosidase, and tannase, which are all related to the degradation of complex polyphenols to small
molecules and are known to cause an increase in total phenolic compounds [29].
The study of kombucha prepared from Chinese black tea, Chinese green tea, Chinese oolong
tea and Sri Lankan black tea also yielded the highest amounts of phenolic compounds on day 1 of
fermentation. Notably, the phenolic compounds maintained a level of stability throughout 7 days of
the kombucha fermentation period. Additionally, individual polyphenol contents yielded variations
in terms of quantity in each type of tea [30]. The enzymes that were liberated from the bacteria and
yeast in the tea fungus consortium degraded the complex of phenolic compounds in the tea, and the
degradation was increased in the acidic environment of the fermentation process [21].
Moreover, kombucha contains other antioxidant substances, such as ascorbic acid and DSL, which
were shown to be present in high levels in the kombucha that had been prepared from black tea. DSL,
a derivative of D-glucaric acid, demonstrated detoxification, anticarcinogenic, and cholesterol-reduction
properties [5,31–33]. DSL has been found to reduce ameliorate alloxan-induced type 1 diabetes by
inhibiting the apoptotic death of pancreatic β-cells [5]. Moreover, DSL also revealed the greatest
benefit in terms of anti-oxidative properties and displayed the ability to decrease oxidative damage to
certain cellular biomolecules, such as on the lipids and proteins found in human blood platelets [34].
In addition, kombucha prepared from green tea revealed the highest level of phenolic content. An
increase in the total phenolic content during kombucha fermentation that occurred from the ability of
the bacteria and yeast was found to liberate enzymes, such as phytase, which could break down the
cellulosic backbone of the tea leaves to release polyphenol compounds [21].
In this study, the kombucha prepared from green, oolong and black teas efficiently inhibited all
tested pathogenic enteric bacteria: Escherichia coli, E. coli O157:H7 DMST 12743, Shigella dysenteriae
DMST 1511, Salmonella Typhi DMST 22842, and Vibrio cholerae. The strongest antibacterial activity of
kombucha tea was related to the presence of organic acid, such as the acetic acid found in kombucha
tea. This antibacterial activity displayed a significant level of inhibitory activity against all tested
bacteria. The studies by Dibner and Buttin [35] reported that organic acids displayed antimicrobial
activity and also displayed an inhibitory effect against acid-intolerant species such as E. coli, Salmonella
sp., and Campylobacter sp. that had been obtained from the guts of piglets. Weak organic acids, such
as acetic acid and benzoic acid, were reported to show antimicrobial activity since the organic acid
molecules could induce cytoplasmic acidification and destroy bacterial cells [36].
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Kombucha tea displayed a remarkable level of antimicrobial activity against a broad range of
microorganisms, which have demonstrated an ability to inhibit the growth of pathogens such as
Helicobacter pylori, Escherichia coli, Entamoeba cloacae, Pseudomonas aeruginosa, Staphylococcus aureus,
S. epidermidis, Agrobacterium tumefaciens, Bacillus cereus, Aeromonas hydrophila, Salmonella typhimurium,
S. enteritidis, Shigella sonnei, Leuconostoc monocytogenes, Yersinia enterocolitica, Campylobacter jejuni,
and Candida albicans [3,37]. Both acetic acid and catechins are known to inhibit a range of Gram-positive
and Gram-negative microorganisms [2]. Therefore, kombucha tea has been recognized as containing
active compound substances that could inhibit bacterial pathogens [23,38]. Battikh et al. [39] reported
that kombucha prepared from green tea could inhibit S. epidermidis, S. aureus, Micrococcus luteus,
S. typhimurium, E. coli, Listeria monocytogenes, and P. aeruginosa with diameters ranging from 12 to
22 mm, while kombucha prepared from black tea showed inhibition zones against these bacteria
ranging from 10.5 to 19 mm. Furthermore, other studies showed that antibacterial activities did not
exclusively from acetic acid or other organic acids such as citric acid, lactic acid, malic acid, and pyruvic
acid [40] but possibly from other biologically active components such as bacteriocins, proteins, enzymes,
and tea-derived phenolic compounds as well as tannins originally present in the tea broth that could
have been involved as antimicrobial substances [37,38].
In contrast, unfermented tea did not display any antimicrobial activity against the tested
microorganisms. This probably occurred because of the low concentrations of tea broth (1%, w/v) and
polyphenol levels. Thus, unfermented tea did not display any inhibitory effects against the tested
microorganisms [41]. In this study, neutralized kombucha did not display any inhibitory activity on all
tested bacteria. Therefore, the use of the kombucha tea will provide natural organic acids for health
benefits. The antibacterial activity of kombucha occurred from the acidity present in the kombucha tea.
The same result was obtained from the previous studies of Cetojevic-Simin et al. [42], all of whom
reported that neutralized kombucha prepared from black tea could not inhibit pathogenic bacteria.
In addition, heat-denatured kombucha tea prepared after boiling (100 ◦C, 20 min) and autoclaving
(121.5 ◦C for 15 min) inhibited all tested pathogenic enteric bacteria. These results confirm that the
antimicrobial components in the kombucha are thermostable. Moreover, heat-denatured kombucha tea
that was achieved by boiling could significantly inhibit bacteria more effectively than the heat-denatured
kombucha tea that had been autoclaved. The acidity of kombucha tea treated by boiling was maintained
and the amount of total acidity was significantly higher than in the kombucha tea that was treated by
autoclave. Moreover, the amount of total acidity present between heat-denatured kombucha tea by
boiling and kombucha tea without any treatment was not significantly different. In contrast, the total
acidity of kombucha tea that was treated by autoclave significantly decreased the amount of acidity
when compared to kombucha tea without any treatment. This phenomenon indicated that the acidity
activity of kombucha tea was reduced at high temperature by being autoclaved. This is particularly
noteworthy with regard to the pasteurization of kombucha tea beverages that were prepared to preserve
the potential antibacterial agents that are present in kombucha tea. Moreover, other components,
such as catechins, and the antioxidant activities recorded after the autoclaving of these tea drinks at
120 ◦C for 20 min also decreased [43].
Kombucha prepared from green, oolong, and black tea were found to display effective toxicity
against Caco-2 colorectal cancer cells. Interestingly, kombucha prepared from green tea and black tea
showed the specific toxicity on cancer cells. Therefore, this is a new report about the cytotoxicity effect
of kombucha prepared from different kinds of tea leaves on Caco-2 colorectal cancer cells. However,
toxicity test of kombucha tea on different types of cancer and normal cell lines should be further studied.
The major beneficial components of green tea, such as EGCG, restrained carcinogenesis in a
variety of tissues through the inhibition of mitogen-activated protein kinases, growth factor-related
cell signaling, activation of activator protein 1 and nuclear factor-B, topoisomerase I, and matrix
metalloproteinases along with other potential targets [44]. Previous reports have shown that kombucha
prepared from black tea contained dimethyl 2-(2-hydroxy-2-methoxypropylidene) malonate and
vitexin that caused certain cytotoxic effects on 786-O (human renal carcinoma) and U2OS (human
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osteosarcoma) cells by the reduction of cell invasion, cell motility, and matrix metalloproteinase
activity [45,46]. Moreover, kombucha tea was found to significantly decrease the survival rate
of prostate cancer cells by downregulating the expression of angiogenesis stimulators like matrix
metalloproteinase, cyclooxygenase-2, interleukin-8, endothelial growth factor, and human inducible
factor-1α [47]. The active substances of kombucha are associated with many of the compounds found in
each type of the tea leaves and are related to the acid production that occurs from the microorganisms.
Tea polyphenols in kombucha that are present in the tea leaves and during kombucha fermentation
were identified as anticancer substances. Tea polyphenols could inhibit the mechanisms of cancer
formation such as gene mutation and cancer cell proliferation. Notably, tea polyphenols also induced
the apoptosis of cancer cells and terminated cancer cell metastasis [48–50]. Both types of tea leaves that
had been infused (1%, w/v) and acidified in the kombucha tea showed the ability to inhibit Caco-2
colorectal cancer cells. In 2013, a study by Zhao et al. [51] showed that fermented and unfermented
specimens of Pu-erh tea and green tea could inhibit HT-29 colon cancer. Additionally, kombucha
prepared from green tea and black tea could inhibit A549 human lung carcinoma cells and Hep-2
epidermoid carcinoma, while kombucha prepared from black tea could inhibit Hep-2 cells [23].
In this study, acetic acid in kombucha displayed toxicity against Caco-2 cancer cells. However,
toxicity activities against cancer cells were also found to have occurred as a result of the presence of
other organic acids such as glucuronic, gluconic, DSL, ascorbic, acetic, and succinic acid. DSL had the
ability to inhibit the activity of glucuronidase enzymes, such as hydrolyzed glucuronides and produced
aglycones. Aglycones are known to be toxic substances that are able to induce normal cells to become
cancer cells [52]. Gluconic acid, glucuronic acid, lactic acid, and ascorbic acid are known to have the
ability to reduce the occurrence of stomach cancer [53]. Notably, kombucha prepared from black tea
was found to contain several organic acids. In this study, black tea revealed the lowest level of toxicity
on Caco-2 cells because of the presence of other components found in the black tea, such as thearubigins
and theaflavin, which were consistently degraded during kombucha fermentation. In contrast,
catechins in green tea and oolong tea were not degraded during kombucha tea fermentation [22].
Theaflavins in black tea have been reported to possess activity against carcinogenesis by interfering
with the signaling pathways and suppressing the transcription of certain oncoproteins [54]. Anticancer
and antibacterial activity decreased when kombucha tea was neutralized at pH 7.0 by adjustments with
NaOH. However, the anticancer components of kombucha tea were found to be thermostable after
the tea was heated by either boiling or by being autoclaved. Especially, kombucha tea prepared from
green and black tea after treatment by boiling at 100 ◦C for 20 min that also retained the cytotoxicity
effect to cancer cells. However, kombucha tea at 15 days of fermentation revealed low pH values
(2.70–2.94). Thus, kombucha tea should be prepared at a pH value of around 4.2 and should not
be consume in amounts of more than 4 oz per day [55]. This scientific research study clarified that
kombucha tea demonstrated the health benefits of effectively treating pathogenic enteric bacterial
infection, anti-oxidation, and toxicity to colorectal cancer cells, which might help to promote the
consumption of kombucha beverages among consumers.
5. Conclusions
In the present study, kombucha tea was fermented with a symbiotic culture of acetic acid bacteria
and yeasts that produced a significant amount of organic acids. The kombucha tea prepared from
different types of tea, namely green, oolong, and black tea, displayed significantly different values
of pH, total acidity, total soluble solids, and organic acid content. Moreover, the HPLC system for
the detection of several organic acids in kombucha tea was optimized in this study using the C18
conventional column. Isocratic elution buffer of 20 mM KH2PO4, pH 2.4 with 210 nm UV detector was
used as a new adaptive HPLC condition for organic acid detection. Kombucha prepared from black tea
at 15 days of fermentation showed the highest degree of organic acid content, such as with glucuronic,
gluconic, DSL, ascorbic, acetic, and succinic acids. These organic acids were found to be effective
against pathogenic enteric bacteria Escherichia coli, E. coli O157:H7, Shigella dysenteriae, Salmonella Typhi,
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and Vibrio cholera. They attributed to a large extent of the antibacterial effect observed to organic acids
because when neutralizing the kombucha samples, antibacterial effect was not observed. Moreover,
kombucha prepared from green tea and black tea demonstrated toxicity on Caco-2 colorectal cancer
cells. These findings indicate the greatest potential health benefits of kombucha tea with regard to
inhibiting pathogenic enteric bacteria and by promoting healthy function of the digestive system
in the gastrointestinal tract. In addition, kombucha displayed antioxidant activity against DPPH
radicals. Therefore, kombucha tea could be considered as a potential source of compounds presenting
antioxidant activity, inhibitory activity against pathogenic enteric bacteria and selective toxicity on
colorectal cancer cells.
Author Contributions: Conceptualization and Investigation, T.K., S.B., and Y.T.; Methodology, T.K., S.B., and Y.T.;
Formal analysis, T.K. and Y.T.; Writing—original draft preparation, T.K. and Y.T.; Writing—review and editing,
T.K. and Y.T.; Funding acquisition, Y.T.
Funding: This research study was supported by the Royal Golden Jubilee (RGJ) Ph.D. Program Scholarship, the
Thailand Research Fund, grant no. PHD/0061/2558; and was partially supported by the Center of Excellence
in Bioresources for Agriculture, Industry, and Medicine, Department of Biology, Faculty of Science, and The
Graduate School, Chiang Mai University, Chiang Mai, Thailand.
Acknowledgments: This research work was partially supported by Chiang Mai University. The Tea Gallery
Group (Thailand) Co., Ltd. and Chatchai Kitipornchai are also thoughtfully acknowledged. Department of
Medical Technology, Faculty of Associated Medical Sciences, Department of Biology, Faculty of Science, and The
Graduate School, Chiang Mai University, Chiang Mai, Thailand are also acknowledged.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Teoh, A.L.; Heard, G.; Cox, J. Yeast ecology of kombucha fermentation. Int. J. Food Microbiol. 2004, 95, 119–126.
[CrossRef] [PubMed]
2. Jayabalan, R.; Malbasa, R.V.; Loncar, E.S.; Vitas, J.S.; Sathishkumar, M. A review on kombucha tea—
Microbiology, composition, fermentation, beneficial effects, toxicity, and tea fungus. Compr. Rev. Food Sci.
Food Saf. 2014, 13, 538–550. [CrossRef]
3. Dufresne, C.; Farnworth, E. Tea, Kombucha, and health. Food Res. Int. 2000, 33, 409–421. [CrossRef]
4. Banerjee, D.; Hassarajani, S.A.; Maity, B.; Narayan, G.; Bandyopadhya, S.K.; Chattopadhyay, S. Comparative
healing property of kombucha tea and black tea against indomethacin induced gastric ulceration in mice:
Possible mechanism of action. J. Funct. Foods 2010, 1, 284–293. [CrossRef]
5. Bhattacharya, S.; Gachhui, R.; Sil, P.C. The prophylactic role of D-saccharic acid-1,4-lactone against
hyperglycemia-induced hepatic apoptosis via inhibition of both extrinsic and intrinsic pathways in diabetic
rats. J. Funct. Foods 2013, 4, 283–296. [CrossRef]
6. Yang, Z.W.; Ji, B.P.; Zhou, F.; Li, B.; Luo, Y.; Yang, L.; Li, T. Hypocholesterolaemic and antioxidant effects of
kombucha tea in high-cholesterol fed mice. J. Sci. Food Agric. 2009, 89, 150–156. [CrossRef]
7. Jigisha, A.; Nishant, R.; Navin, K. Green tea: A magical herb with miraculous outcomes. Int. Res. J. Pharm.
2012, 3, 139–148.
8. Peterson, J.; Dwyer, J.; Jacques, P.; Rand, W.; Prior, R.; Chui, K. Tea variety and brewing techniques influence
flavonoid content of black tea. J. Food Compos. Anal. 2004, 17, 397–405. [CrossRef]
9. Cooper, R.; Morre, D.J.; Morre, D.M. Medicinal benefits of green tea. J. Altern. Complement. Med. 2005, 11,
521–528. [CrossRef]
10. Sajilata, M.G.; Poonam, R.B.; Singhal, R.S. Tea polyphenols as nutraceuticals. Compr. Rev. Food Sci. Food Saf.
2008, 7, 229–254. [CrossRef]
11. Chu, S.C.; Chen, C. Effects of origins and fermentation time on the antioxidant activities of kombucha. Food
Chem. 2005, 98, 502–507. [CrossRef]
12. Talawat, S.; Ahantharik, P.; Laohawiwattanakul, S.; Premsuk, A.; Ratanapo, S. Efficacy of fermented teas in
antibacterial activity. Kasetsart J. 2006, 40, 925–933.
13. Srihari, T.; Satyanarayana, U. Changes in free radical scavenging activity of kombucha during fermentation.
Int. J. Pharm. Sci. Res. 2012, 4, 1978–1981.
126
Microorganisms 2019, 7, 700
14. Markov, S.L.; Malbasa, R.V.; Hauk, M.J.; Cvetkovic, D.D. Investigation of tea fungus microbe associations.
The Yeasts. Acta Period. Technol. 2001, 32, 133–138.
15. Miliauskas, G.; Venskutonis, P.R.; van Beek, T.A. Screening of radical scavenging activity of some medicinal
and aromatic plant extracts. Food Chem. 2004, 85, 231–237. [CrossRef]
16. Singhatong, S.; Leelarungrayub, D.; Chaiyasut, C. Antioxidant and toxicity activities of Artocarpus lakoocha
Roxb. Heartwood extract. J. Med. Plants Res. 2010, 4, 947–953.
17. Battikh, H.; Chaieb, K.; Bakhrouf, A.; Ammar, E. Antibacterial and antifungal activities of black and green
kombucha teas. J. Food Biochem. 2013, 37, 231–236. [CrossRef]
18. John, H.R.; Ferraro, M.J. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically,
9th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2012; pp. 12–34.
19. Umthong, S.; Phuwapraisirisan, P.; Puthong, S. In vitro antiproliferative activity of partially purified Trigona
laeviceps propolis from Thailand on human cancer cell lines. BMC Complement. Altern. Med. 2011, 11, 1–8.
[CrossRef]
20. Ross, P.; Mayer, R.; Benziman, M. Cellulose biosynthesis and function in bacteria. Microbiol. Rev. 1991, 55, 35–58.
21. Blanc, P.J. Characterization of the tea fungus metabolites. Biotechnol. Lett. 1996, 18, 139–142. [CrossRef]
22. Bauer-Petrovska, B.; Petrushevska-Tozi, L. Mineral and water soluble vitamin content in the Kombucha
drink. Int. J. Food Sci. Technol. 2000, 35, 201–205. [CrossRef]
23. Deghrigue, M.; Chriaa, J.; Battikh, H.; Abid, K.; Bakhrouf, A. Antiproliferative and antimicrobial activities of
Kombucha tea. Afr. J. Microbiol. Res. 2013, 7, 3466–3470.
24. Jain, A.; Manghani, C.; Kohli, S.; Nigam, D.; Rani, V. Tea and human health. Toxicol. Lett. 2013, 220, 82–87.
[CrossRef] [PubMed]
25. Horwitz, W. Official Methods of Analysis of AOAC International, 17th ed.; The Association of Official Analytical
Chemists (AOAC International): Gaithersburg, MD, USA, 2000.
26. Ilmara, V.; Raimonds, L.; Arturs, P.; Pavels, S. Glucuronic acid from fermented beverages: Biomedical
function in humans and its role in health protection. IJRRAS 2013, 14, 218–230.
27. Dipti, P.; Yogesh, B.; Kain, A.K.; Pauline, T.; Anju, B.; Sairam, M. Lead induced oxidative stress: Beneficial
effects of kombucha tea. Biomed. Environ. Sci. 2003, 16, 276–282.
28. Jayabalan, R.; Marimuthu, S.; Swaminathan, K. Changes in content of organic acids and tea polyphenols
during kombucha tea fermentation. Food Chem. 2007, 102, 392–398. [CrossRef]
29. Duenas, M.; Hernandez, T.; Estrella, I. Changes in the content of bioactive polyphenolic compounds of
lentils by the action of exogenous enzymes. Effect on their antioxidant activity. Food Chem. 2007, 101, 90–97.
[CrossRef]
30. Watawana, M.I.; Jayawardena, N.; Waisundara, V.Y. Value-added Tea (Camellia sinesis) as a functional food
using the Kombucha ‘Tea Fungus’. Chiang Mai J. Sci. 2018, 45, 136–146.
31. Hanausek, M.; Walasze, Z.; Slaga, T.J. Detoxifying cancer causing agents to prevent cancer. Integr. Cancer
Ther. 2003, 2, 139–144. [CrossRef]
32. Olas, B.; Saluk-Juszcak, J.; Nowak, P.; Glowacki, R.; Bald, E.; Wachowicz, B. Protective effects of d-glucaro
1,4-lactone against oxidative/nitrative modifications of plasma proteins. J. Nutr. 2007, 23, 164–171. [CrossRef]
33. Walaszek, Z.; Szemraj, J.; Hanausek, M.; Adams, A.K.; Sherman, U. d-Glucaric acid content of various fruits
and vegetables and cholesterol-lowering effects of dietary d-glucarate in the rat. Nutr. Res. 1996, 16, 673–681.
[CrossRef]
34. Saluk-Juszcak, J.; Olas, B.; Nowak, P.; Staron, A.; Wachowicz, B. Protective effects of d-glucaro 1,4-lactone
against oxidative modifications in blood platelets. Nutr. Metab. Cardiovasc. Dis. 2008, 18, 422–428. [CrossRef]
[PubMed]
35. Dibner, J.J.; Buttin, P. Use of organic acids as a model to study the impact of gut microflora on nutrition and
metabolism. J. Appl. Poult. Res. 2002, 11, 453–463. [CrossRef]
36. Ludovico, P.; Sansonetty, F.; Silva, M.T.; Corte-Real, M. Acetic acid induces a programmed cell death process
in the food spoilage yeast Zygosaccharomyces bailii. FEMS Microbiol. Lett. 2003, 3, 91–96. [CrossRef]
37. Sreeramulu, G.; Zhu, Y.; Knol, W. Characterization of antimicrobial activity in kombucha fermentation.
Acta Biotechnol. 2001, 21, 49–56. [CrossRef]
38. Sreeramulu, G.; Zhu, Y.; Knol, W. Kombucha fermentation and its antimicrobial activity. J. Agric. Food Chem.
2000, 48, 2589–2594. [CrossRef]
127
Microorganisms 2019, 7, 700
39. Battikh, H.; Bakhrouf, A.; Ammar, E. Antimicrobial effect of kombucha analogues. J. Food Sci. Technol.
2011, 47, 71–77. [CrossRef]
40. Hoffmann, N. The Ubiquitous Co-Enzyme UDP Glucuronic Acid Detoxifying Agent in Kombucha Tea.
2000. Available online: www.bluemarble.de/Norbert/kombucha/Glucuron/body_glucuron.htm (accessed on
1 July 2002).
41. Velicanski, A.S.; Cvetkovic, D.D.; Markov, S.L.; Tumbas, V.T.; Savatovic, S.M. Antimicrobial and antioxidant
activity of lemon balm kombucha. Acta Period. Technol. 2007, 38, 165–172. [CrossRef]
42. Cetojevic-Simin, D.D.; Bogdanovic, G.M.; Cvetkovic, D.D.; Velicanski, A.S. Antiproliferative and antimicrobial
activity of traditional Kombucha and Satureja montana L. Kombucha. J. BUON 2008, 13, 395–401.
43. Chen, Z.Y.; Zhu, Q.Y.; Tsang, D.; Huang, Y. Degradation of green tea catechins in tea drinks. J. Agric. Food
Chem. 2001, 49, 477–482. [CrossRef]
44. Chen, L.; Zhang, H.Y. Cancer preventive mechanisms of the green tea polyphenol (-)-Epigallocatechin-
3-gallate. Molecules 2007, 12, 946–957. [CrossRef] [PubMed]
45. Choi, H.J.; Eun, J.S.; Kim, B.G.; Kim, S.Y.; Jeon, H. Vitexin, an HIf-1α alpha inhibitor, has anti-metastatic
potential in PC12 cells. Mol. Cells 2006, 22, 291–299. [PubMed]
46. Jayabalan, R.; Chen, P.N.; Hsieh, Y.S.; Prabhakaran, K.; Pitchai, P.; Marimuthu, S.; Thangaraj, P.;
Swaminathan, K.; Yun, S.E. Effect of solvent fractions of kombucha tea on viability and invasiveness
of cancer cells-characterization of dimethyl 2-(2-hydroxy-2-methoxypropylidine) malonate and vitexin.
Indian J. Biotechnol. 2011, 10, 75–82.
47. Srihari, T.; Arunkumar, R.; Arunakaran, J.; Satyanarayana, U. Downregulation of signalling molecules
involved in angiogenesis of prostate cancer cell line (PC-3) by kombucha (lyophilized). Biomed. Prev. Nutr.
2013, 3, 53–58. [CrossRef]
48. Conney, A.H.; Lu, Y.P.; Lou, Y.R.; Huang, M.T. Inhibitory effects of tea and caffeine on UV-induced
carcinogenesis: Relationship to enhanced apoptosis and decreased tissue fat. Eur. J. Cancer Prev. 2002, 2, 28–36.
49. Ioannides, C.; Yoxall, V. Antimutagenic activity of tea: Role of polyphenols. Curr. Opin. Clin. Nutr. Metab.
Care 2003, 6, 649–656. [CrossRef]
50. Park, A.M.; Dong, Z. Signal transduction pathways: Targets for green and black tea polyphenols. J. Biochem.
Mol. Biol. 2003, 6, 66–77.
51. Zhao, X.; Song, J.L.; Kim, J.D.; Lee, J.S.; Park, K.Y. Fermented Pu-erh tea increases In Vitro anticancer activities
in HT-29 cells and has antiangiogenetic effects on HUVECs. J. Environ. Pathol. Toxicol. Oncol. 2013, 32, 275–288.
[CrossRef]
52. Wang, K.; Gan, X.; Tang, X.; Wang, S.; Tan, H. Determination of D-saccharic acid-1,4-lactone from brewed
kombucha broth by high performance capillary electrophoresis. J. Chromatogr. B 2010, 878, 371–374. [CrossRef]
53. Hemila, H.; Herman, Z. Vitamin C and the common cold: A retrospective analysis of chalmers review. J. Am.
Coll. Nutr. 1995, 14, 116–123. [CrossRef]
54. Weisburger, J.H.; Hara, Y.; Dolan, L.; Luo, F.Q.; Pittman, B.; Zang, E. Tea polyphenols as inhibitors of
mutagenicity of major classes of carcinogens. Mutat. Res. 1996, 371, 57–63. [CrossRef]
55. Centers for Disease Control and Prevention, CDC. Unexplained severe illness possibly associated with
consumption of kombucha tea—Iowa. MMWR-Morb. Mortal. Wkly. Rep. 1995, 44, 892–900.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Silver Nanoparticles against Foodborne Bacteria.
Effects at Intestinal Level and Health Limitations
Irene Zorraquín-Peña, Carolina Cueva, Begoña Bartolomé and M. Victoria Moreno-Arribas *
Institute of Food Science Research (CIAL), CSIC-UAM, C/Nicolás Cabrera 9, Campus de Cantoblanco,
28049 Madrid, Spain; irene.zorraquin@csic.es (I.Z.-P.); carolina.cueva@csic.es (C.C.); b.bartolome@csic.es (B.B.)
* Correspondence: victoria.moreno@csic.es; Tel.:+34-91-0017969; Fax: +34-910017905
Received: 5 December 2019; Accepted: 13 January 2020; Published: 17 January 2020
Abstract: Foodborne diseases are one of the factors that endanger the health of consumers, especially
in people at risk of exclusion and in developing countries. The continuing search for effective
antimicrobials to be used in the food industry has resulted in the emergence of nanotechnology in
this area. Silver nanoparticles (Ag-NPs) are the nanomaterial with the best antimicrobial activity and
therefore, with great potential of application in food processing and packing. However, possible
health effects must be properly addressed to ensure food safety. This review presents a detailed
description on the main applications of Ag-NPs as antimicrobial agents for food control, as well
as the current legislation concerning these materials. Current knowledge about the impact of the
dietary exposure to Ag-NPs in human health with special emphasis on the changes that nanoparticles
undergo after passing through the gastrointestinal tract and how they alter the oral and gut microbiota,
is also summarized. It is concluded that given their potential and wide properties against foodborne
pathogens, research in Ag-NPs is of great interest but is not exempt from difficulties that must be
resolved in order to certify the safety of their use.
Keywords: foodborne antimicrobials; silver nanoparticles; gut and microbiota; health
1. Introduction
It is estimated that there are 600 million cases of foodborne illnesses and 420,000 deaths annually
worldwide. Unsafe foods are a risk to human health and countries’ economy and mainly affect people
at risk of exclusion, migrants and population under conflicts. The majority of foodborne diseases
are related to pathogenic bacteria belonging to the genera Salmonella, Listeria, Escherichia, Clostridium
and Campylobacter. Microbial contamination of food can occur at different stages of the process,
such as harvesting, slaughtering, processing and distribution (“farm to fork”) and can be caused by
environmental contamination, such as water, soil or air [1]. The most common symptoms of foodborne
diseases are gastrointestinal, such as diarrhea, but other consequences may be kidney and liver failure,
brain and neural disorders, reactive arthritis and others. These diseases can be more severe in children,
pregnant women, the elderly and those with a weakened immune system [2]. Traditional techniques
such as salting, drying, freezing or fermentation are applied to extend the shelf life of food products,
but there may be risk of recontamination. Therefore, there is a continuous need for antimicrobial agents
that act in both food processing (preservation) and packaging (safety) stages [3].
In recent years, nanotechnology has experienced a noticeable rise in its applications, from agri-food
to biotechnology, going through the engineering, cosmetic and textile industry. It can be considered a
technological revolution [4]. Focusing on the field of food and health, nanotechnology is used in drug
delivery system and nutrient release systems (nanoencapsulation), increasing the rate of recognition
of disease symptoms and providing rapid treatments. It can also be applied to crops in the form of
fertilizers and nanoscale additives or create nanoscale sensors to detect chemical, viral or bacterial
contamination. In the case of food processing, it is a still emerging but promising technology [5].
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Nanomaterials can be natural, accidental or manufactured and can be constituted by loose particles,
aggregates or agglomerate in the form of nanoparticles, nanotubes, nanowires, nanofibers, and others.
Of these, nanoparticles (NPs), wherein 50% or more of them in the numerical granulometry have one
or more of the external dimensions between 1 and 100 nanometers, are possibly the most studied and
the ones having more variety of sizes and shapes, which results in a large number of technological
applications [6–8].
NPs are generally classified into organic and inorganic. Organic NPs incorporate carbon, whereas
inorganic NPs incorporate metallic (Ag, Au, Cu), magnetic (Co, Fe, Ni), and/or semi-conductor
components (ZnO, ZnS, CdS) [9]. Focusing our interest on silver nanoparticles (Ag-NPs), these have
been widely used in medicine and biotechnology fields, due to their properties as antimicrobials.
In this sense, numerous research studies have confirmed the effectiveness of Ag-NPs to inhibit the
growth of pathogenic bacteria such as Staphylococcus aureus, Streptococcus mutans, Streptococcus pyogenes,
Escherichia coli and Proteus vulgaris [10–12]. Interestingly, this activity has been also demonstrated using
Ag-NPs obtained by ‘biological methods’ which are considered a great tool to reduce the negative effects
associated with traditional nanoparticle synthesis commonly used in the laboratory [13]. In particular,
two recent studies have shown the antimicrobial activity of Ag-NPs from apple pomace and from
exopolysaccharides isolated from green microalgae against E. coli and S. aureus [14,15].
Shape, size, surface and charge are highlighted as the factors that influence the antimicrobial
properties of Ag-NPs (Figure 1). Regarding shape (i.e., triangular, decahedron, spherical, cubic,
platelet, among others), the spherical and the triangular forms seem to lead to higher antimicrobial
activity [16–18]. Size is one of the most important factors when synthesizing nanoparticles, 1 to 30 nm
being the most widely used range. Many studies have shown the size-dependent antibacterial activity
of Ag-NPs [19–22]. Concerning the nanoparticle surface, it may be modified through the addition
of coating agents, such as polymers (chitosan, polyethyleneimine, polyethylene glycol, polygamma
glutamic acid), proteins (milk casein, bovine serum albumin, human serum albumin), antioxidants
(glutathione) and/or polyvalent anion salts. Finally, the charge of the Ag-NPs determines their
interaction with biological environments and its cellular uptake, which leads to a modulation of its
antibacterial activity. Moreover, the antimicrobial activity of silver nanoparticles is bacteria strain- and
cell wall structure-dependent [23].
The mechanisms of action by which Ag-NPs exert their antimicrobial effects are not completely
clear, but two main hypothesis have been proposed: (i) a direct interaction of the nanoparticle with
the cell membrane, and (ii) the release of ionic silver [24]. In the first hypothesis, the Ag-NPs would
be adhered to the cell membrane via electrostatic attractions between the positive charges of the
nanoparticles and the negative charges of the cells [25] or via the interaction of the nanoparticles into
the sulfur and phosphorylated proteins present in the cell wall [26]. In any case, the interaction of
the Ag-NPs with the cell membrane would produce its partial dissolution (Figure 1). In the second
hypothesis, the Ag-NPs would enter into the cell and lead to a release of silver ions and the subsequent
increase of reactive oxygen species (ROS) that would damage the enzymes involved in the cellular
oxidation-reduction respiratory process and be finally responsible for cell death [16] (Figure 1). The two
hypotheses could occur together as it has been showed that after interaction of the nanoparticle with
the cell membrane, an internalization step takes place. In turn, this process can be affected by the
nanoparticle charge [27]. Despite the antimicrobial effectiveness, some bacterial resistance against silver
nanoparticles has been reported. Mechanisms such as negative regulation of porins, chromosomal
resistance genes or plasmids with resistance genes have been proposed. However, this is still a field
under study and more information to clarify this point at the frame of the food industry is clearly
needed [24,28].
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Figure 1. Main factors of influence and hypothetical mechanisms for the antimicrobial activity of
silver nanoparticles.
On the other hand, the increased incorporation of silver nanoparticles into consumer products
makes it essential to address their potential risk for human health. Nevertheless, there is still a lack of
knowledge about their specific aspects of the intestinal uptake of silver nanoparticles [5]. The oral route
of exposure has been poorly explored, despite the incorporation of such nanoparticles into packaging
in contact with foods. After their ingestion, these nanoparticles pass through the digestive tract, where
they may undergo physicochemical transformations, with consequences for the luminal environment,
before crossing the epithelial barrier to reach the systemic compartment. Therefore, Ag-NPs toxicity
and in particular, their effects at the gut level, are major concerns in the use and development of
these nanomaterials.
This review presents a detailed description on the main applications of silver nanoparticles as
antimicrobial agents for food control, as well as the current legislation concerning these materials.
In addition, we summarize current knowledge about the impact of the dietary exposure to silver
nanoparticles in human health with special emphasis in the gastrointestinal environment and microbiota,
and highlight the areas where information is lacking. Finally, conclusions and future directions about
both topics are summarized.
2. Applications of Antimicrobial Silver Nanoparticles in the Food Industry
Microbial food spoilage is a major global concern that can reduce the shelf life of food while
increasing the risk of foodborne diseases. In this framework, the use of well-known potent antimicrobial
agents such as silver nanoparticles constitutes an interesting approach. An overview of the effectiveness
of silver nanoparticles to inhibit the growth of different microorganisms is shown in Table 1.
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Among other relevant results, Silvan et al. [33] demonstrated the antibacterial effect of Ag-NPs
against multi-drug resistant (MDR) Campylobacter strains isolated from the chicken food chain and
clinical patients. In another study, nanoparticles synthesized through Forsythia suspensa fruit water
extract showed antibacterial activities against the most common foodborne pathogens, including
Listeria monocytogenes, Vibrio parahaemolyticus, Escherichia coli O157:H7 and Salmonella typhimurium [36].
Similarly, the Ag-NPs synthesized from jack fruit seeds showed an antibacterial effect against E. coli
and S. typhimurium [35]. The toxic effect of Ag-NPs synthesized using a bacterial exopolysaccharide as
a reducing and stabilizing agent against various food pathogens (L. monocytogenes, Aspergillus spp.
and Penicillum spp.) was also demonstrated [31]. Based on these promising results and in order to
improve the shelf life and safety of food, there are various food preservation and safety strategies in
which Ag-NPs have been employed (or proposed to be employed) in the food industry (Figure 2).
Specifically, in this section, we report on the last studies assessing the use of silver nanoparticles in
food processing and food packaging, and also the current regulation about it.
 
Figure 2. Classification of the use of Ag-NPs as antimicrobials in the food industry (adapted from
Singh et al. [39]).
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2.1. Food Processing (Preservation)
As feed additives, Ag-NPs has shown to be effective in the reduction of potentially pathogenic
organisms such as E. coli and Clostridium perfringens [40–43], which could reduce the use of antibiotics
in livestock [43]. Additionally, some Ag-NPs have also showed effective antiparasitic activity [44–46].
Ag-NPs have also been successfully applied in water treatment by incorporating them to filters
with foam or by impregnating ultrafiltration membranes [29,30]. Although the investigation of Ag-NPs
as a food additive is not very widespread, attractive attempts have been made to replace the use
of sulfur dioxide by the use of antimicrobial nanoparticles. This is the case in the wine industry.
For example, the effectiveness of a colloidal silver complex of a size < 1 nm was studied, managing to
control the growth of lactic acid bacteria [47,48]. Another study confirmed the antimicrobial activity of
two coated Ag-NPs against lactic acid bacteria and other microorganisms such as S. aureus and E. coli,
with potential application in winemaking [49].
2.2. Food Packaging (Safety)
Food packaging is one of the areas where nanoparticles research and use is most relevant. The need
of protection against foodborne diseases and the requirement of consumers to extend the useful life
of the products urged the development of antimicrobial food packaging, special packaging that
releases active biocide substances in order to improve the quality of the food [50]. The use of natural
substances, such as green tea and chilto extracts and essential oils in packaging materials has already
been investigated [51–53] but the use of Ag-NPs would be a more effective alternative because their
antimicrobial activity is greater than phytochemicals. Nanotechnology in food packaging can be
divided into three categories: (i) active packaging, (ii) ecofriendly packaging, and (iii) smart packaging,
although packaging combinations are also possible (i.e., active and ecofriendly packing). In active
packaging, the silver nanoparticles interact directly with the food or the environment polymer matrix
which can be a non-degradable polymeric film such as polyethylene (PE), polyvinyl chloride (PVC)
and ethylene vinyl alcohol (EVOH) or a biodegradable edible coating film made by a polymer or
a stabilizing agent (ecofriendly packaging). In addition, Ag-NPs offer a good stability and slow
release rates of silver ions in stored foods which makes them suitable candidates to be used in food
packaging [54]. In line with this, Yu et al. [38] demonstrated the antibacterial effect of a material
composed of Ag-NPs and cellulose nanofibrils against E. coli and L. monocytogenes. Similarly, silver
nanoparticles immobilized with laponite showed a good growth inhibitory activity against E. coli,
S. aureus, A. niger and P. citrinum [34]. Similar effects of silver nanoparticles against chicken meat (breasts
and sausages) were found. The bacterial growth of S. aureus, S. typhimurium decreased, although there
were also increases in cadaverine and thiamine [32,37]. On the other hand, the protective effect of
silver nanoparticles in long-term packaging of nuts has also been demonstrated. The 3% silver package
achieved a significant reduction in the presence of mold and coliforms and also achieved an antioxidant
effect. Finally, the silver nanoparticles had a significant effect on increasing the shelf life of nuts [55].
At the framework of food safety, smart packaging, that is, packing with biosensors for the detection
of pathogens represents a novel approach for food preservation, although still under development.
The operation mode is based on the union or reaction of biological components with target species
(microorganisms, toxins, etc.) and the transformation into detectable signals, which leads to the rapid
detection of food contaminants [56]. Examples can be found in studies such as Abbaspour et al. [57]
which described a selective sandwich biosensor for the detection of S. aureus. Combination of fluorescent
carbon points (CDF) with silver nanoparticles has been reported for the detection and elimination
of bacteria such as E. coli and S. aureus at low concentrations [58]. In the same way, the conjugated
polyelectrolytes (CPs)–silver nanostructure pair has showed a high detection power against E. coli [59].
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2.3. Regulation about Silver Nanoparticles Use in Foods and Food Industry Packaging (Safety)
The panel of the European Food Safety Agency (EFSA) on food additives and sources of nutrients
added to food determined that there is insufficient information on Ag to assess its risk and, therefore,
in the European Union (EU), Ag-NPs are not allowed in food supplements or food packaging unless
authorized. EFSA has also provided Ag migration limits from the packaging (<0.05 mg/L in water and
<0.05 mg/kg in food [60,61]. Therefore, manufacturers must carry out migration evaluations as well
as genotoxicity, absorption, distribution, metabolism and in vitro excretion tests [60,61]. With all this
information, EFSA will carry out a risk assessment of the specific case to determine if that package can
be marketed or not. To date there are no known products that have been approved. On the other hand,
in November 2015, Regulation (EU) 2015/2283 of the European Parliament and the European Council
on new foods was approved. In this regulation, it appears the definition of “artificial nanomaterial”
to include, within this new category (“novel foods”), all the foods that consist or contain artificial
nanomaterials [62]. In spite of this, Ag-NPs still do not appear in the legislation of allowed food
additives or in the materials in contact with food. Otherwise, in the United States, these regulations
are influenced by the existing regulatory restrictions on the release of silver to the environment and
are the responsibility of three agencies: the Environmental Protection Agency (EPA), the Food and
Drug Administration (FDA) and the agency of the Institute National Occupational Safety and Health
(NIOSH). The FDA published a guide for the use of nanotechnology in food or materials in contact
with them and recommended that manufacturers study and prepare a toxicological profile for each
container with nanomaterials [63,64].
As mentioned above, one of the problems of using these nanoparticles in food packaging is
silver migration. Echegoyén and Nerín [65] conducted an analysis of the form of silver migration,
whether ions or particles, into food simulants. They demonstrated that silver migrated to food and was
dependent on food and warming, with acidic foods and oven heating presenting a higher migration.
However, in their study, they found that Ag migration is well below the maximum migration limits
established by European Union legislation. However, other studies did not observe any temperature
or time-dependent increase in the migration of Ag packaged foods [66]. Gallocchio et al. [67] tested
a container with Ag-NPs to store chicken breasts and did not observe that the silver content of the
breasts was higher than that allowed by the EU.
3. Impact of Dietary Exposure to Silver Nanoparticles in Health: Gut Nanotoxicology Effects
As the investigation into the application of nanotechnology in the food sector increases, the
potential of nanotechnology in food science/industry also expands and consequently, so does the human
exposure to these substances. In the case of antimicrobial silver nanoparticles with application in food
industry, the subject of this review, the main human exposure source is through the oral-gastrointestinal
tract [68]. The mean dietary exposure level of Ag-NPs is estimated at 70–90 μg/day [69]. After ingestion,
the Ag-NPs come in contact with lumen of the oral cavity and esophagus. There is little published
information on the absorption rate of particulates through the epithelium of these two compartments,
probably due to both a low surface area and a short residence time for most food matrices [68]. After
that, during the gastrointestinal digestion process in the stomach and small intestine, the interaction
of Ag-NPs with biological fluids can lead to its agglomeration, aggregation, and dissolution [69–73].
In addition, silver nanoparticle absorption (transcellular and paracellular transport and vesicular
phagocytosis) through the gastrointestinal tract epithelium could take place. Finally, the nanoparticles
that escape the absorption process reach the colon where they could modulate the composition
and/or activity of gut microbiota, affecting the production and toxicity of bacterial metabolites [69].
Part of the initial intake of nanoparticles could be extracted in feces. According to the anatomy of
the gastrointestinal tract, several environments characterizdc by specific microbiota composition are
found. Gut microbiota harbors more than 100,000 billion microorganisms, including bacteria, fungi,
viruses, protozoa and archaea, with bacteria representing a majority. The dominant gut bacterial phyla
are the Firmicutes (including Clostridium, Enterococcus, Lactobacillus, and Ruminococcus genera) and
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Bacteroidetes (including Bacteroides and Prevotella genera). These bacteria play an important role in
the development and conservation of host health. Gut microbes play a role in human physiology
through several mechanisms, including their contribution to nutrient and xenobiotic metabolism (e.g.,
synthesis of vitamins, digestion of oligo, and polysaccharides, drugs, etc.) and to the regulation of
immune and neurodendocrine functions. Some of these effects are mediated by products of bacterial
metabolism, such as short-chain fatty acids (SCFA), including propionate, butyrate or acetate, which
influence the gut barrier, the inflammatory tone and the metabolic homeostatic control in different
tissues [74]. To date, little is known about the effect of nanoparticles on the intestinal microbiota, but
what is known is that there are numerous factors that can produce an imbalance in the intestinal
bacterial populations, like food, triggering certain diseases. That is why the investigation of the
NPs-gut microbiota relationship is so important and should continue [68,69].
The physical and chemical transformations of Ag-NPs during the gastrointestinal digestion could
involve modifications in their toxic effect. Despite the specific features of these particles and the
differences among them, they all display a close relationship between physicochemical reactivity
and bioavailability/biopersistence in the gastrointestinal tract. Recently, Mercier-Bonin et al. [68] and
Bouwmeester et al. [72] discussed the potential impact of the luminal and gastrointestinal environment
on nanomaterial properties and toxicity studies. In this section, with a specific focus on silver
nanoparticles, we report in vitro and in vivo studies considering both local and systemic levels effects,
with a particular emphasis on their impact on gut microbiota.
3.1. In Vitro Studies: Static and Dynamic Gut Simulators and Epithelium Cell Models
Today, several in vitro models, from cell models to static and dynamic gastrointestinal models can be
used alone or in combination for the study of Ag-NPs toxicity. As mentioned above, concentration/dose
is a very important factor for the use of nanoparticles as an antimicrobial agent in the food field.
In general, cytotoxicity of Ag-NPs is concentration-dependent. Moreover, depending on the cell type,
silver nanoparticles cytotoxicity varies notably, and this should be taken into consideration for their
application in consumer products [75]. As said above in relation to their antimicrobial activity, size,
shape, charge and surface are also factors that affect the cytotoxicity of these nanoparticles. Ag-NPs’
security depends on their state as they can form aggregates during their synthesis and use due to surface
charge or they are covered by a high viscosity substance or suspended in a high viscosity environment.
It has been shown that coated silver nanoparticles have lower cytotoxic due to the stabilization effect of
the coating, which in turn, depends on the coating material and the thickness of the layer [76,77].
Different studies have evaluated the cytotoxic effect of silver nanoparticles in various human cell
lines trying to understand the possible risks after exposure or ingestion (Table 2). However, today
there are not many studies that evaluated the effect of silver nanoparticles in the oral cavity and the
evaluation of the effect of these nanoparticles on oral microbiota is even more limited [68]. In one of
these studies, it was found that Ag-NPs increased oxidative stress, inflammation and apoptosis in the
human gingival fibroblast cell line (CRL-2014) [78]. Likewise, Niska et al. [79] observed that Ag-NP
induced cell death in a concentration-dependent manner, not being toxic until concentrations greater
than 40 μg/mL on human gingival fibroblasts (HGF-1). On the other hand, Hernández-Sierra et al. [80]
studied the effect of Ag-NPs of different sizes of periodontal fibroblasts extracted from volunteers.
They concluded that only nanoparticles with a size smaller than 20 nm increased the cytotoxicity of
fibroblasts. Another study with human periodontal fibroblasts, specifically with the cell line HPLF,
found that nanoparticles at low concentrations (≤16 μg/mL) had little influence on proliferation and cell
cycle, while at high concentrations (32 and 64 μg/mL), they inhibited cell proliferation and significantly
changed morphology [81]. The effect of Ag-NPs on oral bacteria has also been evaluated, with bacteria
of the genus Streptococcus being more sensitive to them [82]. In another work, it was observed how
the MIC and MBC of the silver nanoparticles was between 100 and 250 μg/mL for peri-implantitis
pathogens [83]. On the other hand, Lu et al. [19] reported a MIC range between 25 and 50 μg/mL and
this could be due to the smaller size of the nanoparticles used.
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Table 2. Studies regarding silver nanoparticles cytotoxicity effects in several cell lines.




<10 nm, 15–20 nm,
and 80–100 nm
Small-sized Ag-NPs (<20 nm)
increased cytotoxicity in cells in a
dose and time dependent manner.
[80]
Human gingival
fibroblast (CRL-2014) 2 nm
Ag-NPs increased oxidative stress,
inflammation and cell apoptosis. [78]
Human gingival
fibroblasts (HGF-1) 10 nm
All the nanoparticles tested were less
toxic and exerted a greater





Ag-NPs at low concentration did not
alter morphology or cell proliferation,
while at high concentration they
significantly altered morphology,





There were no significant differences
in cell viability between digested and
undigested nanoparticles up to a
concentration of 40 μg/mL. There was
a viability reduction (65%) when




16 nm in average
with sporadic
occurrence of
particles with a size
of around 80 nm
Ag-NPs did not affect the viability of
EpiOral and EpiGingival tissues. In
addition, the release of IL-1 decreased
significantly in EpiOral tissue. On the
other hand, exposure of the
EpiIntestinal tissue to gastric fluids
with or without AG-NPs produced a






After 24 h of exposure with Ag-NPS, a
decrease in dose-dependent cell
viability was observed (2–10 μg/mL).
A cytotoxicity of approximately 50%




cells (HT-29 and Caco-2)
and colon regular cells
(CCD-18)
10–50 nm
Cytotoxicity occurred in the cells at a




cells (Caco-2) ≈7.74 nm
In this work, there was no significant
decrease in cell viability after 24 h at a






Cellular uptake decreased when using
digested versus undigested Ag-NPs
and the nanoparticles coated with
lipolic acid dissolved to a greater






4–6 nm and 10–50 nm
for GSH-AgNPs
A significant decrease in cell viability
was observed by exposing cells to
digested nanoparticles (both coatings),
but not to undigested nanoparticles.
[74]
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Table 2. Cont.




25, 50 and 80 nm
Ag-NPs were more cytotoxic at lower
concentrations for a size of 25 and
40 nm. On the contrary, for a size of




cells (MCF-7) 20–80 nm
Ag-NPs caused apoptosis and
necrosis in a dose-dependent manner
to a concentration of 80 μg/mL. At
higher concentrations, the apoptotic




cells (HepG2) 10 and 100 nm
Ag-NPs at low doses increased
cell proliferation. [91]
Human breast epithelial
cells (MCF-7) 31.4 nm
Ag-NPs at a concentration of
60 μg/mL exhibited a cytotoxicity of
70% against the cell line. It was also
observed that AgNP were much less





Except for the sodium oleate and
sodium dodecyl sulfate solutions, the
rest prevented the aggregation of the
nanoparticles, stabilized them and did
not produce a significant cytotoxic
effect on the cells.
[76]
Unlike what happens with the oral cavity, there are numerous in vitro investigations on the effect
of silver nanoparticles in the intestine (Table 2). It was observed that the intake of Ag-NPs within
a food matrix increased its absorption by colon epithelial cells, the opposite being the case when
ingested without food. This shows us the ease with which nanoparticles can reach our intestines due
to their consumption along with food [84]. The toxicity difference between digested and undigested
silver nanoparticles was also studied. It was possible to verify how the undigested ones were mostly
captured by the cellular model Caco-2/HT29-MTX [88]. In the study of Silvan et al. [33], exposure
of GSH-Ag NPs to epithelial cells (HT-29, Caco-2 and CCD-18) showed a dose-dependent cytotoxic
effect and no significant cytotoxicity occurred until concentrations of 4.93 μg/mL. This is supported by
other works in which the toxicity of silver nanoparticles is usually in the range of 10 to 100 μg [93].
It was observed in the work of Vila et al. [87] that the exposure of small-sized Ag-NPs (≈ 8 nm) at a
concentration of 100 μg/mL only reached 20% cytotoxicity in Caco-2 cells. It was also shown that cell
integrity was not altered using concentrations below 50 μg/mL.
The toxicity of these nanoparticles has not only been studied on oral and intestinal cell lines. There
is a study in which non-cytotoxic doses of Ag-NPs were used against the HepG2 cell line. Moreover, at
low doses (2 and 4 mg/L), Ag-NPs presented “hormesis” effects by accelerating cell proliferation and
an activation of mitogen-activated protein kinase (MAPK) [91]. On the other hand, Khorrami et al. [92]
described a cytotoxicity level of 70%, at concentrations between 10 and 60 μg/mL, on the MCF-7
breast cancer cell line, while for the L-929 cell line (non-carcinogenic), it was only 15%. In another
study, the toxic effect of Ag-NPs on the MCF-7 cell line was also evaluated. Cellular cytotoxicity was
observed from a nanoparticle concentration of 10 μg/mL [90]. This is opening the door to the use
of this nanomaterial against cancer cells and therefore, to be a possible cancer therapy, alone or in
combination with other existing methods [86,94]. Other studies reported that Ag-NPs may interact
with the cerebral microvasculature producing a proinflammatory cascade in rat brain microvessel
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endothelial cells, as well as that larger NPs were less toxic, and blood–brain barrier (BBB) dysfunction
and astrocyte swelling causing neuronal degeneration [89,95].
In reference to static models of gastrointestinal digestion (Table 3), there is one study that showed
that Ag-NPs with a size of 60 nm and a concentration of 10 mg/mL (1661 particles/mL) in the presence of
proteins survived the extreme conditions of the digestion and reached the intestine [71]. This probably
means that epithelial cells of the intestine would be exposed to these nanoparticles, causing cellular
damage. On the contrary, in the absence of proteins, the fraction of NPs that reached the intestine was
smaller [71]. In other works they also studied the effect of nanoparticles during the passage through
the gastrointestinal tract. It was found that by contacting them with synthetic human stomach fluid,
the Ag-NPs aggregated significantly and also released ionic silver that was physically associated with
the aggregates of particles such as silver chloride. In addition, it was seen that NPs smaller than 10 nm
were added to a greater extent than larger one [96]. It was also demonstrated that depending on the
composition and pH, the morphology and the size of the Ag-NPs changed when passing through
the different fluids (simulated saliva and gastric and intestinal fluids); in addition, there was only
a low toxicity in a pilot study of reconstituted human tissues model [85]. When Ag-NPs interact
with proteins, a corona is always formed and it decreases the entry of nanoparticles into cells and
therefore, cellular toxicity decreases [97]. Gil-Sánchez et al. [74] evaluated the effect of static in vitro
digestion on silver nanoparticles with two types of coating. It was observed that the glutathione-coated
nanoparticles agglomerated less than those that had the polyethylene glycol coating and were less
toxic to colon cells. Studying the changes of NPs in dynamic models is more limited. In the work
of Cueva et al. [98], the dynamic gastrointestinal simulator simgi® was used to digest Ag-NPs and
study their effect on the colonic microbiota (Table 3). They did not observe changes in the bacterial
composition or in the production of ammonium ions during the simulations, so it was concluded
that Ag-NPs did not alter the composition and metabolic activity of the human intestinal microbiota.
Another dynamic study showed that 90% of Ag-NPs were already dissolved by passing through the
stomach and that many of the released ions bind to the food matrix. This results in less bioavailable
ions and therefore, less toxicity (Table 3) [73].
Table 3. Studies in in vitro static and gastrointestinal simulation models regarding silver nanoparticles
effects at gut level and microbiota.
Static/Dynamic Particle Size Main Results Reference
Static Ag-NPs 10–50 nm
The range of MIC and MBC for oral
bacteria was between 100 and
250 μg/mL. Of the four oral bacteria
tested, the most sensitive to silver
nanoparticles were Porphyromonas
gingivalis and Fusobacterium nucleatum.
[83]
Static Ag-NPs 5, 15 and 55 nm
In this work it was observed that for the
smaller nanoparticles the MIC was
between 25 and 50 μg/mL. Oral aerobic
bacteria were more susceptible than
anaerobic bacteria.
[19]
Static Ag-NPs 30–50 nm
A MIC between 15 and 90 μg/mL was
reported for the exposure of Ag-NPs
against 5 oral pathogens, much lower
than for chlorhexidine.
[82]
Static Ag-NPs 60 nm
AG-NPs of a size of 60 nm digested
under physiological conditions can
reach the wall of the intestine. It was
also observed that after ingestion of Ag
+ ions nanoparticles ended up forming.
[71]
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Table 3. Cont.
Static/Dynamic Particle Size Main Results Reference
Static Ag-NPs 10 and 75 nm
After the intake of Ag-NPs, these
nanoparticles can be aggregated and
chemically modified in the stomach
depending on the size and surface
chemistries.
[96]
Static Ag-NPs 10 nm
There was a reduction in the production
of capric and stearic fatty acids after
exposure of the human feces sample to
Ag-NPs, while palmitic acid increased.




16 nm in average with
sporadic occurrence of
particles with a size of
around 80 nm
The size and morphology of the Ag-NPs
changed due to the action of different
gastric fluids and digestive enzymes.
The study showed that nanoparticles
agglomerate and partially react to form
AgCl during exposure to fluids.
[85]
Static Ag-NPs 14 nm
A decrease in Bacteroidetes and an
increase in Firmicutes was observed,
resulting in an alteration of the
Firmicutes/Bacteroidetes ratio. Exposure






5–25 nm for PEG-AgNPs
20; 4–6 nm and 10–50 nm
for GSH-AgNPs
AgNPs agglomerated less and were less
toxic in colon cells than PEG-AgNPs 20. [74]
Dynamic Ag-NPs 15 and 40 nm
It was observed that 90% of the silver
nanoparticles had dissolved as they
passed through the stomach and the







3–5 nm and 10–25 nm for
PEG-AgNPs 20; 4–6 nm
and 10–50 nm for
GSH-AgNPs
Ingestion of Ag-NPs did not alter the
microbial composition of the intestine
or the metabolic activity of the bacteria.
It was also observed how during the
digestion the nanoparticle size was
predominantly 3–5 nm, although small
populations of agglomerates of these
small nanoparticles were found.
[98]
A limited number of studies on the interaction of nanomaterials with the microbiome are
available, most of them in rodents. In one in vitro study, it was observed that the Ag-NPs modified
the Firmicutes/Bacteroidetes phylum ratio, increasing Firmicutes and decreasing Bacteroidetes. It was
seen that the nanoparticles altered the intestinal microbiota as would a metabolic and inflammatory
disease [100]. On the other hand, after exposure of silver nanoparticles (10 nm) to a concentration
range of 0–100 μg/mL, a marked decrease in saturated fatty acids was observed, except in palmitic acid,
which increased by 26–32%. The observation of these variations led to the sequencing of bacterial DNA.
According to the results of Das et al. [99], Ag-NP ingestion, either deliberate or inadvertent, could
have negative consequences on our intestinal microbiota, as evidenced by a significant decreasing of
Bacteroidetes due to both ionic silver (AgCl; 25–200 mg/L) and nanosilver-mediated changes.
141
Microorganisms 2020, 8, 132
3.2. In Vivo Studies: Animal and Human Trials
When conducting studies in vivo, five main types of models have been used: rats, mice,
Caenorhabditis elegans, fish (zebrafish), Drosophila melanogaster and, in a lesser extent, human studies
(Table 4). Each model has its advantages and limitations, but all provide a great deal of information
that helps us to conclude facts. Within all these models, rats and mice may be the most used, but the
one that generates the most interest is the human model, since it provides real data when it comes to
human applications.
Table 4. In vivo studies regarding silver nanoparticles effects at gut level and microbiota, organs
and tissues.
Model Study Design Main Results Reference
C57BL/6N mice
Ag-NPs 29,3 nm Dose:
100 mg/kg, 500 mg/kg or
1000 mg/kg
The production of significant alterations of
selective genes in the caudate, frontal cortex
and hippocampus of mice was observed
after exposure to the nanoparticles. The
data concluded that nanoparticles can





Ag-NPs 60 nm; 28 days Four
groups (10 rats in each
group): vehicle control,




A dose-dependent increased accumulation
of Ag-NPs was observed in the lamina
propria in both the small and large intestine,
and also in the tip of the upper villi in the
ileum and protruding surface of the fold in
the colon. Rats that consumed
nanoparticles also released more anormal
mucus in the crypt lumen and ileal lumen
and there was also detachment of cells at
the tip of the villi.
[102]
F344 rats
Ag-NPs 56 nm; 13 weeks




and high-dose (500 mg/kg).
Significant dose-dependent changes were
found in alkaline phosphatase and
cholesterol, indicating that exposure to
more than 125 mg/kg of silver nanoparticles
may result in slight liver damage.
Histopathologic examination revealed a
higher incidence of bile-duct hyperplasia,
with or without necrosis. There was also a




Ag-NPs 3–20 nm; 21 days
Daily dose: 5, 10, 15 y
20 mg/kg
Mice treated with a dose of 10 mg/kg
showed great weight loss. It was found that
Ag-NPs damaged the microvilli of
epithelial cells and intestinal glands. This
may be the cause of weight loss due to
intestinal malabsorption.
[104]
Wistar rats Ag-NPs 10 nm; 14 daysDaily dose: 0.02 mg/kg
Ag-NPs intake produced a synaptic
degeneration and potential neuronal cell
death due to alterations in synaptic
structures and reduced levels of proteins




Ag-NPs 3–10 nm (98.7%),
10–30 nm (1.3%); 14 days
Daily dose: 1 mg/kg or
10 mg/kg Three groups
(6 rats in each group):
control group, low-dose
group (1 mg/kg), high-dose
group (10 mg/kg)
After ingestion of Ag-NPs, neuron
shrinkage, cytoplasmic or foot
inflammation of the astrocytes and
extravascular lymphocytes occurred. This
led to the conclusion that Ag-NPs can
induce neuronal degeneration and swelling
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Table 4. Cont.
Model Study Design Main Results Reference
C57BL/6NCrl
mice
Ag-NPs 110 nm and 20 nm
(PVP), 110 nm and 20 nm
(Citrate); 28 days
Daily dose: 10 mg/kg
None of the nanoparticles tested caused
alterations in the structure or diversity of




Ag-NPs 10, 75 and 100 nm;
13 weeks
Daily dose: 9, 18 and
36 mg/kg twice a day
It was possible to observe how the
nanoparticles produced changes in the
intestinal microbiota of the rats. There was
an increase in Gram-negative bacteria.
Exposure to smaller Ag-NPs resulted in a





Ag-NPs 12 nm; single
exposure and multiple
exposures over 30 days Daily
doses: 2000 and 250 mg/kg
for single and multiple
administrations,
respectively.
Single and multiple administrations
resulted in silver accumulation in the liver,
kidneys, spleen, stomach, and small
intestine. But, concentrations of silver
detected in tissues were far smaller than the
administered doses (<99%), indicating its
efficient excretion from the organism.
[109]
BALB/C mice
Ag-NPs 294 nm (NanoAg1)
and 122 nm (NanoAg 2);
3 days
Daily dose: 100 μL
suspension
The administration of NanoAg1 increased
the number of Clostridium perfringens and
Escherichia coli and decreased that of
Lactobacillus spp., But the results were not
significant. NanoAg2 acted in reverse. It
could also be seen how nanoparticle




Ag-NPs 55.17 nm; 28 days
Doses: 0 (control), 11.4, 114
and 1140 μg Ag-NP/kg
In this work, an increase in the
Firmicutes/Bacteroidetes ratio was
observed, similar to that described in





Ag-NPs 50 nm; 24 h
Dose: 0 (control), 2.5, 10, and
25 μg Ag-NPs/L
More silver accumulated in the brain than
in gills and liver at all concentrations. There
was also an increase in oxidative stress, as
well as damage to the enterocytes in fish
exposed to higher concentrations.
[112]
Zebrafish Ag-NPs 58.6 nm; 14 daysDose: 500 mg/kg twice a day
Despite not finding lesions in the integrity
of the intestinal epithelium, in this study it
was observed that Ag-NPs decreased to a




Ag-NPs 10, 40 and 100 nm;
4 days
Dose: 1, 5, 10, 50, 100, 150 y
200 ppm
It was observed that the salts and cations of
the medium decreased the dissolution of
the silver, thus limiting its action. Ag-NPs
with a size of 10 and 100 nm caused
developmental defects in the muscles and
intestine of the embryo, while those of 40
nm produced lethal effects.
[114]
Zebrafish
Ag-NPs 20 and 100 nm; 96 h
Dose: 0.61, 1.07, 0.67, and
1.28 mg/L
The coating of the nanoparticles increased
the survival rate of the fish compared to the
control. It was also observed that the
smaller Ag-NPs were more lethal than the
100 nm. More nanoparticles accumulated in
the intestines than in the gills.
[115]
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Table 4. Cont.
Model Study Design Main Results Reference
Caenorhabditis
elegans Ag-NPs 79 nm
The effect of silver nanoparticles for 10
generations of the nematode was studied.
From the second a pronounced sensitization




Ag-NPs 25 and 75 nm; 12 h
Dose: 5 mg/L
Exposure of E. coli to the nanoparticles and
of the nematode to E. coli induced





Ag-NPs <100; 40 h
Dose: 0, 1, 3, and 5 mg/kg
Different silver nanomaterials induce
growth inhibition and reproductive toxicity




elegans Ag-NPs ≈ 69 nm
Factors that increased sensitivity and
reproductive toxicity from the second
generation could not be verified. Therefore,
long-term risk cannot be assessed and other
inheritance mechanisms, such as





Dose: 10–100 μg Ag/mL
(accute intake) and 5 μg
Ag/mL (chronic exposure)
After the acute intake, a significant toxic
effect was observed at the concentration of
20 μg/mL and 50% of the flies could not
complete their development cycle. In the
case of the chronic exposure in 8
generations, a decrease in fertility was
observed in the first three generations, after





Dose: 10, 50, 100, 200 g/mL
All nanoparticles tested (synthesized from
different natural extracts) significantly
reduced the number of hatched larvae.
In addition, those synthesized from
mulberry, fig and olive produced a high




Ag-NPs 20–100 nm; 3,
10 and 30 days
Dose: 5, 25, 50 and 250 μg
Ag/mL
The effect of Ag-NPs depends on the dose
and the stage of development of the flies.
In general it alters the ability to lay eggs,





Ag-NPs 3.44 nm; 10 days
Dose: 0.016, 0.08, 0.4, 1 y
2 mM
The 10 nM dose was completely toxic.
Despite this, depigmentation was observed
at all concentrations. Significant levels of





Ag-NPs 5–10 nm (10 ppm) or
25–40 nm (32 ppm)
Study 1: 10 ppm with 3, 7,
and 14 day time periods
Study 2: 32 ppm for 14 days
Daily dose: 100 μg/day for
10 ppm, and 480 μg/day for
32 ppm
No significant changes were observed in
metabolism, hematology, urine, physical
findings, sputum morphology or changes
in images. Nor were statistically significant
changes detected in the markers of
hydrogen peroxide production or
peroxiredoxin protein expression. Instead,
silver could be detected in human serum.
[124]
Regarding the findings with rat and mice, several studies have been carried out to evaluate the
effect of these nanoparticles on the gastrointestinal tract. An abnormal mucus composition of the
intestines of the animals was observed, as well as pigmentation of the villi and discharge of mucus
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granules [102,103,109]. In another study, it was discovered that Ag-NP damaged the microvilli of
epithelial cells and intestinal glands in rats, thus decreasing the intestinal absorption of nutrients [104].
In the study by van den Brule et al. [111], by using Next Generation Sequencing (NGS), they observed
how the intake of dietary doses Ag-NPs during 28 d did not significantly alter, in a dose-dependent
manner, either the uniformity of the intestinal microbiota or populations in rats. But they could see
an increase in the relationship between Firmicutes and Bacteroidetes phyla. Human and mouse gut
microbiota are very similar at the phylum level, but not at the genera or species level; however, at
least at the phylum level, these results could be extrapolated to humans. It was also discovered
that the consumption of Ag-NPs modified the values of cholesterol and alkaline phosphatase in rats,
which indicated that exposure to these nanoparticles could cause mild liver damage [103]. Silver
nanoparticles are also easily able to cross the tight junction of the blood–brain barrier (BBB); therefore,
they can be considered as neurotoxic. Rahman et al. [101] showed a neurotoxic effect induced by
oxidative stress of Ag-NPs in three regions of the brain, including the caudate nucleus, the frontal
cortex and the hippocampus of adult mice. In addition, another study showed that Ag-NPs produced
neuronal degeneration and inflammation of astrocytes in the rat brain due to a low dose of exposure
by oral and intragastric administration [105,106].
There are studies with other animal models like fishes. After exposure of fish at Ag-NPs
concentrations of 2.5, 10, and 25 μg/L for 24 h, it was observed that the accumulation of silver in
the brain was greater than in the liver and gills. In addition, fish that were exposed to the highest
concentrations showed alterations in markers of oxidative stress [112]. In another study, various
sizes of Ag-NPs coated with gum arabic (10, 40 and 100 nm) were used. Zebrafish embryos were
exposed to various concentrations of these nanoparticles for 4 days and only an increase in lethality
was observed with the 40 nm nanoparticles. This could be because of the retention of silver in the
intestine depends on the particle size and the agglomerates [114]. In the same line is the work of
Liu et al. [115], in which they demonstrated that the particle size is more influenced by the toxicity
of Ag-NPs than the coating. Ag-NPs of small size (20 nm) and with citrate coating were more toxic
and the toxic effect was greater in the intestine than in the gills or muscles. Merrifield et al. [113]
showed, in adult zebrafish, that exposure to silver nanoparticles (500 mg/kg food) for 14 days had
no effect on the richness and diversity of the microbiota. Similarly, Wilding et al. [107] found that
the oral administration of silver nanoparticles of two different sizes (20 and 110 nm) and with two
different coatings (PVP and citrate) for 28 days (10 mg/kg bw/day) did not change the diversity of the
gut microbiome in mice. In another study, the effect of Ag-NPs in mouse models with inflammatory
bowel disease was evaluated. A decrease in inflammation and a positive modulation of the gut
microbiota could be observed [110]. By contrast, another study on rats fed twice-daily with oral silver
nanoparticles for 13 weeks at various doses (9, 18 and 36 mg/kg bw/day) reported a general increase in
the levels of Gram negative bacteria, and a decrease in the levels of Firmicutes [108]. It is important to
note that there are differences between the human and zebrafish and rodent microbiome. Moreover,
differences during gut transit and the interactions with the composition of the food matrix between
animals and humans can affect nanomaterial properties in a different way during digestive transit and
their putative effects.
There are also studies with Caenorhabditis elegans. In one of them, it was observed how the
reactive oxygen species in the nematode increased when exposed to E. coli contaminated with Ag-NPs.
They also increased reproductive toxicity and neurotoxicity [117]. Moon et al. [118] showed that the
presence of different silver nanomaterials (including nanoparticles) in the soil decreased the growth and
reproduction of C. elegans. Similarly, in another study, the hereditary reproductive toxicity produced by
Ag-NPs in C. elegans was demonstrated and it was observed that this toxicity contributed to inducing
germline mutations [116,119].
Finally, another of the most used non-human models is Drosophila melanogaster. In one of the
studies, the larvae were fed with silver nanoparticles, which were able to reach the intestinal barrier.
This was demonstrated by analyzing the increase in intracellular ROS [123]. Reproductive toxicity was
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also evaluated in this model. It was observed that exposure of adult specimens to Ag-NPs significantly
affected the ability to lay eggs along with a deteriorated ovarian growth [121,122]. In a study of acute
and chronic exposure, it was observed that the effect of a solution of Ag-NPs at a concentration of
20 ug/mL 50% of the larvae did not end their development cycle. In addition, after chronic exposure to
an Ag-Nps solution of 5 ug/mL, it was shown that after three generations, the flies adapted to silver,
recovering the fecundity lost in the first three [120].
As can be seen in the aforementioned paragraphs, Ag-NPs have been shown to have toxic effects
to both in in vitro and in vivo models; however, there is a limited number of studies that reported
the impacts of Ag-NPs on human health. One of them is the one carried out by Munger et al. [124].
A total of 60 healthy subjects ingested nanoparticles at concentrations of 10 and 32 ppm (Ag-NPs size:
5–10 nm) for 14 days. No significant changes were detected in the morphology of heart, lungs and
other organs, nor in the reactive oxygen species or in the generation of proinflammatory cytokines.
Nor did significant changes in metabolic measures appear in the conditions studied. The authors
stressed the need to evaluate the effects of longer-term exposure.
Because of the increased potential for consumer exposure to Ag NP, it appeared urgent to assess
the possible impact on the gut microbiota and on human health. As reviewed, few studies have
investigated this issue and none are conclusive. The differences of results between studies could be
related to the techniques used to analyze the microbiota. Moreover, it is difficult to make a comparison
between studies published today because different sizes, shapes and concentrations of nanoparticles
have been used. As a suggestion, future experiments should consider validated standards to ensure
more comparable results and thus, make more reliable conclusions. Moreover, the transfer of results
from animals to humans could be improved with the use of “humanized” animals by inoculation of
human gut microbiota as well as by investigations conducted with longer exposure durations to better
mimic human exposure scenarios.
4. Conclusions and Future Perspectives
Nanotechnology and specifically, silver nanoparticles, have a promising future ahead in the field
of food. Silver nanoparticles have demonstrated extensive antimicrobial activity against foodborne
pathogens as well as great effectiveness when they are incorporated into different types of packaging.
Today, most studies focusing on the use of Ag-NPs in packaging are at the laboratory level and in most
countries, are not allowed. In the European Union, in particular, more data are necessary to define the
regulation of their employment. Therefore, investigation of the use of nanoparticles as a food additive is
needed, as well as the evaluation of their effect on consumer health, since there are no long-term studies
that assess the real concerns of their consumption. Very few studies have focused on the relationships
between nanoparticles and oral microbiota, and, in the same way, effects of silver nanoparticles on the
composition of the intestinal microbiota and the consequences on their metabolic activity are largely
unknown. The range of models and diverse experimental conditions, such as in vitro, ex vivo and
in vivo approaches, animal models and control conditions, make it even more difficult to compare the
results and draw final conclusions. A crucial aspect for in vitro studies is to take care to incorporate the
changing physiochemical properties of silver nanoparticles during transit of the gastrointestinal tract
in the study design. It is also necessary to continue studying the different types of silver nanoparticles
including form, size distribution as well as dose and modes of administration/exposure of them to state
detrimental effects on health. Finally, the difficulties involved in the evaluation in vivo of the effects
of ingested nanoparticles in the gut, due to differences between species (rodents vs. humans), may
also be highlighted. Probable variability between individuals, not only in terms of the composition,
but also in terms of the functional metabolic properties of the microbiota, should also be taken into
account along with host physiological characteristics and environmental factors. In conclusion, given
their potential and wide properties against foodborne pathogens, research into silver nanoparticles is
of great interest for the food industry but is not exempt from difficulties that must be resolved in order
to certify the safety of their use.
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